Atorvastatin是一种口服活性HMG-CoA还原酶抑制剂,有效降低血脂。阿托伐他汀抑制人类SV-SMC增殖和侵袭的IC50值分别为0.39 μM和2.39 μM。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Atorvastatin inhibits pre-proET-1 mRNA expression in a concentration- and time-dependent fashion (60-70% maximum inhibition) and reduces immunoreactive ET-1 levels (25-50%), this inhibitory effect is maintained in the presence of oxidized LDL (1-50 mg/mL). Atorvastatin significantly reduces angiotensin II-induced and epidermal growth factor-induced ROS production in VSMCs. Atorvastatin downregulates mRNA expression of the NAD(P)H oxidase subunit nox1 in VSMCs, whereas p22phox mRNA expression is not significantly altered. Atorvastatin inhibits membrane translocation of rac1 GTPase, which is required for the activation of NAD(P)H oxidase. Atorvastatin (0.1 μM) significantly diminishes NF-κB activation induced by Ang II and TNF-α in mononuclear cells and VSMC. Atorvastatin (1 μM) diminishes MCP-1 expression induced by Ang II, TNF-α and is reversed by Mevalonate only in Ang II-stimulated cells. Atorvastatin (1 μM) diminishes IP-10 expression induced by Ang II and by TNF-α in VSMC, and this reduction is partially reversed by Mevalonate. Atorvastatin and Gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation.[1-2] |
Dose | Rats: 10 mg/kg, max = 20 mg/kg[3] |
Administration | p.o. |
Toxicity (LD50) | Rats: 40 mg/kg p.o.[3] |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00768638 | Chronic Kidney Disease | Phase 4 | Completed | - | Canada ... 展开 >> Hôtel-Dieu de Québec Hospital Quebec, Canada, G1R2J6 收起 << |
NCT02497638 | Prostate Cancer | Phase 2 | Not yet recruiting | December 2022 | Canada, Ontario ... 展开 >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Principal Investigator: Robert Hamilton, MD, MPH, FRCSC Principal Investigator: Neil Fleshner, MD, MPH, FRCSC 收起 << |
NCT00974740 | Type 1 Diabetes | Phase 1 | Terminated(for lack of recruit... 展开 >>ment) 收起 << | - | Germany ... 展开 >> Diabetes-Zentrum Mergentheim Bad Mergentheim, Germany, 97980 Gemeinschaftskrankenhaus Havelhöhe Berlin, Germany, 14089 Helios Klinikum Emil von Behring Berlin, Germany, 14165 Praxis Dr. Friedhelm Schmitten Bestwig-Ramsbeck, Germany, 59909 DDZ Deutsches Diabetes Zentrum Düsseldorf, Germany, 40221 St. Josefs Krankenhaus Heidelberg, Germany, 69115 St. Antonius Krankenhaus, Med. Klinik Köln, Germany, 50968 Praxisklinik Leipzig Leipzig, Germany, 04103 Praxis Dr. Gerhard Willms Leverkusen, Germany, 51373 Praxis Dr. Heinz-Georg Ley Marl, Germany, 45770 Diabetologische Schwerpunktpraxis, Angiologie Münster, Germany, 48145 Praxis Dr. Werner Stürmer Würzburg, Germany, 97070 收起 << |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.79mL 0.36mL 0.18mL |
8.95mL 1.79mL 0.90mL |
17.90mL 3.58mL 1.79mL |
CAS号 | 134523-00-5 |
分子式 | C33H35FN2O5 |
分子量 | 558.64 |
别名 | 阿伐他汀 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,2-8°C |
溶解度 |
DMSO: 50 mg/mL(89.5 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |
Tags: Atorvastatin | 阿伐他汀 | HMGCR | AmBeed-信号通路专用抑制剂 | Atorvastatin 纯度/质量文件 | Atorvastatin 生物活性 | Atorvastatin 动物研究 | Atorvastatin 临床数据 | Atorvastatin 参考文献 | Atorvastatin 实验方案 | Atorvastatin 技术信息
请填写此表格索取QC报告。我们很快就会发送到您的邮箱。您的信息在我们这里是安全的。*是必填项.
靶点 | 数值 |
需要的总药量: mg
您需要配制的工作液浓度为:mg/mL
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00768638 | Chronic Kidney Disease | Phase 4 | Completed | - | Canada ... 展开 >> Hôtel-Dieu de Québec Hospital Quebec, Canada, G1R2J6 收起 << |
NCT02497638 | Prostate Cancer | Phase 2 | Not yet recruiting | December 2022 | Canada, Ontario ... 展开 >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Principal Investigator: Robert Hamilton, MD, MPH, FRCSC Principal Investigator: Neil Fleshner, MD, MPH, FRCSC 收起 << |
NCT00974740 | Type 1 Diabetes | Phase 1 | Terminated(for lack of recruit... 展开 >>ment) 收起 << | - | Germany ... 展开 >> Diabetes-Zentrum Mergentheim Bad Mergentheim, Germany, 97980 Gemeinschaftskrankenhaus Havelhöhe Berlin, Germany, 14089 Helios Klinikum Emil von Behring Berlin, Germany, 14165 Praxis Dr. Friedhelm Schmitten Bestwig-Ramsbeck, Germany, 59909 DDZ Deutsches Diabetes Zentrum Düsseldorf, Germany, 40221 St. Josefs Krankenhaus Heidelberg, Germany, 69115 St. Antonius Krankenhaus, Med. Klinik Köln, Germany, 50968 Praxisklinik Leipzig Leipzig, Germany, 04103 Praxis Dr. Gerhard Willms Leverkusen, Germany, 51373 Praxis Dr. Heinz-Georg Ley Marl, Germany, 45770 Diabetologische Schwerpunktpraxis, Angiologie Münster, Germany, 48145 Praxis Dr. Werner Stürmer Würzburg, Germany, 97070 收起 << |
NCT02979704 | Hyperlipidemia | Phase 2 Phase 3 | Unknown | July 2017 | Bangladesh ... 展开 >> BSMMU Recruiting Dhaka, Bangladesh Contact: Samia Tonu, MBBS +8801769350011 tonusamia@gmail.com Contact: Nargis Akhter, Mphill, MSc +880152391036 nargisakhter@hotmail.com 收起 << |
NCT03460808 | Immune Thrombocytopenia | Phase 1 Phase 2 | Not yet recruiting | January 1, 2023 | China, Beijing ... 展开 >> Peking University Insititute of Hematology, Peking University People's Hospital Not yet recruiting Beijing, Beijing, China, 100044 Contact: Xiao-hui Zhang, Professor zhangxh100@sina.com 收起 << |
NCT00653588 | Hypercholesterolemia ... 展开 >> Coronary Heart Disease 收起 << | Phase 3 | Completed | - | - |
NCT02023892 | Endothelium H... 展开 >>ydroxymethylglutaryl-CoA Reductase Inhibitors 收起 << | Phase 4 | Unknown | - | - |
NCT00469326 | Coronary Artery Disease | Phase 3 | Completed | - | Czech Republic ... 展开 >> Department of Cardiology, CardioVascular Center, University Hospital Motol Prague, Czech Republic, 150 18 收起 << |
NCT01765023 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Inje University Pusan Paik Hospital Busan, Korea, Republic of, 614-735 收起 << |
NCT00637481 | Atypical Ductal Breast Hyperpl... 展开 >>asia Breast Cancer Ductal Breast Carcinoma in Situ Lobular Breast Carcinoma in Situ 收起 << | Phase 1 | Completed | - | United States, Texas ... 展开 >> M D Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT02355704 | Renal Insufficiency | Phase 3 | Completed | - | Mexico ... 展开 >> Western Medical Center, Mexican Institute of Social Security Guadalajara, Jalisco, Mexico, 44340 收起 << |
NCT01096875 | Coronary Artery Bypass Surgery... 展开 >> Elective Surgical Procedure 收起 << | Phase 4 | Completed | - | Turkey ... 展开 >> Ankara University Medical Faculty, Department of Cardiovascular Surgery Ankara, Cebeci, Turkey, 06340 收起 << |
NCT03037372 | HIV Infection | Phase 3 | Not yet recruiting | December 31, 2022 | - |
NCT01096875 | - | Completed | - | - | |
NCT01351025 | HIV-1 Infection | Phase 2 | Completed | - | - |
NCT01929135 | - | Completed | - | - | |
NCT01351025 | - | Completed | - | - | |
NCT00758004 | Hypercholesterolemia | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 收起 << |
NCT01547455 | Acute Kidney Injury | Not Applicable | Completed | - | China, Beijing ... 展开 >> Cardiovascular Institute&Fuwai Hospital Beijing, Beijing, China, 100037 收起 << |
NCT00361283 | Inflammation | Phase 4 | Completed | - | United States, Florida ... 展开 >> University of Florida Gainesville, Florida, United States, 32610 收起 << |
NCT00361283 | - | Completed | - | - | |
NCT01929135 | Chronic Periodontitis | Phase 2 | Completed | - | Chile ... 展开 >> Centro de Salud Universidad de los Andes, San Bernardo Santiago, Región Metropolitana, Chile CIBRO Universidad de los Andes Santiago, Región Metropolitana, Chile 收起 << |
NCT00979940 | - | Terminated(Slower than anticip... 展开 >>ated enrollment for pilot study.) 收起 << | - | - | |
NCT01072097 | Polycystic Ovary Syndrome | Not Applicable | Completed | - | Finland ... 展开 >> Department of Obstetrics and Gynaecology, University of Oulu Oulu, Finland, 90014 收起 << |
NCT00777517 | Hypercholesterolemia | Phase 1 | Completed | - | Singapore ... 展开 >> Pfizer Investigational Site Singapore, Singapore, 188770 收起 << |
NCT00808717 | Myocardial Infarction ... 展开 >> Angioplasty Percutaneous Coronary 收起 << | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Severance Hospital Seoul, Korea, Republic of, 120-752 收起 << |
NCT01013103 | Coronary Artery Disease ... 展开 >> HMG-CoA Reductase Inhibitor Toxicity Atherosclerosis Oxidative Stress Endothelial Dysfunction 收起 << | Phase 4 | Completed | - | Greece ... 展开 >> Hippocration Hospital, Athens University Medical School Athens, Attiki, Greece, 115 28 收起 << |
NCT02166593 | Combined Dyslipidemia | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of 收起 << |
NCT01570530 | Atrial Fibrillation | Phase 3 | Terminated(End of finantial su... 展开 >>pport) 收起 << | - | Spain ... 展开 >> Hospital Clínico Universitario de Valladolid Valladolid, Spain, 47005 收起 << |
NCT01974297 | Mixed Hyperlipidemia | Not Applicable | Unknown | July 2014 | Korea, Republic of ... 展开 >> Severance Hospital, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of Contact: Sang-Hak Lee, PhD 82-2-2228-8456 SHL1106@hanmail.net Contact: Jiyeong Jeong, bachelor 82-2-2228-8277 jiyoung112@yuhs.ac Principal Investigator: Sang-Hak Lee, PhD 收起 << |
NCT02452502 | Stroke | Phase 4 | Unknown | July 2017 | China, Jilin ... 展开 >> Jilin First Hospital Not yet recruiting Changchun, Jilin, China Contact: Zhenni Guo, M.D. zhen1ni2@163.com Principal Investigator: Yi Yang, M.D. China, Zhejiang Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310009 Contact: Min Lou, Ph.D 8657187784811 loumingxc@vip.sina.com 收起 << |
NCT01175148 | Graft vs Host Disease | Phase 2 | Completed | - | United States, West Virginia ... 展开 >> West Virginia University Hospitals Mary Babb Randolph Cancer Center Morgantown, West Virginia, United States, 26506 收起 << |
NCT01980823 | Breast Cancer ... 展开 >> Breast Tumors Cancer of Breast 收起 << | Early Phase 1 | Recruiting | April 2018 | United States, New York ... 展开 >> Columbia University Medical Center - Herbert Irving Cancer Center Recruiting Manhattan, New York, United States, 10032 Contact: Dan Otap 212-342-0937 do2267@cumc.columbia.edu Principal Investigator: Kevin Kalinsky, MD 收起 << |
NCT01175148 | - | Completed | - | - | |
NCT00185731 | Leukemia Lymp... 展开 >>homa, Non-Hodgkin 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 << |
NCT00414531 | Myotoxicity of Atorvastatin Tr... 展开 >>eatment 收起 << | Phase 4 | Completed | - | Norway ... 展开 >> Rikshospitalet-Radiumhospitalet HF, Lipid clinic Oslo, Norway, 0027 收起 << |
NCT00185731 | - | Completed | - | - | |
NCT01997294 | Acute Myocardial Infarction | Not Applicable | Unknown | February 2017 | China, Shanghai ... 展开 >> Ruijin Hospital, Dept. of Cardiology Shanghai, Shanghai, China, 200025 收起 << |
NCT00979940 | Coronary Artery Disease | Not Applicable | Terminated(Slower than anticip... 展开 >>ated enrollment for pilot study.) 收起 << | - | United States, Indiana ... 展开 >> Methodist Hospital Indianapolis, Indiana, United States, 46202 Wishard Hospital Indianapolis, Indiana, United States, 46202 收起 << |
NCT02470455 | - | Completed | - | India ... 展开 >> SCB Medical College Cuttack, Odisha, India, 752001 收起 << | |
NCT00529191 | Type 1 Diabetes | Phase 2 | Completed | - | United States, Pennsylvania ... 展开 >> Diabetes Center for Children & Clinical Translational Research Center Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT01527097 | Psoriasis | Phase 3 | Withdrawn(We strongly feel tha... 展开 >>t the ability to recruit the required number of patients is very low and thus decided to stop the study.) 收起 << | - | Israel ... 展开 >> Rabin Medical Center, Beilinson Hospital Petach Tikva, Israel, 49100 收起 << |
NCT00911339 | Stable Coronary Artery Disease | Phase 3 | Unknown | April 2010 | Italy ... 展开 >> Fondazione Irccs Policlinico San Matteo Pavia, Italy, 27100 收起 << |
NCT01491958 | Acute Myelogenous Leukemia ... 展开 >> Acute Lymphocytic Leukemia Myelodysplastic Syndrome 收起 << | Phase 2 | Completed | - | United States, Ohio ... 展开 >> Ohio State University Columbus, Ohio, United States, 43210 收起 << |
NCT01058057 | Coronary Artery Disease ... 展开 >> Coronary Angioplasty 收起 << | Phase 3 | Unknown | - | Czech Republic ... 展开 >> Dpt. of Cardiology, University Hospital Motol Recruiting Prague, Czech Republic, 15018 Contact: David Zemanek, MD +420608921566 zejada@seznam.cz 收起 << |
NCT01491958 | - | Completed | - | - | |
NCT02522117 | Renal Insufficiency | Phase 3 | Completed | - | Mexico ... 展开 >> Western Medical Center, Mexican Institute of Social Security Guadalajara, Jalisco, Mexico, 44340 收起 << |
NCT01645449 | Healthy | Phase 1 | Completed | - | Germany ... 展开 >> Nuvisan Pharma Services GmbH & Co. KG Neu-Ulm, Germany, 89231 收起 << |
NCT00529191 | - | Completed | - | - | |
NCT00441597 | Ischemia Reperfusion Injury ... 展开 >> Cardiovascular Disease 收起 << | Phase 4 | Completed | - | Netherlands ... 展开 >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500 HB 收起 << |
NCT01447797 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Korea University Anam Hospital Seoul, Korea, Republic of 收起 << |
NCT01250834 | Healthy Volunteers | Phase 1 | Completed | - | United Kingdom ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leeds, West Yorkshire, United Kingdom, LS2 9LH 收起 << |
NCT03066466 | Acute Myeloid Leukemia ... 展开 >> Acute Lymphocytic Leukemia Myelodysplastic Syndrome 收起 << | Phase 3 | Recruiting | February 28, 2021 | United States, Illinois ... 展开 >> Loyola University Medical Center Recruiting Maywood, Illinois, United States, 60153 Contact: Patrick Stiff, MD 708-327-3148 pstiff@lumc.edu Contact: Mary Lee, RN 708-327-2241 mlee@luc.edu 收起 << |
NCT01645423 | Healthy | Phase 1 | Completed | - | India ... 展开 >> Veeda Clinical Research Pvt. Ltd., Ahmedabad, Gujrat, India, 3 80015, 收起 << |
NCT03461081 | Hypertension With Hyperlipidem... 展开 >>ia 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of 收起 << |
NCT02659397 | Hyperlipidemia | Phase 2 | Completed | - | United States, California ... 展开 >> Anaheim, California, United States, 92801 Los Angeles, California, United States, 90057 Northridge, California, United States, 91324 United States, Florida Clearwater, Florida, United States, 33765 Jacksonville, Florida, United States, 32216 Miami, Florida, United States, 33126 Port Orange, Florida, United States, 32127 United States, Idaho Boise, Idaho, United States, 83642 United States, Illinois Chicago, Illinois, United States, 60607 Springfield, Illinois, United States, 62711 United States, Kentucky Louisville, Kentucky, United States, 40213 United States, New Jersey Berlin, New Jersey, United States, 08009 United States, South Dakota Rapid City, South Dakota, United States, 57701 United States, Texas Carrollton, Texas, United States, 75006 United States, Utah West Jordan, Utah, United States, 84088 United States, Virginia Arlington, Virginia, United States, 22203 Lynchburg, Virginia, United States, 24501 Richmond, Virginia, United States, 23294 United States, Washington Renton, Washington, United States, 98057 收起 << |
NCT02192320 | Chronic Subdural Hematoma | Phase 2 | Unknown | September 2015 | China, Beijing ... 展开 >> Beijing Anzhen Hospital, Capital Medical University Not yet recruiting Beijing, Beijing, China, 100029 China, Tianjin Tianjin Medical University General Hospital Not yet recruiting Tianjin, Tianjin, China, 300052 收起 << |
NCT01946815 | Coronary Artery Disease | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Ulsan University Hospital Ulsan, Gyeongbuk, Korea, Republic of Inje University Ilsan Paik Hospital Ilsan, Kyeongki, Korea, Republic of Keimyung University Dongsan Medical center Daegu, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of 收起 << |
NCT01257009 | Stable Chronic Kidney Disease ... 展开 >> Hypertension 收起 << | Phase 4 | Completed | - | Netherlands ... 展开 >> University Medical Center utrecht Utrecht, Netherlands, 3584CX 收起 << |
NCT01785615 | - | Completed | - | - | |
NCT01250834 | - | Completed | - | - | |
NCT00739999 | Pediatric Heterozygous Hyperch... 展开 >>olesterolemia 收起 << | Phase 1 | Completed | - | Canada ... 展开 >> Pfizer Investigational Site Quebec, Canada, G1V 4G2 Greece Pfizer Investigational Site Athens, Greece, 115 27 Norway Pfizer Investigational Site Oslo, Norway, 0027 收起 << |
NCT01086020 | Coronary Artery Disease | Phase 4 | Unknown | December 2012 | China, Shanghai ... 展开 >> Ruijin Hospital, Recruiting Shanghai, Shanghai, China, 200025 Contact: Ruiyan Zhang, MD 862164370045 ext 665215 zhangruiyan@263.net Contact: Xin Chen, MD 862164370045 ext 665380 rjchenxin@yahoo.com.cn Principal Investigator: Ruiyan Zhang, MD 收起 << |
NCT00739999 | - | Completed | - | - | |
NCT02749578 | Healthy | Phase 1 | Completed | - | United States, Arizona ... 展开 >> Celerion Tempe, Arizona, United States, 85283 收起 << |
NCT01322711 | Type 2 Diabetes Mellitus ... 展开 >> Hypercholesterolemia 收起 << | Phase 4 | Unknown | December 2015 | Italy ... 展开 >> Stefania Basili Rome, Italy, 00161 收起 << |
NCT01503671 | Heart Failure | Phase 4 | Unknown | October 2015 | Taiwan ... 展开 >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Cho-Kai Wu, MD 886-23123456 ext 62152 chokaiwu@yahoo.com.tw Principal Investigator: Cho-Kai Wu, MD Sub-Investigator: Jenq-Wen Huang, MD Sub-Investigator: Chia-Ti Tsai, MD, PhD 收起 << |
NCT01785615 | Metabolic Syndrome | Phase 1 Phase 2 | Completed | - | United States, New York ... 展开 >> University of Rochester Medical Center Rochester, New York, United States, 14642 收起 << |
NCT00435045 | Hypertriglyceridemia | Phase 3 | Completed | - | - |
NCT01341730 | Atherosclerosis ... 展开 >> Coronary Artery Disease 收起 << | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Cardiovascular center, Seoul St. Mary's hospital Seoul, Korea, Republic of, 137-701 收起 << |
NCT01491256 | Acute Coronary Syndrome | Not Applicable | Unknown | February 2012 | Korea, Republic of ... 展开 >> Kangwon National University Hospital Recruiting Chuncheon, Korea, Republic of, 200-722 Contact: Bong-Ki Lee, MD, PhD +82-10-6373-9290 nicedr@nate.com Principal Investigator: Bon-Kwon Koo, MD, PhD Principal Investigator: Chang-WooK Nam, MD, PhD Principal Investigator: Seung-Woon Rha, MD, PhD Principal Investigator: Joon-Hyung Doh, MD, PhD Principal Investigator: Woo-Young Chung, MD, PhD Principal Investigator: Seung-Jae Tahk, MD, PhD Principal Investigator: Jin-Bae Lee, MD, PhD Principal Investigator: Ki-Dong Yoo, MD, PhD 收起 << |
NCT02910778 | Ischemia | Phase 4 | Completed | - | Austria ... 展开 >> Medical University of Vienna, Department of Clinical Pharmacology Vienna, Austria, 1090 收起 << |
NCT00435045 | - | Completed | - | - | |
NCT01115985 | Healthy Pharm... 展开 >>acokinetics of Atorvastatin 收起 << | Phase 1 | Completed | - | Japan ... 展开 >> Tokyo, Japan 收起 << |
NCT02133534 | - | Terminated(failure to enroll) | - | - | |
NCT02197065 | - | Completed | - | - | |
NCT01842256 | Essential Hypertension ... 展开 >> Hyperlipidemia 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Severance Hospital Seoul, Korea, Republic of 收起 << |
NCT02197065 | Hip Fracture ... 展开 >>Myocardial Ischemia Inflammation 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> Hospital for Special Surgery New York, New York, United States, 10021 New York Presbyterian Hospital (Cornell) New York, New York, United States, 10065 收起 << |
NCT01555632 | Recurrent Prostate Cancer ... 展开 >> Stage I Prostate Cancer Stage IIA Prostate Cancer Stage IIB Prostate Cancer Stage III Prostate Cancer Stage IV Prostate Cancer 收起 << | Not Applicable | Withdrawn(Other more favorable... 展开 >> treatments are now available.) 收起 << | - | - |
NCT01605344 | Advanced Adenocarcinoma of the... 展开 >> Colon or Rectum 收起 << | Phase 1 | Withdrawn(Study was withdrawn ... 展开 >>due to lack of patient enrollment.) 收起 << | July 2014 | United States, North Carolina ... 展开 >> University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 收起 << |
NCT02133534 | Chronic Kidney Disease ... 展开 >> High Cholesterol 收起 << | Phase 4 | Terminated(failure to enroll) | - | - |
NCT02114099 | Kawasaki Disease ... 展开 >> Aneurysm, Coronary 收起 << | Phase 2 | Unknown | December 2016 | Taiwan ... 展开 >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Ming-Tai Lin, MD 886-2-23123456 ext 71734 mingtailin@ntu.edu.tw Principal Investigator: Ming-Tai Lin, MD 收起 << |
NCT01964326 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT02022293 | Nasopharyngeal Carcinoma ... 展开 >> Radiation Therapy Complication 收起 << | Phase 2 | Suspended(Enrollment target co... 展开 >>uld not be achieved.) 收起 << | January 2024 | China, Guangdong ... 展开 >> Dongguan People's Hospital Dongguan, Guangdong, China, 523059 Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University Guangzhou, Guangdong, China, 510120 Zengcheng People's Hospital Zengcheng, Guangdong, China, 511300 The Affiliated Hospital of Guangdong Medical College Zhanjiang, Guangdong, China, 524001 China, Guangxi The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China, 530021 收起 << |
NCT01964326 | - | Completed | - | - | |
NCT02364258 | Dyslipidemia | Phase 1 | Recruiting | December 2017 | United States, Missouri ... 展开 >> Children's Mercy Hospital Recruiting Kansas City, Missouri, United States, 64108 Contact: Jon Wagner, DO 816-234-3000 ext 59373 jbwagner@cmh.edu Principal Investigator: Jon B Wagner, DO 收起 << |
NCT00973986 | Coronary Heart Disease | Phase 1 | Completed | - | China, Guangdong ... 展开 >> Guangzhou General Hospital of Guangzhou Military Command Guangzhou, Guangdong, China, 510010 收起 << |
NCT01635946 | Pharmacokinetics of Isavuconaz... 展开 >>ole Pharmacokinetics of Atorvastatin Healthy Volunteers 收起 << | Phase 1 | Completed | - | United States, Florida ... 展开 >> Clinical Pharmacology of Miami Miami, Florida, United States, 33014 收起 << |
NCT02967653 | Lithium Use, Nephrogenic Diabe... 展开 >>tes Insipidus 收起 << | Phase 2 | Recruiting | January 2020 | Canada, Quebec ... 展开 >> McGill University Health Centre Not yet recruiting Montréal, Quebec, Canada, H3A1A1 Contact: Jocelyn Fotso Soh, MSc 514-340-8222 ext 25205 jfs702@mun.ca Principal Investigator: Pablo Cervantes, MD Jewish General Hospital Not yet recruiting Montréal, Quebec, Canada, H3T1E4 Contact: Jocelyn Fotso Soh, MSc 514-340-8222 ext 25025 jfs702@mun.ca Principal Investigator: Soham Rej, MD, MSc Douglas Mental Health University Institute Recruiting Montréal, Quebec, Canada, H4H1R3 Contact: Soham Rej, MD, MSc 514-340-8222 ext 25205 soham.rej@gmail.mcgill.ca Contact: Jocelyn Fotso Soh, MSc 5147156942 jfs702@mun.ca Principal Investigator: Soham Rej, MD, MSc 收起 << |
NCT02767362 | Endometrial Cancer | Early Phase 1 | Recruiting | November 2020 | United States, North Carolina ... 展开 >> University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Leslie Clark, MD 919-843-7572 leslie_clark@med.unc.edu Principal Investigator: Leslie Clark, MD 收起 << |
NCT02764736 | Complication of Renal Dialysis | Not Applicable | Withdrawn(Enrollment did not p... 展开 >>rogress as anticipated. No participants enrolled.) 收起 << | - | - |
NCT01780948 | Difference of 12-hour AUC | Not Applicable | Completed | - | Thailand ... 展开 >> King Chulalongkorn Memorial Hospital Bangkok, Thailand, 10330 收起 << |
NCT01821404 | Prostatic Neoplasms | Phase 2 | Completed | - | Finland ... 展开 >> Päijät-Häme Central Hospital Lahti, Finland Satakunta Central Hospital Pori, Finland Tampere University Hospital, Department of Urology Tampere, Finland, 33521 收起 << |
NCT01645410 | Healthy | Phase 1 | Completed | - | India ... 展开 >> Veeda Clinical Research Pvt. Ltd., Ahmedabad, Gujrat, India, 380 015 收起 << |
NCT01645384 | Healthy | Phase 1 | Completed | - | India ... 展开 >> Vimta Labs Limited Hyderabad, Andhra Pradesh, India, 500 051 收起 << |
NCT01779687 | HIV Hyperchol... 展开 >>esterolaemia 收起 << | Phase 1 | Completed | - | Netherlands ... 展开 >> CRCN Radboud University Nijmegen Medical Centre Nijmegen, Netherlands 收起 << |
NCT01306565 | Cardiovascular Disease | Not Applicable | Completed | - | Iran, Islamic Republic of ... 展开 >> Hormozgan University of Medical Sciences Bandar Abbas, Hormozgan, Iran, Islamic Republic of, 097145-3388 收起 << |
NCT02378441 | Healthy | Phase 1 | Completed | - | - |
NCT01255852 | CVD | Phase 4 | Completed | - | China, Jiangsu ... 展开 >> Department of Neurology, Jinling Hospital, Nanjing University School of Medicine Nanjing, Jiangsu, China, 210002 收起 << |
NCT01766076 | - | Completed | - | - | |
NCT02080455 | Effect of Atorvastatin on the ... 展开 >>Pharmacokinetics of Lomitapide 收起 << | Phase 1 | Completed | - | United States, Texas ... 展开 >> Covance Clinical Research Unit, Inc Dallas, Texas, United States, 75247 收起 << |
NCT01761656 | Stable Angina ... 展开 >> Unstable Angina Acute Non-ST-segment Elevation Myocardial Infarction 收起 << | Phase 2 | Unknown | February 2014 | China, Hunan ... 展开 >> Xiangtan Clinical College affiliated to Central South University Recruiting Xiangtan, Hunan, China, 411100 Contact: Zhishan SUN, doctor +8613637405536 ext +8673158211893 clinton_sun@163.com 收起 << |
NCT01732718 | Sickle Cell Disease ... 展开 >> Sickle Cell Nephropathy 收起 << | Phase 2 | Completed | - | United States, North Carolina ... 展开 >> UNC School of Medicine Clinical&Translational Research Ctr Chapel Hill, North Carolina, United States, 27599 收起 << |
NCT02588235 | Coronary Artery Disease | Phase 4 | Unknown | November 2017 | China, Shaanxi ... 展开 >> Xijing Hospital, Fourth Military Medical University Recruiting Xi'an, Shaanxi, China, 710032 Contact: Dongdong Sun, M.D., Ph.D. 收起 << |
NCT01766076 | Acquired Immune Deficiency Syn... 展开 >>drome Virus 收起 << | Phase 3 | Completed | - | - |
NCT03247400 | Non-segmental Vitiligo | Phase 1 Phase 2 | Recruiting | April 30, 2019 | Poland ... 展开 >> Clinic of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University, Faculty of Medicine in Bydgoszcz Recruiting Bydgoszcz, Cuiavian-Pomeranian, Poland, 85094 Contact: Anna Niezgoda, MD +48 606889288 anna.niezg@gmail.com 收起 << |
NCT03009097 | Chronic Periaortitis ... 展开 >> Intrabony Periodontal Defect 收起 << | Phase 4 | Completed | - | - |
NCT03433196 | Hypercholesterolemia in Corona... 展开 >>ory Heart Disease 收起 << | Phase 3 | Completed | - | - |
NCT01665677 | Graft vs Host Disease | Phase 2 | Active, not recruiting | December 2023 | United States, West Virginia ... 展开 >> West Virginia University Hospitals Mary Babb Randolph Cancer Center Morgantown, West Virginia, United States, 26506 United States, Wisconsin Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 收起 << |
NCT02370784 | Scleroderma | Phase 2 | Recruiting | December 2019 | United States, Pennsylvania ... 展开 >> University of Pittsburgh Recruiting Pittsburgh, Pennsylvania, United States, 15261 Contact: Dana Ivanco 412-648-7040 des2@pitt.edu Contact: Maureen Laffoon 412-648-5037 laffoonm@pitt.edu Principal Investigator: Robyn T Domsic, MD, MPH 收起 << |
NCT01431105 | Kawasaki Disease | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> University of California San Diego San Diego, California, United States, 92093 收起 << |
NCT02097589 | Healthy Controls | Phase 1 | Completed | - | United States, Florida ... 展开 >> University of Florida Clinical Translational Research Building Gainesville, Florida, United States, 32610 收起 << |
NCT02901379 | Myocardial Edema | Phase 3 | Completed | - | - |
NCT03079115 | Carotid Artery Stenosis | Phase 4 | Recruiting | December 30, 2019 | China, Beijing ... 展开 >> Beijing Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Xin Wang +8613661174001 wangxinannie@126.com 收起 << |
NCT02225834 | Ischemic Stroke | Phase 4 | Completed | - | Italy ... 展开 >> Internal Medicine Ward, University of Palermo Palermo, Italy, 90127 收起 << |
NCT03560882 | Malignant Disease ... 展开 >> Solid Tumor Acute Myeloid Leukemia 收起 << | Phase 1 | Recruiting | August 1, 2020 | United States, Kansas ... 展开 >> University of Kansas Cancer Center - CRC Recruiting Fairway, Kansas, United States, 66205 Contact: Kerry Hepler, RN 913-945-7552 ctnursenav@kumc.edu 收起 << |
NCT03692754 | Immune Thrombocytopenia ... 展开 >> Purpura, Thrombocytopenic 收起 << | Phase 4 | Recruiting | December 1, 2020 | China, Shandong ... 展开 >> Qilu hospital, Shandong University Recruiting Jinan, Shandong, China, 250012 Contact: Ming Hou houming@medmail.com.cn Principal Investigator: Ming Hou 收起 << |
NCT01477853 | - | Terminated(The study was termi... 展开 >>nated early by the Sponsor for business reasons.) 收起 << | - | - | |
NCT00756886 | - | Completed | - | - | |
NCT00654407 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00756886 | Arrhythmia | Not Applicable | Completed | - | United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 收起 << |
NCT01477853 | Type 2 Diabetes Mellitus | Phase 3 | Terminated(The study was termi... 展开 >>nated early by the Sponsor for business reasons.) 收起 << | - | - |
NCT02171039 | Healthy | Phase 1 | Completed | - | - |
NCT00520585 | Heterogeneity of Cardiomyocyte... 展开 >>s Repolarisation Autonomic Changes of Cardiomyocytes Repolarisation 收起 << | Not Applicable | Unknown | November 2007 | - |
NCT02125682 | Dyslipidemia in Patients With ... 展开 >>Diabetes Mellitus 收起 << | Phase 4 | Completed | - | Lebanon ... 展开 >> Hotel Dieu de France Hospital Beirut, Lebanon, Beirut 收起 << |
NCT01299181 | Bronchiectasis | Phase 4 | Completed | - | United Kingdom ... 展开 >> Royal Infirmary of Edinburgh Edinburgh, Scotland, United Kingdom, EH16 4SA 收起 << |
NCT01186289 | Neurocognitive Dysfunction | Not Applicable | Withdrawn(Principal Investigat... 展开 >>or decided not to pursue enrollment due to changes in standard of care.) 收起 << | October 2012 | United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27710 收起 << |
NCT02066207 | Dyslipidemia (Fredrickson Type... 展开 >> Ⅱa) Dyslipidemia (Fredrickson Type Ⅱb) 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of 收起 << |
NCT00993915 | - | Completed | - | - | |
NCT00644709 | Dyslipidemias | Phase 4 | Completed | - | Belgium ... 展开 >> Pfizer Investigational Site Antwerpen, Belgium, 2018 Pfizer Investigational Site Brasschaat, Belgium, 2930 Pfizer Investigational Site Brussels, Belgium, 1180 Pfizer Investigational Site Genk, Belgium, B-3600 Pfizer Investigational Site Gent, Belgium, 9000 Pfizer Investigational Site Gilly (charleroi), Belgium, 6060 Pfizer Investigational Site La Louvière, Belgium, 7100 Pfizer Investigational Site Mechelen, Belgium, 2800 Pfizer Investigational Site Menen, Belgium, 8930 Pfizer Investigational Site Merksem, Belgium, 2170 Pfizer Investigational Site Mortsel, Belgium, 2640 Pfizer Investigational Site Roeselare, Belgium, 8800 Pfizer Investigational Site Seraing, Belgium, 4100 Pfizer Investigational Site Wilrijk, Belgium, 2610 Pfizer Investigational Site Wingene, Belgium, 8750 收起 << |
NCT00993915 | - | Completed | - | - | |
NCT01288469 | Hypercholesterolemia | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Investigational Site Number 840616 Mesa, Arizona, United States, 85206 Investigational Site Number 840601 Tucson, Arizona, United States, 85710 United States, California Investigational Site Number 840610 Los Angeles, California, United States, 90057 Investigational Site Number 840608 Newport Beach, California, United States, 92660 United States, Florida Investigational Site Number 840603 Doral, Florida, United States, 33166 Investigational Site Number 840611 Jacksonville, Florida, United States, 32223 Investigational Site Number 840618 Jupiter, Florida, United States, 33458 Investigational Site Number 840612 Miami, Florida, United States, 33138 Investigational Site Number 840614 Miami, Florida, United States, 33138 Investigational Site Number 840607 St. Petersburg, Florida, United States, 33609 United States, Illinois Investigational Site Number 840605 Chicago, Illinois, United States, 60610 Investigational Site Number 840619 Chicago, Illinois, United States, 60610 United States, New Jersey Investigational Site Number 840604 Edison, New Jersey, United States, 08817 United States, New York Investigational Site Number 840606 Rochester, New York, United States, 14609 United States, Ohio Investigational Site Number 840615 Cincinnati, Ohio, United States, 45219 Investigational Site Number 840617 Cincinnati, Ohio, United States, 45219 United States, Oregon Investigational Site Number 840602 Eugene, Oregon, United States, 97404 United States, Virginia Investigational Site Number 840621 Richmond, Virginia, United States, 23227 United States, Washington Investigational Site Number 840609 Olympia, Washington, United States, 98502 United States, Wisconsin Investigational Site Number 840613 Oregon, Wisconsin, United States, 53575 收起 << |
NCT01812707 | - | Completed | - | - | |
NCT01526460 | Platelet Dysfunction | Phase 2 | Completed | - | Italy ... 展开 >> IRCCS San Raffaele Monte Tabor Milan, Italy, 20132 收起 << |
NCT01812707 | Hypercholesterolemia | Phase 2 | Completed | - | Japan ... 展开 >> Investigational Site Number 392002 Koganei-Shi, Japan Investigational Site Number 392001 Shinjuku-Ku, Japan Investigational Site Number 392003 Suita-Shi, Japan Investigational Site Number 392004 Suita-Shi, Japan 收起 << |
NCT00741715 | Hypercholesterolemia | Phase 3 | Terminated(AVE5530 in hypercho... 展开 >>lesterolemia was stopped due to insufficient efficacy) 收起 << | - | United States, New Jersey ... 展开 >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Puerto Rico Sanofi-Aventis Administrative Office Puerto Rico, Puerto Rico 收起 << |
NCT00134511 | Hypercholesterolemia, Familial | Phase 3 | Completed | - | United States, Massachusetts ... 展开 >> Pfizer Investigational Site Boston, Massachusetts, United States, 02114 Canada, Quebec Pfizer Investigational Site Chicoutimi, Quebec, Canada, G7H 5H6 Pfizer Investigational Site Ste-Foy, Quebec, Canada, G1V 4M6 South Africa Pfizer Investigational Site Parktown, Johannesburg, South Africa, 2193 Pfizer Investigational Site Bloemfontein, South Africa, 9301 Pfizer Investigational Site Cape Town, South Africa, 7925 收起 << |
NCT01617538 | Stenosis | Phase 1 Phase 2 | Unknown | September 2013 | China ... 展开 >> FuXing Hospital,Capital Medicial University Recruiting Beijing, China, 100038 Contact: Xu Bin, master 86-010-88062285 xubincj1992@yahoo.com.cn Principal Investigator: Xu Bin, master 收起 << |
NCT01733953 | - | Completed | - | - | |
NCT00134498 | Hypertriglyceridemia ... 展开 >> Hyperlipoproteinemia Type IV 收起 << | Phase 3 | Completed | - | - |
NCT01733953 | Cardiovascular Disease ... 展开 >> Childhood ALL Childhood NHL 收起 << | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00134264 | Coronary Disease ... 展开 >> Diabetes Mellitus 收起 << | Phase 3 | Terminated | - | - |
NCT00330785 | Hypertension ... 展开 >>Dyslipidemia 收起 << | Phase 3 | Completed | - | - |
NCT00344955 | Healthy | Phase 4 | Completed | - | Denmark ... 展开 >> Medical Research Holstebro, Denmark, 7500 收起 << |
NCT00405717 | Ischemic Heart Disease ... 展开 >> Acute Coronary Syndromes 收起 << | Phase 4 | Completed | - | China, Liaoning ... 展开 >> Northern Hospital Shenyang, Liaoning, China 收起 << |
NCT00159835 | Cardiovascular Diseases | Phase 4 | Completed | - | - |
NCT00457340 | Arrhythmia | Phase 4 | Completed | - | Belgium ... 展开 >> Pfizer Investigational Site Aalst, Belgium Pfizer Investigational Site Antwerpen, Belgium Pfizer Investigational Site Brugge, Belgium Pfizer Investigational Site Edegem, Belgium Pfizer Investigational Site Gent, Belgium Pfizer Investigational Site Hasselt, Belgium Pfizer Investigational Site Leuven, Belgium Greece Pfizer Investigational Site Athens, Greece Pfizer Investigational Site Crete, Greece Pfizer Investigational Site Rio Patra, Greece 收起 << |
NCT00134485 | Hypercholesterolemia, Familial... 展开 >> Hyperlipidemia 收起 << | Phase 3 | Completed | - | - |
NCT01059864 | Rheumatoid Arthritis | Phase 2 | Completed | - | United States, Alabama ... 展开 >> Pfizer Investigational Site Birmingham, Alabama, United States, 35209 Pfizer Investigational Site Huntsville, Alabama, United States, 35801 United States, Arizona Pfizer Investigational Site Gilbert, Arizona, United States, 85234 Pfizer Investigational Site Scottsdale, Arizona, United States, 85251 United States, California Pfizer Investigational Site Upland, California, United States, 91786 United States, Florida Pfizer Investigational Site Jacksonville, Florida, United States, 32216 United States, Ohio Pfizer Investigational Site Dayton, Ohio, United States, 45417 Pfizer Investigational Site Mayfield Village, Ohio, United States, 44143 United States, South Carolina Pfizer Investigational Site Greenville, South Carolina, United States, 29601 United States, Texas Pfizer Investigational Site Allen, Texas, United States, 75013 Korea, Republic of Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 Pfizer Investigational Site Seoul, Korea, Republic of, 120-752 Pfizer Investigational Site Seoul, Korea, Republic of, 133-792 Pfizer Investigational Site Seoul, Korea, Republic of, 137-701 Pfizer Investigational Site Seoul, Korea, Republic of, 143-729 收起 << |
NCT00678522 | Healthy Subjects | Phase 4 | Completed | - | Denmark ... 展开 >> Medical Reseach, Holstebro Hospital Holstebro, Denmark, 5500 Department of Medical Research, Holstebro Hospital Holstebro, Denmark, 7500 收起 << |
NCT02260648 | Hypercholesterolemia | Phase 3 | Terminated(Study termination d... 展开 >>ue to insufficient efficacy.) 收起 << | - | Japan ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 650-0021 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ibaragi, Japan, 311-3516 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ibaraki, Japan, 311-4153 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyoto, Japan, 6150035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 530-0001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saitama, Japan, 350-1305 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shizuoka, Japan, 424-0855 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 103-0028 收起 << |
NCT02260648 | - | Terminated(Study termination d... 展开 >>ue to insufficient efficacy.) 收起 << | - | - | |
NCT00159718 | Angina | Phase 4 | Completed | - | - |
NCT02674204 | Breast Cancer ... 展开 >> Heart Disease Cardiotoxicity Myocardial Dysfunction 收起 << | Phase 2 | Terminated(Closed due to low a... 展开 >>ccrual) 收起 << | - | United States, California ... 展开 >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 收起 << |
NCT01059864 | - | Completed | - | - | |
NCT00335504 | Colon Cancer ... 展开 >>Precancerous Condition Rectal Cancer 收起 << | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT00163202 | Coronary Arteriosclerosis ... 展开 >> Hypercholesterolemia 收起 << | Phase 4 | Completed | - | - |
NCT00335504 | - | Completed | - | - | |
NCT00620542 | Coronary Atherosclerosis | Phase 3 | Completed | - | - |
NCT02943590 | Heart Failure | Phase 2 | Recruiting | May 2022 | United States, Massachusetts ... 展开 >> Massachusetts general Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Tomas Neilan, MD 617-643-0239 Principal Investigator: Tomas Neilan, MD Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Eric Jacobsen, MD 617-632-4564 Principal Investigator: Eric Jacobsen, MD 收起 << |
NCT00446940 | Hepatitis C | Phase 2 | Completed | - | United States, Oklahoma ... 展开 >> VA Hospital OKlahoma City, Oklahoma, United States, 73104 收起 << |
NCT02245269 | Healthy | Phase 1 | Completed | - | - |
NCT01448642 | Acute Coronary Syndrome | Phase 4 | Active, not recruiting | November 2018 | Brazil ... 展开 >> Hospital do Coracao Sao Paulo, SP, Brazil, 04005-000 收起 << |
NCT00654225 | Hypercholesterolemia ... 展开 >> Dyslipidaemia 收起 << | Phase 3 | Completed | - | - |
NCT00276458 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00411190 | Osteoarthritis | Phase 1 | Completed | - | Belgium ... 展开 >> GSK Investigational Site Antwerpen, Belgium, 2060 GSK Investigational Site Liège, Belgium, 4000 收起 << |
NCT00276458 | - | Completed | - | - | |
NCT02437084 | Hyperlipidemia | Phase 4 | Recruiting | December 2019 | United States, California ... 展开 >> Stanford University School of Medicine Recruiting Stanford, California, United States, 94305 收起 << |
NCT00620542 | - | Completed | - | - | |
NCT00871351 | Primary Hypercholesterolemia | Phase 4 | Completed | - | - |
NCT00871351 | - | Completed | - | - | |
NCT00653965 | Hypercholesterolemia ... 展开 >> Dyslipidaemia 收起 << | Phase 3 | Completed | - | - |
NCT01442987 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> 16 institutions including Seoul National University Hospital Seoul, Korea, Republic of 收起 << |
NCT03047772 | Myocardial Infarction ... 展开 >> Stem Cell Transplantation Angioplasty, Transluminal, Percutaneous Coronary 收起 << | Phase 2 | Not yet recruiting | December 31, 2018 | - |
NCT01304641 | - | Completed | - | - | |
NCT00418834 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00811330 | Aortic Valve Stenosis ... 展开 >> Ventricular Hypertrophy 收起 << | Phase 3 | Unknown | January 2018 | France ... 展开 >> Service de Chirurgie Cardio-VasculaireHôpital Civil Recruiting Strasbourg, France, 67 091 Contact: Michel KINDO, MD 33.3.69.55.08.11 michel.kindo@chru-strasbourg.fr 收起 << |
NCT00329069 | Coronary Artery Disease ... 展开 >> Hypercholesterolemia Monocyte Function 收起 << | Not Applicable | Completed | - | Germany ... 展开 >> University Hospital Ulm Ulm, Germany, 89081 收起 << |
NCT00418834 | - | Completed | - | - | |
NCT00327418 | Major Coronary Event ... 展开 >> Cerebrovascular Accident Coronary Artery Bypass Graft Angina, Unstable Revascularization 收起 << | Phase 4 | Completed | - | - |
NCT00150371 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT01030328 | Coronary Atherosclerosis | Phase 3 | Terminated(Lack of patient pop... 展开 >>ulation) 收起 << | - | United States, Georgia ... 展开 >> Piedmont Hospital Atlanta, Georgia, United States, 30309 收起 << |
NCT02455869 | Chronic Periodontitis | Phase 2 Phase 3 | Completed | - | - |
NCT00382460 | Actue Coronary Syndromes | Phase 4 | Completed | - | - |
NCT01304641 | - | Completed | - | - | |
NCT00139061 | Hyperlipidemia | Phase 3 | Completed | - | France ... 展开 >> Pfizer Investigational Site Angers, France, 49 000 Pfizer Investigational Site Angers, France, 49 100 Pfizer Investigational Site Bordeaux Cauderan, France, 33 200 Pfizer Investigational Site Briollay, France, 49125 Pfizer Investigational Site Dijon, France, 21000 Pfizer Investigational Site Hagondange, France, 57 300 Pfizer Investigational Site Haut Mauco, France, 40 280 Pfizer Investigational Site Jarny, France, 54800 Pfizer Investigational Site Lille, France, 59 037 Cedex Pfizer Investigational Site Mars LA Tour, France, 54800 Pfizer Investigational Site Metz, France, 57070 Pfizer Investigational Site Monguilhem, France, 32 240 Pfizer Investigational Site Mont de Marsan CEDEX, France, 40010 Pfizer Investigational Site Mont de Marsan, France, 40 010 cedex Pfizer Investigational Site Mont de Marsan, France, 40 010 Pfizer Investigational Site Mont de Marsan, France, 40000 Pfizer Investigational Site Moutiers, France, 54660 Pfizer Investigational Site Murs Erigne, France, 49610 Pfizer Investigational Site Nantes, France, 44 093 Cedex 01 Pfizer Investigational Site Pouilly en Auxois, France, 21 850 Pfizer Investigational Site Saint Justin, France, 40 240 Pfizer Investigational Site Saint Martin D'Oney, France, 40090 Pfizer Investigational Site Seysses, France, 31600 Pfizer Investigational Site Strasbourg, France, 67000 Pfizer Investigational Site Thouars, France, 79100 Pfizer Investigational Site Tierce, France, 49 125 收起 << |
NCT00767572 | Coarctation of the Aorta | Phase 4 | Terminated(low enrollment) | - | United States, California ... 展开 >> UCSF Medical Center, 505 Parnassus Ave San Francisco, California, United States, 94143 收起 << |
NCT00767572 | - | Terminated(low enrollment) | - | - | |
NCT01600170 | HIV Dementia | Phase 4 | Completed | - | United States, Pennsylvania ... 展开 >> University of Pennsylvania School of Medicine Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT00141232 | Diabetes, Type 2 | Phase 4 | Completed | - | - |
NCT03110848 | Thyroid Associated Ophthalmopa... 展开 >>thy Hypercholesterolemia 收起 << | Phase 2 | Not yet recruiting | June 30, 2020 | - |
NCT00137176 | Multiple Sclerosis | Not Applicable | Completed | - | United States, North Carolina ... 展开 >> University of North Carolina-Chapel Hill MS Clinic Within the Neuroscience Hospital Chapel Hill, North Carolina, United States, 27599 收起 << |
NCT00639158 | Dyslipidemias ... 展开 >> Coronary Heart Disease Combined (Atherogenic) Dyslipidemia Mixed Dyslipidemia 收起 << | Phase 3 | Completed | - | - |
NCT00631189 | Type IIa and IIb Hypercholeste... 展开 >>rolaemia 收起 << | Phase 4 | Completed | - | - |
NCT00639158 | - | Completed | - | - | |
NCT00631189 | - | Completed | - | - | |
NCT02245087 | Coronary Artery Disease | Phase 2 | Recruiting | - | Canada, Ontario ... 展开 >> Dr. Killian De Blacam Family Medical Practice Recruiting Sudbury, Ontario, Canada, P3A 2A3 Contact: Amanda Garrioch, BSc amanda.garrioch@uhn.ca Principal Investigator: Killian de Blacam, MD Dr. Gregory Garrioch Family Medical Practice Recruiting Sudbury, Ontario, Canada, P3E 3C6 Contact: Amanda Garrioch, BSc amanda.garrioch@uhn.ca Principal Investigator: Gregory F Garrioch, MD Dr. Reena Dhatt Recruiting Sudbury, Ontario, Canada, P3E6C3 Principal Investigator: Reena Dhatt, MD FRCP CCFP 收起 << |
NCT00115817 | Atherosclerosis | Phase 3 | Completed | - | United States, Massachusetts ... 展开 >> Brigham and Womens Hospital Boston, Massachusetts, United States, 02115 收起 << |
NCT02331095 | Venous Thromboembolism | Phase 1 Phase 2 | Recruiting | October 2019 | United States, Ohio ... 展开 >> The Ohio State University Medical Center Recruiting Columbus, Ohio, United States, 43210 Contact: Tzu-Fei Wang, MD 614-293-9441 Tzu-Fei.Wang@osumc.edu Contact: Melanie Heinlein 614-293-5176 Melanie.Heinlein@osumc.edu 收起 << |
NCT00331565 | Morbid Obesity | Phase 4 | Completed | - | Norway ... 展开 >> Hospital in Vestfold Tønsberg, Norway, 3103 收起 << |
NCT02029534 | Cardiothoracic Surgery ... 展开 >> Post-operative Atrial Fibrillation 收起 << | Phase 4 | Unknown | June 2017 | United States, Nebraska ... 展开 >> Creighton University Recruiting Omaha, Nebraska, United States, 68131 Principal Investigator: Aiman Smer, MBBCh Sub-Investigator: Manu Kaushik, MBBS Sub-Investigator: Janardhana Gorthi, MD Sub-Investigator: Daniel E Hilleman, PharmD Sub-Investigator: Hussam Abuissa, MD Sub-Investigator: Tammy L Burns, PharmD Sub-Investigator: Aryan N Mooss, MD 收起 << |
NCT00286312 | Myocardial Infarction ... 展开 >> Reperfusion Injury 收起 << | Phase 4 | Completed | - | Netherlands ... 展开 >> St. Antonius Hospital Nieuwegein, Netherlands, 3435CM University Medical Centre Utrecht Utrecht, Netherlands 收起 << |
NCT01925937 | Congestive Heart Failure | Not Applicable | Unknown | - | Iran, Islamic Republic of ... 展开 >> Vice Chancellery for Research of Isfahan University of Medical Sciences, Isfahan, Iran Recruiting Isfahan, Iran, Islamic Republic of, 8174673461 Contact: Amin Nemati, MD 00989131009918 nemati@med.mui.ac.ir Principal Investigator: Javad Shahabi, MD 收起 << |
NCT00130481 | Type 1 Diabetes Mellitus ... 展开 >> Type 2 Diabetes Mellitus 收起 << | Not Applicable | Completed | - | United States, Florida ... 展开 >> University of Florida Gainesville, Florida, United States, 32610 收起 << |
NCT00491400 | Diabetes Mellitus ... 展开 >> Metabolic Syndrome 收起 << | Not Applicable | Terminated(Insufficient enroll... 展开 >>ment) 收起 << | - | United States, Massachusetts ... 展开 >> Boston Medical Center Boston, Massachusetts, United States, 02118 收起 << |
NCT00645151 | Dyslipidemias | Phase 4 | Completed | - | Brazil ... 展开 >> Pfizer Investigational Site Belo Horizonte, MG, Brazil Pfizer Investigational Site Curitiba, PR, Brazil, 80540-010 Pfizer Investigational Site Porto Alegre, RS, Brazil, 90035-170 Pfizer Investigational Site Porto Alegre, RS, Brazil, 90610-000 Pfizer Investigational Site São José, SC, Brazil, 88103-460 Pfizer Investigational Site São Paulo, SP/Brazil, Brazil, 04039-001 Pfizer Investigational Site Campinas, SP, Brazil, 13012-000 Pfizer Investigational Site Campinas, SP, Brazil, 13059-740 Pfizer Investigational Site Sao Paulo, SP, Brazil, 01244-030 Pfizer Investigational Site Sao Paulo, SP, Brazil, 04012-180 Pfizer Investigational Site São José do Rio Preto, SP, Brazil, 15090-000 Pfizer Investigational Site São Paulo, SP, Brazil Pfizer Investigational Site Rio de Janeiro, Brazil, 20550-030 Chile Pfizer Investigational Site Santiago, Región Metropolitana, Chile Colombia Pfizer Investigational Site Bogota, Cundinamarca, Colombia Pfizer Investigational Site Bogotá, Cundinamarca, Colombia Pfizer Investigational Site Barranquilla, Colombia Pfizer Investigational Site Bogotá, C/marca, Colombia Pfizer Investigational Site Cali, Valle, Colombia Ecuador Pfizer Investigational Site Quito, Pichincha / Ecuador, Ecuador Guatemala Pfizer Investigational Site Guatemala, Guatemala, 01015 Mexico Pfizer Investigational Site Guadalajara, Jalisco, Mexico, 44290 Pfizer Investigational Site Zapopan, Jalisco, Mexico, 45200 Pfizer Investigational Site Monterrey, Nuevo Leon, Mexico, 64060 Pfizer Investigational Site Monterrey, Nuevo Leon, Mexico, 64410 Pfizer Investigational Site Chihuahua, Mexico, 31238 Pfizer Investigational Site Durango, Mexico, 34300 Panama Pfizer Investigational Site Panama, Panama Venezuela Pfizer Investigational Site Dtto. Federal, Caracas, Venezuela, 1020 Pfizer Investigational Site Caracas, Dtto Federal, Venezuela, 1061 Pfizer Investigational Site Caracas, Dtto Federal, Venezuela, 1081 Pfizer Investigational Site Caracas, Edo. Miranda, Venezuela, 1061 Pfizer Investigational Site Caracas, Venezuela, 1020 收起 << |
NCT02566187 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Inje University Busan Paik Hospital Busan, Korea, Republic of 收起 << |
NCT00491400 | - | Terminated(Insufficient enroll... 展开 >>ment) 收起 << | - | - | |
NCT00388596 | Osteoporosis | Phase 1 | Completed | - | United States, Florida ... 展开 >> GSK Investigational Site Miami, Florida, United States, 33169 收起 << |
NCT01053065 | Symptomatic Carotid Stenosis ... 展开 >> Hypercholesterolemia Indication for Carotid Endarterectomy 收起 << | Not Applicable | Completed | - | Italy ... 展开 >> University of Chieti Medical School Chieti, Italy, 66100 University of Padova Medical School Padova, Italy, 35128 University of Padova Medical School - Treviso Branch Treviso, Italy, 31100 收起 << |
NCT00214630 | Acute Coronary Syndromes | Phase 3 | Completed | - | - |
NCT00645424 | Hyperlipidemias | Phase 4 | Completed | - | Taiwan ... 展开 >> Pfizer Investigational Site Kaohsiung Hsien, Taiwan Pfizer Investigational Site Kaohsiung, Taiwan Pfizer Investigational Site Taichung, Taiwan Pfizer Investigational Site Taipei, Taiwan Pfizer Investigational Site Taoyuan Hsien, Taiwan 收起 << |
NCT02577042 | Aging-related Inflammation in ... 展开 >>HIV-infected Patients 收起 << | Phase 4 | Completed | - | Spain ... 展开 >> Germans Trias i Pujol Hospital Badalona, Barcelona, Spain, 08916 收起 << |
NCT02060032 | Chronic Periodontitis | Phase 2 Phase 3 | Completed | - | - |
NCT00647543 | Dyslipidemias | Phase 4 | Completed | - | Thailand ... 展开 >> Pfizer Investigational Site Bangkok, Thailand, 10400 Pfizer Investigational Site Bangkok, Thailand, 10700 Pfizer Investigational Site Chiang Mai, Thailand, 50200 收起 << |
NCT00669695 | Obstructive Sleep Apnea Syndro... 展开 >>me 收起 << | Phase 2 | Terminated(Interim analysis pe... 展开 >>rformed without efficient results) 收起 << | - | France ... 展开 >> Universitary Hospital of Angers Angers, France, 49033 Hospital of Annemasse Annemasse, France, 74017 University Hospital of Grenoble Grenoble, France, 38043 Switzerland Universitary Hospital of Geneva Geneva, Switzerland, 1211 收起 << |
NCT02397590 | Hypertension | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of 收起 << |
NCT01220973 | Prostate Cancer | Phase 2 | Completed | - | United States, Michigan ... 展开 >> Karmanos Cancer Center Detroit, Michigan, United States, 48201 United States, New Jersey Cooper Hospital Camden, New Jersey, United States, 08103 Robert Wood Johnson University Hospital at Hamilton Hamilton, New Jersey, United States, 08690 Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 收起 << |
NCT01220973 | - | Completed | - | - | |
NCT01543555 | Myocardial Infarction ... 展开 >> Peripheral Vascular Disease Aortic Aneurism 收起 << | Phase 3 | Completed | - | Brazil ... 展开 >> Hospital do Coração São Paulo, SP, Brazil, 04005-000 收起 << |
NCT02800902 | Chronic Periodontitis | Phase 2 Phase 3 | Completed | - | India ... 展开 >> Government Dental College and Research Institute Bangalore, Karnataka, India, 560002 收起 << |
NCT02579356 | Diseases of the Circulatory Sy... 展开 >>stem Essential Hypertension 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Chonbuk National University Hospital Seoul, Korea, Republic of 收起 << |
NCT00616772 | Coronary Artery Disease ... 展开 >> Coronary Heart Disease Dyslipidemia 收起 << | Phase 3 | Completed | - | - |
NCT00163150 | Cerebrovascular Accident ... 展开 >> Hypercholesterolemia 收起 << | Phase 4 | Completed | - | France ... 展开 >> Pfizer Investigational Site Paris, Cedex 18, France, 75877 收起 << |
NCT00065806 | Lupus Erythematosus, Systemic | Phase 3 | Completed | - | United States, North Carolina ... 展开 >> Duke Medical Center / Duke Clinical Research Institute Durham, North Carolina, United States, 27715 收起 << |
NCT00616772 | - | Completed | - | - | |
NCT01161082 | Hypercholesterolemia | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Site 1 Cincinnati, Ohio, United States United States, Tennessee Site 2 Knoxville, Tennessee, United States 收起 << |
NCT00065806 | - | Completed | - | - | |
NCT01497912 | Type 1 Diabetes Mellitus ... 展开 >> Dyslipidemia 收起 << | Phase 4 | Completed | - | Sweden ... 展开 >> Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital Stockholm, Sweden, 182 88 收起 << |
NCT00632840 | Obesity Lipid... 展开 >> Disorders Hypertriglyceridemia Cardiovascular Disease 收起 << | Phase 4 | Completed | - | - |
NCT02185066 | Healthy Volunteers | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Inje University Busan Paik Hospital Busan, Korea, Republic of 收起 << |
NCT00965055 | High Cholesterol ... 展开 >> Coronary Artery Disease 收起 << | Phase 3 | Terminated(The study was termi... 展开 >>nated due to inability to recruit subjects. A total of 2/100 anticipated were radomized.) 收起 << | - | United States, California ... 展开 >> UCSD Medical Center in Hillcrest Clinical Trials Facility San Diego, California, United States, 92103 收起 << |
NCT01279590 | Myalgia Hyper... 展开 >>cholesterolemia Hyperlipidemia 收起 << | Phase 2 | Completed | - | - |
NCT01214746 | Cardiovascular Diseases ... 展开 >> Nephropathy 收起 << | Phase 2 | Completed | - | Denmark ... 展开 >> Medicinsk Forskning, Regionshospitalet Holstebro Holstebro, Denmark, 7500 收起 << |
NCT00791648 | - | Completed | - | - | |
NCT03745300 | Chronic Periodontitis Wth Diab... 展开 >>etes Mellitus 收起 << | Phase 2 Phase 3 | Completed | - | India ... 展开 >> Department of Periodontics, GDCRI Bangalore Bangalore, Karnataka, India, 560002 收起 << |
NCT01015144 | - | Completed | - | - | |
NCT00403533 | Hepatitis C | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 << |
NCT00242944 | Coronary Disease ... 展开 >> Hypercholesterolemia 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> Juntendo University School of Medicine Bunkyo-ku, Tokyo, Japan, 113-8421 Yamaguchi University Graduate School of Medicine Ube, Yamaguchi, Japan, 755-8505 Kyoto University Graduate School of Medicine Kyoto, Japan, 606-8507 收起 << |
NCT01795937 | Healthy | Phase 1 | Completed | - | Germany ... 展开 >> 1220.61.1 Boehringer Ingelheim Investigational Site Ingelheim, Germany 收起 << |
NCT01111656 | Relapsing-remitting Multiple S... 展开 >>clerosis 收起 << | Phase 2 | Completed | - | Switzerland ... 展开 >> Department of Neurology, Bern University Hospital, and University of Bern Bern, Switzerland, 3007 收起 << |
NCT00362934 | Hyperlipidemia | Phase 3 | Completed | - | - |
NCT00235950 | Coronary Heart Disease | Phase 4 | Completed | - | Sweden ... 展开 >> Research Site Danderyd, Sweden Research Site Eksjö, Sweden Research Site Falun, Sweden Research Site Göteborg, Sweden Research Site Helsingborg, Sweden Research Site Jönköping, Sweden Research Site Karlskrona, Sweden Research Site Karlstad, Sweden Research Site Ljungby, Sweden Research Site Lund, Sweden Research Site Malmö, Sweden Research Site Skövde, Sweden Research Site Stockholm, Sweden Research Site Sundsvall, Sweden Research Site Uppsala, Sweden Research Site Västerås, Sweden Research Site Växjö, Sweden Research Site Örebro, Sweden 收起 << |
NCT01795937 | - | Completed | - | - | |
NCT00276484 | - | Completed | - | - | |
NCT00791648 | Acute Kidney Injury ... 展开 >> Post-Operative Delirium Icu Delirium Acute Renal Failure Delirium 收起 << | Not Applicable | Completed | - | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37212 收起 << |
NCT00143234 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 3 | Completed | - | - |
NCT00276484 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00644670 | Dyslipidemias | Phase 4 | Completed | - | Belgium ... 展开 >> Pfizer Investigational Site Antwerpen, Belgium, 2018 Pfizer Investigational Site Brasschaat, Belgium, 2930 Pfizer Investigational Site Brussels, Belgium, 1180 Pfizer Investigational Site Edegem, Belgium, 2650 Pfizer Investigational Site Genk, Belgium, B-3600 Pfizer Investigational Site Gent, Belgium, 9000 Pfizer Investigational Site Gilly (charleroi), Belgium, 6060 Pfizer Investigational Site La Louvière, Belgium, 7100 Pfizer Investigational Site Liège, Belgium, 4000 Pfizer Investigational Site Mechelen, Belgium, 2800 Pfizer Investigational Site Menen, Belgium, 8930 Pfizer Investigational Site Merksem, Belgium, 2170 Pfizer Investigational Site Mortsel, Belgium, 2640 Pfizer Investigational Site Roeselare, Belgium, 8800 Pfizer Investigational Site Seraing, Belgium, 4100 Pfizer Investigational Site Wilrijk, Belgium, 2610 Pfizer Investigational Site Wingene, Belgium, 8750 收起 << |
NCT00616187 | Relapsing Remitting Multiple S... 展开 >>clerosis 收起 << | Phase 2 | Completed | - | - |
NCT00151502 | Alzheimer's Disease | Phase 3 | Completed | - | - |
NCT00675779 | Endometriosis ... 展开 >> Pain 收起 << | Not Applicable | Unknown | March 2011 | Poland ... 展开 >> Poznan University of Medical Sciences, Department of Gynecology and Obstetrics Poznan, Poland, 60-535 收起 << |
NCT00861861 | Hypercholesterolemia ... 展开 >> Coronary Artery Disease 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> Kumamoto University Graduate School of Medical Sciences Department of Cardiocascular Medicine Kumamoto, Japan, 860-8556 收起 << |
NCT00910221 | Acute Kidney Dysfunction | Phase 2 Phase 3 | Completed | - | Australia, Victoria ... 展开 >> Austin Health Melbourne, Victoria, Australia, 3084 收起 << |
NCT02029573 | Glioblastoma Multiforme | Phase 2 | Completed | - | Saudi Arabia ... 展开 >> King Fahad Medical City Riyadh, Saudi Arabia, 11525 收起 << |
NCT02591836 | Hypercholesterolemia | Phase 2 | Completed | - | - |
NCT00404599 | Diabetes Mellitus ... 展开 >> Hypertension 收起 << | Phase 4 | Unknown | July 2009 | Netherlands ... 展开 >> VU University Medical Center Recruiting Amsterdam, Netherlands, 1007 MB 收起 << |
NCT02603328 | Cerebral Cavernous Malformatio... 展开 >>n 收起 << | Phase 1 Phase 2 | Recruiting | August 2022 | United States, Illinois ... 展开 >> University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Kristina Piedad, BSN, RN 773-326-9839 ATCASH@uchospitals.edu 收起 << |
NCT00942591 | Multiple Sclerosis | Phase 2 | Completed | - | Switzerland ... 展开 >> Prof. H. Mattle, Dep. of Neurology, Bern University Hospital Bern, Switzerland, 3010 收起 << |
NCT00134550 | Foot Ulcer Di... 展开 >>abetes 收起 << | Phase 2 | Completed | - | Norway ... 展开 >> Asker and Baerum Hospital RUD, Norway, 1309 Østfold County Hospital Sarpsborg, Norway, 1723 收起 << |
NCT00505336 | Diastolic Heart Failure | Not Applicable | Completed | - | Ireland ... 展开 >> St Vincent's University Hospital Ballsbridge, Dublin, Ireland, 4 收起 << |
NCT01572623 | Carotid Stenosis | Phase 4 | Unknown | September 2012 | Italy ... 展开 >> Campus Bio Medico University of Rome Recruiting Rome, RM, Italy, 00128 Contact: Patti Giuseppe, MD 06225411899 g.patti@unicampus.it Sub-Investigator: Melfi Rosetta, MD Sub-Investigator: Macrì Michele, MD Sub-Investigator: Picarelli Silvia, MD 收起 << |
NCT01842230 | Essential Hypertension ... 展开 >> Hyperlipidemia 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Severance Hospital Seoul, Korea, Republic of 收起 << |
NCT01863225 | Dyslipidemia ... 展开 >>Coronary Artery Disease 收起 << | Phase 2 | Terminated | - | Australia, South Australia ... 展开 >> Royal Adelaide Hospital / CMAX Adelaide, South Australia, Australia, 5000 收起 << |
NCT01288469 | - | Completed | - | - | |
NCT02089061 | Acute Coronary Syndromes | Phase 1 | Completed | - | - |
NCT00202904 | Hypercholesterolemia ... 展开 >> Coronary Heart Disease 收起 << | Phase 4 | Completed | - | - |
NCT01166633 | Hypercholesterolemia | Phase 4 | Completed | - | - |
NCT00496730 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00496730 | - | Completed | - | - | |
NCT00442897 | - | Completed | - | - | |
NCT01710007 | Hypercholesterolemia | Phase 3 | Completed | - | Taiwan ... 展开 >> Buddhist Taipei TzuChi General Hospital New Taipei City, Taiwan, 23142 Cardinal Tien Hospital New Taipei City, Taiwan, 231 Taipei Medical University - Shuang Ho Hospital New Taipei City, Taiwan, 23561 Taichung Veterans General Hospital Taichung City, Taiwan, 40705 Taipei Veterans General Hospital Taipei City, Taiwan, 11217 Cheng Hsin General Hospital Taipei City, Taiwan, 112 Tri-Service General Hospital Taipei City, Taiwan, 114 Chang Gung Medical Foundation- LinKuo Branch Taoyuan City, Taiwan, 333 收起 << |
NCT00442897 | Hypercholesterolemia | Phase 4 | Completed | - | - |
NCT03004001 | Nephrotic Syndrome | Not Applicable | Recruiting | December 2018 | United States, Texas ... 展开 >> DallasVAMC Recruiting Dallas, Texas, United States, 75216 Contact: Sanjai Sabu 214-857-0323 收起 << |
NCT00072826 | Sickle Cell Disease | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00120055 | Myopathy | Phase 4 | Completed | - | - |
NCT00408382 | Hypercholesteremia ... 展开 >> Coronary Artery Disease 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> Osaka, Japan Tokyo, Japan 收起 << |
NCT01236430 | Hyperlipidemia | Phase 1 | Completed | - | - |
NCT03696940 | Dyslipidemias ... 展开 >> Cardiovascular Risk Factor 收起 << | Phase 3 | Active, not recruiting | January 31, 2019 | Mexico ... 展开 >> Laboratorios Grossman Sa Mexico City, Mexico, 04040 收起 << |
NCT00163163 | Hypercholesterolaemia | Phase 3 | Completed | - | - |
NCT00296374 | Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT00917527 | Coronary Heart Disease | Phase 4 | Unknown | June 2013 | Korea, Republic of ... 展开 >> Severance Cardiovascular Hospital, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 120-752 Contact: Hyuk-Jae Chang, MD, PhD 收起 << |
NCT00770796 | Contrast Induced Nephropathy | Phase 4 | Completed | - | - |
NCT00292201 | Asthma | Phase 2 | Terminated(Lack of funding to ... 展开 >>complete subject recruitment and testing) 收起 << | - | Canada, Ontario ... 展开 >> Kingston General Hospital Kingston, Ontario, Canada, K7L 2V6 收起 << |
NCT03657472 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 收起 << |
NCT00380939 | Coronary Arteriosclerosis | Phase 4 | Completed | - | - |
NCT02155530 | Coronary Artery Disease | Not Applicable | Completed | - | Korea, Republic of ... 展开 >> Severance Hospital Seoul, Korea, Republic of, 120-752 收起 << |
NCT00293748 | - | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << | |
NCT00296374 | - | Completed | - | - | |
NCT00409773 | - | Completed | - | - | |
NCT02600520 | Chronic Periodontitis | Phase 2 Phase 3 | Completed | - | - |
NCT00409773 | Hypercholesterolemia ... 展开 >> Metabolic Syndrome 收起 << | Phase 3 | Completed | - | - |
NCT00681525 | Pharmacokinetics | Phase 1 | Completed | - | United States, Florida ... 展开 >> Site Reference ID/Investigator# 8087 Gainesville, Florida, United States, 32608 收起 << |
NCT00181181 | Hypertension | Phase 4 | Terminated(Coronary flow by ec... 展开 >>ho Doppler was obtainable in about 50% of subjects. The study was stopped early because of insufficient sample size to achieve adequate power) 收起 << | - | United States, Maryland ... 展开 >> Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 收起 << |
NCT00585611 | Diastolic Heart Failure | Not Applicable | Terminated(Unable to recruit i... 展开 >>nto the study) 收起 << | - | United States, Wisconsin ... 展开 >> University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 收起 << |
NCT00728910 | Dyslipidemia | Phase 2 | Completed | - | United States, Pennsylvania ... 展开 >> CTRC (Clinical Translational Research Center) Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT00728910 | - | Completed | - | - | |
NCT00395486 | Metabolic Syndrome X | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Research Site Pusan, Korea, Republic of Research Site Seoul, Korea, Republic of Research Site Suwon, Korea, Republic of 收起 << |
NCT00795912 | Heart Failure | Phase 4 | Completed | - | Ireland ... 展开 >> Heart Failure Unit, St Vincents University Hospital Dublin, Co Dublin, Ireland, 4 收起 << |
NCT01112670 | Healthy | Phase 4 | Completed | - | United States, Colorado ... 展开 >> University of Colorado Denver Aurora, Colorado, United States, 80045 收起 << |
NCT00549926 | Coronary Disease ... 展开 >> Hypercholesterolemia 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> Yokohama City University Medical Center Yokohama, Japan 收起 << |
NCT01446679 | - | Completed | - | Japan ... 展开 >> Chubu, Japan Chugoku, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Shikoku, Japan Touhoku, Japan 收起 << | |
NCT01112670 | - | Completed | - | - | |
NCT01259284 | Advanced Cancers | Phase 2 Phase 3 | Terminated(Terminated due to l... 展开 >>ow accrual.) 收起 << | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT03760848 | Healthy | Phase 1 | Active, not recruiting | February 2019 | United Kingdom ... 展开 >> Hammersmith Medicines Research (HMR) London, United Kingdom, NW10 7EW 收起 << |
NCT03054467 | Quality of Life | Phase 4 | Not yet recruiting | April 28, 2019 | - |
NCT00395486 | - | Completed | - | - | |
NCT02458755 | Stroke Intrac... 展开 >>ranial Atherosclerosis 收起 << | Phase 4 | Unknown | June 2018 | Korea, Republic of ... 展开 >> Oh Young Bang Recruiting Seoul, Korea, Republic of, 135-710 Contact: Oh Young Bang, MD, PhD +82-2-3410-3599 ohyoungbang@samsung.com Contact: Jong-Won Chung, MD, Msc +82-10-9032-9906 neurocjw@gmail.com 收起 << |
NCT00134173 | Coronary Disease ... 展开 >> Coronary Arteriosclerosis Hyperlipidemia 收起 << | Phase 3 | Completed | - | - |
NCT01259284 | - | Terminated(Terminated due to l... 展开 >>ow accrual.) 收起 << | - | - | |
NCT00136981 | Hypercholesterolemia, Familial... 展开 >> Hyperlipidemia 收起 << | Phase 3 | Completed | - | - |
NCT00004466 | Nephrotic Syndrome ... 展开 >> Hyperlipidemia 收起 << | Phase 2 | Terminated(Very poor enrollmen... 展开 >>t) 收起 << | - | United States, Texas ... 展开 >> Medical City Dallas Hospital Dallas, Texas, United States, 75230 收起 << |
NCT00474240 | Hypercholesterolemia | Phase 2 | Completed | - | United States, Alabama ... 展开 >> Medical Affiliated Research Center Huntsville, Alabama, United States, 35801 United States, Florida Jacksonville Center for Clinical research Jacksonville, Florida, United States, 32205 Jacksonville Center For Clinical Research Jacksonville, Florida, United States, 32216 Renstar Medical Research Ocala, Florida, United States, 34471 United States, Georgia North Georgia Clinical Research Woodstock, Georgia, United States, 30189 United States, Illinois Radiant Research Chicago, Illinois, United States, 60610 United States, Indiana Medsphere Medical Research Center Evansville, Indiana, United States, 47714 Midwest Institute for Clinical Research Indianapolis, Indiana, United States, 46260 United States, Maine Maine Research Associates Auburn, Maine, United States, 04210 United States, Maryland Health Trends Research Baltimore, Maryland, United States, 21209 United States, North Carolina Piedmont Medical Research Associates Winston-Salem, North Carolina, United States, 27103 United States, Ohio Sterling Research Group Cincinnati, Ohio, United States, 45246 United States, South Carolina Coastal Carolina Research Center Goose Creek, South Carolina, United States, 29445 United States, Texas Dallas Diabetes and Endocrine Center Dallas, Texas, United States, 75230 Diabetes and Glandular Disease Research Dallas, Texas, United States, 78229 United States, Virginia Hampton Roads Center for Clinical Research Norfolk, Virginia, United States, 23502 National Clinical Research Richmond, Virginia, United States, 23294 收起 << |
NCT01041729 | Peripheral Arterial Disease | Phase 4 | Completed | - | Spain ... 展开 >> Hospital Universitario Getafe Getafe, Madrid, Spain, 28905 收起 << |
NCT00474240 | - | Completed | - | - | |
NCT00124397 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Denmark ... 展开 >> Department of Medical Research SHF Svendborg, Svendborg, Denmark, 5700 收起 << |
NCT00317967 | Hypertrophic Cardiomyopathy | Phase 3 | Completed | - | Canada, Alberta ... 展开 >> University of Calgary, Faculty of Medicine Calgary, Alberta, Canada, T2N 4N1 收起 << |
NCT00137462 | Hyperlipidemia | Phase 3 | Completed | - | - |
NCT00134238 | Mixed Hyperlipidemia | Phase 3 | Terminated | - | - |
NCT00454545 | Crohns Disease | Phase 2 | Completed | - | Sweden ... 展开 >> Department of Medicine, Division of Gastroenterology and Hepatology Malmö, Sweden, 20502 Malmö 收起 << |
NCT00276133 | Chronic Nephropathy | Phase 4 | Completed | - | Japan ... 展开 >> Yokohama City University Center Hospital Yokohama, Kanagawa, Japan, 232-0024 收起 << |
NCT00442325 | Coronary Arteriosclerosis ... 展开 >> Diabetes Mellitus, Type 2 Cerebrovascular Accident Dyslipidemia Peripheral Vascular Disease 收起 << | Phase 4 | Completed | - | Greece ... 展开 >> Pfizer Investigational Site Ioannina, Greece Pfizer Investigational Site Kallithea, Athens, Greece Pfizer Investigational Site Pireaus, Greece Pfizer Investigational Site Thessaloniki, Greece Hungary Pfizer Investigational Site Budapest, Hungary Pfizer Investigational Site Gyula, Hungary Pfizer Investigational Site Kecskemet, Hungary Pfizer Investigational Site Nyíregyháza, Hungary Pfizer Investigational Site Szekszárd, Hungary Ireland Pfizer Investigational Site Tullamore, Co. Offlay, Ireland Pfizer Investigational Site Tallaght, Dublin, Ireland Pfizer Investigational Site Gorey, Wexford, Ireland Pfizer Investigational Site Cork, Ireland Pfizer Investigational Site Dublin 8, Ireland Pfizer Investigational Site Dublin, Ireland Pfizer Investigational Site Galway, Ireland Poland Pfizer Investigational Site Czestochowa, Poland Pfizer Investigational Site Poznan, Poland Pfizer Investigational Site Warszawa, Poland Pfizer Investigational Site Wroclaw, Poland Pfizer Investigational Site Zabrze, Poland Portugal Pfizer Investigational Site Aveiro, Portugal Pfizer Investigational Site Lisboa, Portugal Pfizer Investigational Site Porto, Portugal Pfizer Investigational Site Vila Franca de Xira, Portugal Russian Federation Pfizer Investigational Site Moscow, Russian Federation Slovakia Pfizer Investigational Site Bratislava, Slovakia Pfizer Investigational Site Kosice, Slovakia Switzerland Pfizer Investigational Site Bern, Switzerland Pfizer Investigational Site Genève, Switzerland Pfizer Investigational Site Mendrisio, Switzerland Pfizer Investigational Site Zürich, Switzerland 收起 << |
NCT01544309 | Hypercholesterolemia With Conc... 展开 >>omitant Type 2 Diabetes 收起 << | Not Applicable | Completed | - | - |
NCT00289900 | Mixed Hyperlipidemia | Phase 3 | Completed | - | - |
NCT01163851 | - | Completed | - | - | |
NCT00519363 | Systemic Lupus Erythematosus | Phase 1 Phase 2 | Completed | - | United States, Missouri ... 展开 >> The Center for Rheumatic Disease, Allergy, and Immunology Kansas City, Missouri, United States, 64111 收起 << |
NCT00289900 | - | Completed | - | - | |
NCT01163851 | Hypercholesterolemia ... 展开 >> Dyslipidemia 收起 << | Phase 1 | Completed | - | United States, Arizona ... 展开 >> Premier Research Group, Limited Peoria, Arizona, United States, 85381 Dedicated Phase 1, Inc. Phoenix, Arizona, United States, 85013 Premier Research Group Limited Phoenix, Arizona, United States, 85027 United States, Kansas Vince and Associates Clinical Research Overland Park, Kansas, United States, 66211 Vince and Associates Clinical Research Overland Park, Kansas, United States, 66212 收起 << |
NCT00701220 | Cardiovascular Disease ... 展开 >> Cardiomyopathy Heart Disease Myocardial Disease Myocardial Ischemia 收起 << | Phase 4 | Completed | - | United States, Ohio ... 展开 >> The Ohio State University Columbus, Ohio, United States, 43210 收起 << |
NCT00651404 | Hypercholesterolemia ... 展开 >> Atherosclerosis 收起 << | Phase 3 | Completed | - | - |
NCT01544309 | - | Completed | - | - | |
NCT03625089 | Arthritis, Rheumatoid ... 展开 >> Arthritis, Psoriatic 收起 << | Not Applicable | Not yet recruiting | September 30, 2020 | Hong Kong ... 展开 >> Department of Medicine and Therapeutics Hong Kong, Hong Kong 收起 << |
NCT02098460 | Severe Hypercholesterolemia | Phase 4 | Unknown | April 2017 | China ... 展开 >> Anzhen hospital Recruiting Beijing, China Contact: Jie Lin, Dr 00861064412431 Principal Investigator: Jie Lin, Dr 收起 << |
NCT03639480 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 3 | Enrolling by invitation | October 2018 | Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Korea, Republic of 收起 << |
NCT02608697 | Hypercholesterolemia | Phase 2 | Completed | - | - |
NCT00465088 | Hyperlipidemia ... 展开 >> Mixed Dyslipidemia 收起 << | Phase 3 | Completed | - | - |
NCT00442845 | Coronary Arteriosclerosis ... 展开 >> Diabetes Mellitus, Type 2 Cerebrovascular Accident Dyslipidemia Peripheral Vascular Disease 收起 << | Phase 4 | Completed | - | - |
NCT00465088 | - | Completed | - | - | |
NCT02157337 | Aortic Surgery ... 展开 >> Acute Kidney Injury 收起 << | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Department of Anesthesiology and Pain Medicine Seoul, Korea, Republic of, 120-752 收起 << |
NCT00166036 | Diabetes Mellitus ... 展开 >> Metabolic Syndrome X Hypercholesterolemia 收起 << | Phase 2 | Completed | - | United States, Georgia ... 展开 >> Emory University Hospital Atlanta, Georgia, United States, 30322 收起 << |
NCT00166036 | - | Completed | - | - | |
NCT00967252 | - | Completed | - | Canada, Ontario ... 展开 >> The Ottawa Hospital Ottawa, Ontario, Canada, K1Y4E9 收起 << | |
NCT01385631 | ST-Segment Elevation Myocardia... 展开 >>l Infarction 收起 << | Phase 4 | Completed | - | Denmark ... 展开 >> Department of Cardiology, Odense University Hospital Odense C, Denmark, 5000 收起 << |
NCT00103974 | Multiple Sclerosis | Phase 1 | Completed | - | United States, Arizona ... 展开 >> Barrow Neurology Clinics Phoenix, Arizona, United States, 85013 United States, California USC, LAC & USC Medical Center Los Angeles, California, United States, 90033 Canada, British Columbia University of British Columbia, MS Research Vancouver, British Columbia, Canada, V6T 2B5 Canada, Quebec Montreal Neurological Institute, Clinical Research Unit and MS clinic Montreal, Quebec, Canada, H3A 2B4 收起 << |
NCT02516111 | Chronic Periodontitis | Phase 2 Phase 3 | Completed | - | - |
NCT00141141 | Hypercholesterolemia | Phase 4 | Completed | - | Italy ... 展开 >> Pfizer Investigational Site S. Benedetto Del Tronto, Ascoli Piceno, Italy, 63039 Pfizer Investigational Site S.Pietro Vernotico, Brindisi, Italy Pfizer Investigational Site Casarano, Lecce, Italy, 73043 Pfizer Investigational Site Pavia, PV, Italy, 27100 Pfizer Investigational Site Orbassano, Torino, Italy, 10043 Pfizer Investigational Site Mestre, VE, Italy, 30174 Pfizer Investigational Site Ancona, Italy, 60100 Pfizer Investigational Site Asti, Italy, 14100 Pfizer Investigational Site Bari, Italy, 70124 Pfizer Investigational Site Cagliari, Italy, 09134 Pfizer Investigational Site Campobasso, Italy, 86100 Pfizer Investigational Site Catania, Italy, 95124 Pfizer Investigational Site Catania, Italy, 95126 Pfizer Investigational Site Catanzaro, Italy, 88100 Pfizer Investigational Site Ferrara, Italy, 44100 Pfizer Investigational Site Genova, Italy, 16132 Pfizer Investigational Site Messina, Italy, 98158 Pfizer Investigational Site Milano, Italy, 20142 Pfizer Investigational Site Milano, Italy, 20145 Pfizer Investigational Site Milano, Italy, 20157 Pfizer Investigational Site Napoli, Italy, 80100 Pfizer Investigational Site Napoli, Italy, 80131 Pfizer Investigational Site Palermo, Italy, 90127 Pfizer Investigational Site Parma, Italy, 43100 Pfizer Investigational Site Perugia, Italy, 06100 Pfizer Investigational Site Pisa, Italy, 56124 Pfizer Investigational Site Potenza, Italy, 85100 Pfizer Investigational Site Rimini, Italy, 47900 Pfizer Investigational Site Roma, Italy, 00155 Pfizer Investigational Site Roma, Italy, 00161 Pfizer Investigational Site Roma, Italy, 00163 Pfizer Investigational Site Roma, Italy, 00168 Pfizer Investigational Site S. Benedetto del Tronto (AP), Italy, 63039 Pfizer Investigational Site Torino, Italy, 10154 Pfizer Investigational Site Udine, Italy, 33100 收起 << |
NCT00703261 | Atherosclerotic Vascular Disea... 展开 >>se 收起 << | Phase 1 | Completed | - | - |
NCT00703261 | - | Completed | - | - | |
NCT01023607 | Coronary Artery Disease ... 展开 >> Hyperlipidemia 收起 << | Phase 4 | Completed | - | China, Heilongjiang ... 展开 >> The Second Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China, 150081 收起 << |
NCT00138762 | Hyperlipidemia | Phase 3 | Completed | - | - |
NCT01660191 | - | Completed | - | - | |
NCT00145431 | Hyperlipoproteinemia Type III | Phase 3 | Terminated | - | - |
NCT01692717 | Healthy Subjects | Phase 1 | Unknown | May 2013 | Brazil ... 展开 >> LAL Clínica Pesquisa e Desenvolvimento Ltda Not yet recruiting Valinhos, São Paulo, Brazil Contact: Alexandre Frederico, physician 55 19 38716399 alexandre@lalclinica.com.br 收起 << |
NCT00300469 | Mixed Dyslipidemia ... 展开 >> Coronary Heart Disease Dyslipidemia 收起 << | Phase 3 | Completed | - | United States, Illinois ... 展开 >> Global Medical Information North Chicago, Illinois, United States, 60064 收起 << |
NCT01660191 | Hypercholesterolemia | Phase 4 | Completed | - | United States, Kansas ... 展开 >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 收起 << |
NCT02612792 | Furcation Defects | Phase 2 Phase 3 | Completed | - | India ... 展开 >> Government Dental College and Research Institute Bangalore, Karnataka, India, 560002 收起 << |
NCT00300469 | - | Completed | - | - | |
NCT02099123 | Independent Living ... 展开 >> Disability Free Survival Elderly Healthy 收起 << | Phase 4 | Enrolling by invitation | December 2022 | Australia, Tasmania ... 展开 >> Tasmania Hobart, Tasmania, Australia Australia, Victoria Victoria Melbourne, Victoria, Australia Australia Queensland Brisbane, Australia New South Wales Newcastle, Australia Western Australia Perth, Australia 收起 << |
NCT00862251 | Cardiovascular Disorder ... 展开 >> Diabetes Mellitus 收起 << | Phase 3 | Completed | - | - |
NCT01288443 | Hypercholesterolemia | Phase 2 | Completed | - | - |
NCT00862251 | - | Completed | - | - | |
NCT01288443 | - | Completed | - | - | |
NCT01013870 | Traumatic Brain Injury ... 展开 >> Post-traumatic Stress Disorder 收起 << | Phase 2 | Terminated(inability to recrui... 展开 >>t adequate numbers of subjects) 收起 << | - | United States, Texas ... 展开 >> Baylor College of Medicine/Ben Taub General Hospital Houston, Texas, United States, 77030 University of Texas Health Science Center at Houston/Memorial Hermann Hospital Houston, Texas, United States, 77030 收起 << |
NCT01013870 | - | Terminated(inability to recrui... 展开 >>t adequate numbers of subjects) 收起 << | - | - | |
NCT00239330 | Hypercholesteremia | Phase 3 | Completed | - | Belgium ... 展开 >> Research Site Antwerpen, Belgium Research Site Arlon, Belgium Research Site Assebroek, Belgium Research Site Ath, Belgium Research Site Aye, Belgium Research Site Bastogne, Belgium Research Site Baudour, Belgium Research Site Borgerhout, Belgium Research Site Bornem, Belgium Research Site Bouge, Belgium Research Site Brugge, Belgium Research Site Brussels, Belgium Research Site Charleroi, Belgium Research Site Dendermonde, Belgium Research Site Frameries, Belgium Research Site Gent, Belgium Research Site Hasselt, Belgium Research Site Havré, Belgium Research Site Kortenberg, Belgium Research Site Leuven, Belgium Research Site Mol, Belgium Research Site Namur, Belgium Research Site Oostende, Belgium Research Site Roeselare, Belgium Research Site Schoten, Belgium Research Site Sint-Agatha-Berchem, Belgium 收起 << |
NCT00147602 | Cardiovascular Disease | Phase 4 | Completed | - | - |
NCT00751907 | Alzheimer's Disease | Phase 2 | Completed | - | United States, Wisconsin ... 展开 >> University of Wisconsin Madison, Wisconsin, United States, 53705 收起 << |
NCT01448174 | Renal Failure Chronic Requirin... 展开 >>g Hemodialysis Metabolic Syndrome Diabetes Mellitus Type 2 Hyperlipidemia 收起 << | Phase 4 | Completed | - | Poland ... 展开 >> BBraun Avitum Dialysis Center Nowy Tomyśl, Wielkopolska, Poland, 64-300 收起 << |
NCT00914017 | Breast Cancer | Phase 2 | Unknown | - | United States, California ... 展开 >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Ono Nyseo 415-885-7638 onouwem.nseyo@ucsfmedctr.org Principal Investigator: Laura Esserman, MD United States, Delaware Delaware Christiana Care CCOP, Helen F. Graham Cancer Center Recruiting Newark, Delaware, United States, 19718 Contact: Pam Eppes 302-623-4125 Principal Investigator: Stephen Grubbs, MD United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Carleen Gentry 617-632-5399 Principal Investigator: Judy Garber, MD, MPH United States, Nevada Southern Nevada Cancer Research Foundation Recruiting Las Vegas, Nevada, United States, 89106 Contact: Jennifer Eccles 702-384-0013 Principal Investigator: John Ellerton, MD United States, North Carolina Duke University Recruiting Durham, North Carolina, United States, 27705 Contact: Shelly Epps, MS 919-956-5644 clark086@mc.duke.edu Principal Investigator: Victoria Seewaldt, MD Southeastern Medical Oncology Center Recruiting Goldsboro, North Carolina, United States, 27534 Contact: Monica Brimberry 919-580-0000 ext 138 monicab@cancersmoc.com Principal Investigator: James Atkins, MD United States, Vermont Vermont Cancer Center Recruiting Burlington, Vermont, United States, 05405 Contact: Fonda Kingsley, MHS 802-656-8502 Fonda.Kingsley@uvm.edu Principal Investigator: Marie E Wood, MD 收起 << |
NCT01029522 | Dyslipidemia | Phase 4 | Completed | - | - |
NCT00195793 | Hyperlipidemia | Phase 3 | Completed | - | - |
NCT00541697 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT02609711 | Healthy Male Subjects | Phase 1 | Unknown | - | Korea, Republic of ... 展开 >> Inha Univ. Hospital Incheon, Korea, Republic of 收起 << |
NCT03311841 | Renal Insufficiency | Phase 1 | Completed | - | United States, Florida ... 展开 >> Clinical Pharmacology of Miami ( Site 0001) Hialeah, Florida, United States, 33014 Orlando Clinical Research Center ( Site 0002) Orlando, Florida, United States, 32809 收起 << |
NCT00296387 | Acute Coronary Syndrome | Phase 3 | Completed | - | - |
NCT00329173 | Hypercholesterolaemia | Phase 3 | Completed | - | - |
NCT00249249 | Primary Hypercholesterolemia ... 展开 >> Dyslipidemia 收起 << | Phase 3 | Completed | - | - |
NCT03231137 | Alveolar Socket Preservations | Phase 4 | Completed | - | - |
NCT02947620 | Type II Diabetes ... 展开 >> Dyslipidemia 收起 << | Phase 3 | Unknown | - | Korea, Republic of ... 展开 >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Daewoong Clinical 收起 << |
NCT00249249 | - | Completed | - | - | |
NCT01305317 | Chronic Kidney Disease | Not Applicable | Completed | - | Iran, Islamic Republic of ... 展开 >> Shahid Mohammadi hospital Bandar Abbas, Hormozgan, Iran, Islamic Republic of, 79176 收起 << |
NCT00432354 | Systemic Lupus Erythematosus | Phase 2 Phase 3 | Unknown | March 2009 | Taiwan ... 展开 >> Buddhist Dalin Tzu Chi General Hospital Not yet recruiting Chia-Yi, Taiwan, 622 Contact: Ming-Chi Lu, MD 886-5-2648000 ext 5201 e360187@yahoo.com.tw Principal Investigator: Ming-Chi Lu, MD Dalin Tzu Chi General Hospital Recruiting Chia-yi, Taiwan, 622 Contact: Ming-Chi Lu, MD 05-2648000 ext 5201 e360187@yahoo.com.tw Contact: Ning-Sheng Lai, MD, Phd 05-2648000 ext 5006 收起 << |
NCT03047538 | Arterial Hypertension ... 展开 >> Dyslipidemias Blood Pressure Lipid Metabolism Disorders 收起 << | Phase 4 | Recruiting | December 31, 2019 | Czechia ... 展开 >> Center for Cardiovascular Prevention, Charles University Medical Faculty and Thomayer Hospital Recruiting Prague, Czechia, 140 59 Contact: Peter Wohlfahrt, MD, PhD +420739777242 wohlfp@gmail.com 收起 << |
NCT03031119 | Healthy Volunteers | Phase 1 | Completed | - | Belgium ... 展开 >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 << |
NCT00154024 | Healthy Subjects | Not Applicable | Completed | - | Germany ... 展开 >> Institute of Clinical Pharmacology, Medical Faculty, University of Technology Dresden, Germany, 01307 收起 << |
NCT00654537 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT01525407 | Malignant Neoplasm | Phase 2 | Completed | - | United States, California ... 展开 >> Stanford University Hospitals and Clinics Stanford, California, United States, 94305 United States, Colorado Colorado Blood Cancer Institute Denver, Colorado, United States, 80907 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT01525407 | - | Completed | - | - | |
NCT02189837 | Primary Hyperlipidemia and Mix... 展开 >>ed Dyslipidemia 收起 << | Phase 3 | Completed | - | Australia, South Australia ... 展开 >> Research Site Adelaide, South Australia, Australia, 5000 Australia, Western Australia Research Site Nedlands, Western Australia, Australia, 6009 收起 << |
NCT00345202 | Healthy | Phase 4 | Completed | - | Denmark ... 展开 >> Medical research unit, Department of medicin, Holstebro Sygehus Holstebro, Ringkøbing countie, Denmark, 7500 收起 << |
NCT02189837 | - | Completed | - | - | |
NCT02422030 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Chonbuk National University Hospital Deokjin-gu, Jeonju-si, Jeollabuk-do, Korea, Republic of, 561-712 收起 << |
NCT00504829 | Dyslipidemia | Phase 2 | Completed | - | United States, Illinois ... 展开 >> Radiant Research, 515 N State Street, Suite 2700 Chicago, Illinois, United States, 60610 收起 << |
NCT03438955 | Hyperlipidemia, Hypertriglycer... 展开 >>idemia 收起 << | Phase 1 | Recruiting | August 31, 2018 | Korea, Republic of ... 展开 >> Dong-A National University Hospital Recruiting Busan, Korea, Republic of, 49201 Contact: Min Kyu Park 收起 << |
NCT00932048 | Type 2 Diabetes ... 展开 >> Atherosclerosis 收起 << | Not Applicable | Withdrawn | March 2012 | Korea, Republic of ... 展开 >> Tae Nyun Kim Seoul, Korea, Republic of, 152-050 收起 << |
NCT01208701 | Nephropathy C... 展开 >>ardiovascular Diseases Diabetes Mellitus 收起 << | Phase 2 | Completed | - | Denmark ... 展开 >> Medicinsk Forskning, Regionshospitalet Holstebro Holstebro, Denmark, 7500 收起 << |
NCT01033058 | STEMI | Phase 4 | Unknown | June 2011 | China, Chaoyang ... 展开 >> Chaoyang Hospital Not yet recruiting Beijing, Chaoyang, China, 100020 Contact: Yanying Shen, Dr. 85201000 Principal Investigator: Xinchun Yang, Prof. 收起 << |
NCT00481364 | Vascular Calcification ... 展开 >> Atherosclerosis Dyslipidemia Inflammation 收起 << | Phase 3 | Completed | - | Turkey ... 展开 >> Ege University School of Medicine, Division of Nephrology Bornova, Izmir, Turkey, 35100 收起 << |
NCT03051100 | Hypercholesterolemia | Phase 2 | Completed | - | United States, Illinois ... 展开 >> PMG Research of Christie Clinic Champaign, Illinois, United States, 61820 United States, North Carolina PMG Research of Cary Cary, North Carolina, United States, 27518 PMG Research of Charlotte Charlotte, North Carolina, United States, 28209 Sensenbrenner Primary Care Charlotte, North Carolina, United States, 28277 PMG Research of Hickory Hickory, North Carolina, United States, 28601 PMG Research of Raleigh Raleigh, North Carolina, United States, 27609 PMG Research of Rocky Mount Rocky Mount, North Carolina, United States, 27804 PMG Research Salisbury Salisbury, North Carolina, United States, 28144 PMG Research of Wilmington Wilmington, North Carolina, United States, 28401 United States, South Carolina PMG Research of Charleston Mount Pleasant, South Carolina, United States, 29464 United States, Virginia Hampton Roads Center for Clinical Research Virginia Beach, Virginia, United States, 23451 收起 << |
NCT00926614 | Hepatitis c | Phase 4 | Completed | - | United States, Texas ... 展开 >> Brooke Army Medical Center San Antonio, Texas, United States, 78234 收起 << |
NCT00427960 | Hypercholesterolaemia | Phase 4 | Terminated(Due to inadequate r... 展开 >>ecruitment) 收起 << | - | United Kingdom ... 展开 >> Research Site Allerton, United Kingdom Research Site Birmingham, United Kingdom Research Site Blackburn, United Kingdom Research Site Bolton, United Kingdom Research Site Crawley, United Kingdom Research SIte Glasgow, United Kingdom Research Site Newcastle, United Kingdom Research SIte Sheffield, United Kingdom Research SIte Slough, United Kingdom 收起 << |
NCT00654485 | Metabolic Syndrome | Phase 3 | Completed | - | - |
NCT00427960 | - | Terminated(Due to inadequate r... 展开 >>ecruitment) 收起 << | - | - | |
NCT00540293 | Dyslipidemias | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Pfizer Investigational Site Daegu, Korea, Korea, Republic of, 705-717 Pfizer Investigational Site Seoul, Korea, Korea, Republic of, 135-710 Pfizer Investigational Site Busan, Korea, Republic of, 602-739 Pfizer Investigational Site Busan, Korea, Republic of, 614-735 Pfizer Investigational Site Daegu, Korea, Republic of, 700-712 Pfizer Investigational Site Daejeon, Korea, Republic of, 302-718 Pfizer Investigational Site Gwangju, Korea, Republic of, 501-757 Pfizer Investigational Site Gwangju, Korea, Republic of, 503-715 Pfizer Investigational Site Gyeonggi-do, Korea, Republic of, 431-070 Pfizer Investigational Site Gyeonggi-do, Korea, Republic of, 463-707 Pfizer Investigational Site Incheon, Korea, Republic of, 405-760 Pfizer Investigational Site Kyunggi-do, Korea, Republic of, 420-717 Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 Pfizer Investigational Site Seoul, Korea, Republic of, 110-746 Pfizer Investigational Site Seoul, Korea, Republic of, 120-752 Pfizer Investigational Site Seoul, Korea, Republic of, 134-010 Pfizer Investigational Site Seoul, Korea, Republic of, 136-705 Pfizer Investigational Site Seoul, Korea, Republic of, 137-701 Pfizer Investigational Site Seoul, Korea, Republic of, 138-736 Pfizer Investigational Site Seoul, Korea, Republic of, 143-914 收起 << |
NCT00689442 | Dyslipidemia | Phase 2 | Completed | - | Netherlands ... 展开 >> Amsterdam, Netherlands 收起 << |
NCT00540293 | - | Completed | - | - | |
NCT00392717 | Obesity Dysli... 展开 >>pidemia Insulin Resistance 收起 << | Phase 3 | Completed | - | Australia, Western Australia ... 展开 >> Royal Perth Hospital Perth, Western Australia, Australia, 6000 收起 << |
NCT02411903 | Cerebral Infarction ... 展开 >> Clopidogrel,Poor Metabolism of (Disorder) 收起 << | Phase 4 | Unknown | August 2016 | - |
NCT01806324 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> Baltimore, Maryland, United States, 21201 收起 << |
NCT00967434 | Inflammation ... 展开 >>Myocardial Infarction Myocardial Ischemia 收起 << | Not Applicable | Completed | - | Canada, Ontario ... 展开 >> The Ottawa Hospital Ottawa, Ontario, Canada, K1Y4E9 收起 << |
NCT01709513 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00570752 | Vascular Diseases | Phase 2 | Completed | - | United States, Florida ... 展开 >> Southeast Clinical Research, Llc Chiefland, Florida, United States, 32626 Jacksonville Center For Clinical Research - Univ Campus Jacksonville, Florida, United States, 32216 Florida Cardiovascular Institute Tampa, Florida, United States, 33609 United States, Indiana Phillip D. Toth, Md Indianapolis, Indiana, United States, 46260 United States, Kentucky L-Marc Research Center Louisville, Kentucky, United States, 40213 Commonwealth Biomedical Research, Llc Madisonville, Kentucky, United States, 42431 United States, Massachusetts Mgh Cardiac Mr Pet Ct Program Boston, Massachusetts, United States, 02114 United States, Michigan Troy Internal Medince Pc/Research Troy, Michigan, United States, 48098 United States, Minnesota Radiant Research, Inc. Edina, Minnesota, United States, 55435 United States, New York Mount Sinai School Of Medicine Imaging Science Laboratories New York, New York, United States, 10029 United States, North Carolina The Lipid Center Statesville, North Carolina, United States, 28677 United States, Ohio Metabolic And Atherosclerosis Research Center Cincinnati, Ohio, United States, 45212 Sterling Research Group Cincinnati, Ohio, United States, 45219 United States, Pennsylvania Hospital Of The University Of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas Radiant Research, Inc. Dallas, Texas, United States, 75231 Baylor College Of Medicine Houston, Texas, United States, 77030 Mcallen Heart Clinic Mc Allen, Texas, United States, 78503 收起 << |
NCT01352897 | - | Completed | - | Singapore ... 展开 >> Research Site Singapore, Singapore 收起 << | |
NCT01709513 | - | Completed | - | - | |
NCT01040936 | Acute Coronary Syndrome | Phase 4 | Unknown | November 2011 | China, Shanghai ... 展开 >> Ruijin Hospital, Dept. of Cardiology Recruiting Shanghai, Shanghai, China, 200025 Contact: Xin Chen, MD +862164370045 ext 665215 rjchenxin@yahoo.com.cn 收起 << |
NCT00335699 | Hypercholesterolemia | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Research Site DaeGu, Korea, Republic of Research Site IkSan, Korea, Republic of Research Site JeonJu, Korea, Republic of Research Site JinJu, Korea, Republic of Research Site KwangJu, Korea, Republic of Research Site Pusan, Korea, Republic of Research Site Ulsan, Korea, Republic of 收起 << |
NCT01527045 | Aggressive Non-Hodgkin Lymphom... 展开 >>a Blasts Under 5 Percent of Bone Marrow Nucleated Cells Chronic Lymphocytic Leukemia Loss of Chromosome 17p Myelodysplastic/Myeloproliferative Neoplasm Non-Hodgkin Lymphoma Prolymphocytic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Aggressive Adult Non-Hodgkin Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Chronic Lymphocytic Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recurrent Diffuse Large B-Cell Lymphoma Recurrent Hodgkin Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Non-Hodgkin Lymphoma Recurrent Plasma Cell Myeloma Recurrent Small Lymphocytic Lymphoma Waldenstrom Macroglobulinemia 收起 << | Phase 2 | Recruiting | - | United States, Colorado ... 展开 >> Presbyterian - Saint Lukes Medical Center - Health One Completed Denver, Colorado, United States, 80218 United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Marco Mielcarek 206-667-2827 mmielcar@fhcrc.org Principal Investigator: Marco Mielcarek 收起 << |
NCT00743925 | Acute Coronary Syndrome | Phase 2 | Completed | - | Georgia ... 展开 >> Cardiological hospital of The Patriarchate of all Georgia Tbilisi, Georgia, 0102 Tbilisi State Medical University, Al. Aladashvili University Clinic Tbilisi, Georgia, 0102 Cardio Reanimation Centre Tbilisi, Georgia, 0141 Cardiological Clinic "Guli" Tbilisi, Georgia, 0144 Tbilisi LTD Cardiology Clinic Tbilisi, Georgia, 0144 Emergency Cardiology Center by acad. G. Chapidze Tbilisi, Georgia, 0159 National Center of Therapy Tbilisi, Georgia, 0159 Multiprofile Clinical Hospital of Tbilisi #2 Tbilisi, Georgia, 0164 Diagnostic Services Clinic Tbilisi, Georgia, 0179 Limited Company "ADAPTI" The Clinic of Angiocardiology "ADAPTI" Tbilisi, Georgia, 0186 Russian Federation New Hospital Medical Union Ekaterinburg, Russian Federation, 620109 Municipal Healthcare Institution Gatchina, Russian Federation, 188300 Municipal Healthcare Institution Kemerovo, Russian Federation, 650002 Non-State Healthcare Institution Kemerovo, Russian Federation, 650055 Krasnoyarsk Medical Academy Krasnoyarsk, Russian Federation, 660022 State Healthcare Intstitution of Moscow Moscow, Russian Federation, 111539 City Clinical Hospital №12 Nizhniy Novgorod, Russian Federation, 603003 Municipal Healthcare Institution Novosibirsk, Russian Federation, 630008 Regional State Healthcare Institution Novosibirsk, Russian Federation, 630047 Municipal Healthcare Institution Perm, Russian Federation, 614107 St.Petersburg State Healthcare Institution Saint-Petersburg, Russian Federation, 190000 St.Petersburg State Healthcare Institution Saint-Petersburg, Russian Federation, 191144 Saint-Petersburg State Healthcare Institution Saint-Petersburg, Russian Federation, 198205 St.Petersburg State Healthcare Institution Saint-Petersburg, Russian Federation, 199106 State Healthcare Institution Samara, Russian Federation, 443070 Saratov State Medical University Saratov, Russian Federation, 410012 Federal State Institution Saratov, Russian Federation, 410028 State Healthcare Institution St-Petersburg, Russian Federation, 195197 St.Petersburg State Healthcare Institution St-Petersburg, Russian Federation, 195257 State Educational Institution for Further Professional Training St.Petersburg, Russian Federation, 191015 Federal State Healthcare Institution St.Petersburg, Russian Federation, 194044 State Institution Research Cardiology Institute Tomsk, Russian Federation, 634012 Tyumen Cardiology Center, Tyumen, Russian Federation, 625026 Ukraine Municipal Clinical Hospital No. 27 Kharkiv, Ukraine, 61002 Department of Cardiology of Central Clinical Hospital Kharkiv, Ukraine, 61018 L.T. Malaya Institute of Therapy of AMS of Ukraine Kharkiv, Ukraine, 61039 Kharkiv Medical Academy of Post-Graduate Education Kharkiv, Ukraine, 61178 Kyiv City Clinical Hospital #1 Kyiv, Ukraine, 02175 National Scientific Center Kyiv, Ukraine, 03680 Lviv Danylo Halytsky National University Lviv, Ukraine, 79000 Lviv Regional State Clinical Treatment and Diagnostics Cardiology Center Lviv, Ukraine, 79015 Uzhgorod National University Uzhgorod, Ukraine, 88014 Zaporizhzhya Regional Cardiological Dispensary Zaporizhzhya, Ukraine, 69000 Zhytomyr city hospital #1 Zhytomyr, Ukraine, 10002 收起 << |
NCT02119520 | Periodontitis | Phase 2 | Completed | - | India ... 展开 >> Govt dental college and research institute Bangalore, Karnataka, India, 560002 收起 << |
NCT01857921 | Coronary Artery | Not Applicable | Unknown | October 2016 | Korea, Republic of ... 展开 >> Severance Hospital Recruiting Seoul, Korea, Republic of, 120-752 Contact: Myeong Ki Hong, MD, PhD 82-2-2228-8460 mkhong61@yuhs.ac 收起 << |
NCT00535405 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00127335 | Myopathic Conditions | Phase 4 | Terminated(Lack of funding) | - | United States, California ... 展开 >> Scripps Mercy Hospital San Diego, California, United States, 92103 收起 << |
NCT01528709 | - | Completed | - | - | |
NCT00535405 | - | Completed | - | - | |
NCT00656331 | Hypertension | Not Applicable | Terminated | June 2012 | United States, New Mexico ... 展开 >> UNMHSC Albuquerque, New Mexico, United States, 87131 收起 << |
NCT02227784 | Hyperlipidemia | Phase 3 | Terminated(Study termination d... 展开 >>ue to program termination.) 收起 << | - | - |
NCT03515772 | - | Recruiting | October 31, 2019 | Switzerland ... 展开 >> Universitätsspital Basel Recruiting Basel, Switzerland, 4031 Contact: Catia Marzolini, PhD +41 77 454 92 28 Catia.Marzolini@usb.ch Centre Hospitalier Universitaire Vaudois (CHUV) Recruiting Lausanne, Switzerland, 1011 Contact: Perrine Courlet +41 21 314 42 60 perrine.courlet@chuv.ch 收起 << | |
NCT02227784 | - | Terminated(Study termination d... 展开 >>ue to program termination.) 收起 << | - | - | |
NCT01528709 | Saphenous Vein Graft Disease | Phase 3 | Completed | - | United States, Florida ... 展开 >> Lynn Heart and Vascular Institute, Boca Raton Regional Hospital Boca Raton, Florida, United States, 33486 Canada, Ontario University of Ottawa Heart Institute Ottawa, Ontario, Canada, K1Y 4W7 收起 << |
NCT03382756 | Dyslipidemias | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Dong-A University Hospital Busan, Seo-gu, Korea, Republic of, 602-812 收起 << |
NCT02055976 | Hypercholesterolemia | Phase 2 | Completed | - | Japan ... 展开 >> Maebashi Hirosegawa Clinic Maebashi, Gunma, Japan, 371-0022 Yokohama Minoru Clinic Yokohama, Kanagawa, Japan, 232-0064 Heishinkai Medical Group Incorporated OCROM Clinic Suita, Osaka, Japan, 565-0853 Meiwa Hospital Chiyoda-ku, Tokyo, Japan, 101-0041 Tokyo-Eki Center-building Clinic Chuo-ku, Tokyo, Japan, 103-0027 Heishinkai Medical Group Incorporated ToCROM Clinic Shinjuku-ku, Tokyo, Japan, 160-0022 Clinical Research Hospital Tokyo Shinjuku-ku, Tokyo, Japan, 162-0053 Oda Clinic Shinjuku-ku, Tokyo, Japan, 169-0072 Sekino Hospital Toshima-ku, Tokyo, Japan, 171-0014 收起 << |
NCT01751295 | Coronary Artery Disease | Not Applicable | Unknown | August 2014 | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Gang nam-Gu, Ilwon-Dong, Korea, Republic of, 135-710 收起 << |
NCT02350959 | Plaque | Phase 4 | Unknown | January 2017 | Korea, Republic of ... 展开 >> National Health Insurance Service Ilsan Hospital Recruiting Goyang-si, Gyeonggi-do, Korea, Republic of Contact: Kyung-Jin Park 82-10-2442-4029 收起 << |
NCT02451098 | Hyperlipidemia | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> The catholic university of korea seoul st. Mary's hospital Seoul, Korea, Republic of 收起 << |
NCT03391830 | Contrast-induced Nephropathy ... 展开 >> Statin Ascorbic Acid AKI 收起 << | Not Applicable | Active, not recruiting | January 1, 2019 | Egypt ... 展开 >> Urology and Nephrology Center Mansourah, Aldakahlia, Egypt, 35516 收起 << |
NCT03351998 | Mitochondrial Diseases | Phase 4 | Recruiting | July 1, 2022 | United States, Kansas ... 展开 >> University of Kansas Medical Center Recruiting Kansas City, Kansas, United States, 66160 United States, North Carolina East Carolina University Recruiting Greenville, North Carolina, United States, 27858 Contact: Patty Brophy Principal Investigator: Darrell Neufer, PhD 收起 << |
NCT01442428 | Immune Reconstitution Inflamma... 展开 >>tory Syndrome Immune Reconstitution Syndrome Tuberculosis HIV-infection/Aids 收起 << | Phase 2 Phase 3 | Withdrawn(2011 Thailand floodi... 展开 >>ng led to loss of GMP pharmacy, project delays, and further regulatory challenges.) 收起 << | June 2016 | Thailand ... 展开 >> Ramathibodi Hospital Bangkok, Thailand Chiang Mai University Chiang Mai, Thailand Bamrasnaradura Infectious Diseases Institute Nonthaburi, Thailand 收起 << |
NCT00716846 | Healthy Volunteers | Not Applicable | Completed | - | Japan ... 展开 >> Hamamatsu University School of Medicine Hamamatsu, Japan 收起 << |
NCT01820767 | Chronic Kidney Disease | Phase 3 | Completed | - | Spain ... 展开 >> Hospital El Bierzo. Servicio de Nefrología. Ponferrada, (León)., Spain, 24411, Hospital de León León, Spain, 24008 收起 << |
NCT00395603 | Cardiovascular Diseases ... 展开 >> Diabetes Mellitus 收起 << | Phase 3 | Terminated(This study was term... 展开 >>inated early due to poor recruitment.) 收起 << | - | - |
NCT03750760 | Myocardial Infarction ... 展开 >> Dyslipidemias 收起 << | Phase 4 | Not yet recruiting | July 2019 | United Kingdom ... 展开 >> Royal Devon & Exeter Hospital Not yet recruiting Exeter, Devon, United Kingdom, EX2 5DW Contact: Andrew Sharp, MBChB, MRCP, MD The Royal Bournemouth General Hospital Not yet recruiting Bournemouth, Dorset, United Kingdom, BH7 7DW Contact: Terry Levy, BSc, MB ChB, FRCP East Sussex Healthcare NHS Trust Not yet recruiting Saint Leonards-on-Sea, East Sussex, United Kingdom, TN37 7PT Contact: Robert Gerber, MBBS Basildon Hospital Not yet recruiting Basildon, Essex, United Kingdom, SS16 5NL Contact: Rajesh Aggarwal, MB ChB, FRCP (London), MD St Mary's Hospital Not yet recruiting London, Greater London, United Kingdom, W2 1NY Contact: Jamil Mayet, MBChB, MD, FESC, FACC, FRC Queen Alexandra Hospital Not yet recruiting Portsmouth, Hampshire, United Kingdom, PO6 3LY Contact: Huw Griffiths, MB BS (Hons), MD, FRCP Southampton General Hospital Not yet recruiting Southampton, Hampshire, United Kingdom, SO16 6YD Contact: Nick Curzen, BM(Hons), PhD, FRCP Northwick Park Hospital Not yet recruiting Harrow, Middlesex, United Kingdom, HA1 3UJ Contact: Ahmed Elghamaz, MB BCh MRCP Hull Royal Infirmary Not yet recruiting Hull, North Humberside, United Kingdom, HU3 2JZ Contact: Richard Oliver, MB BS, RFCP DM, FESC Queens Medical Centre Not yet recruiting Nottingham, Nottinghamshire, United Kingdom, NG7 2UH Contact: Shahnaz Jamil-Copley, MBChB, MRCP, PhD St Peters Hospital Not yet recruiting Chertsey, Surrey, United Kingdom, KT16 0PZ Contact: Sumeet Sharma, MD, MRCP, CCT East Surrey Hospital Not yet recruiting Redhill, Surrey, United Kingdom, RH1 5RH Contact: Rashid Iqbal, MSc, MRCP, MRCPI Freeman Hospital Not yet recruiting Newcastle Upon Tyne, Tyne And Wear, United Kingdom, NE7 7DN Contact: Vijay Kunadian, MBBS, MD, FRCP, FACC, FESC Queen Elizabeth Medical Centre Not yet recruiting Birmingham, West Midlands, United Kingdom, B15 2TH Contact: John Townend, MBChB, MD, FRCP, FESC City Hospital Not yet recruiting Birmingham, West Midlands, United Kingdom, B18 7QH Contact: Derek Connolly, MBChB, PhD, FRCP Worchestershire Royal Hospital Not yet recruiting Worcester, Worcestershire, United Kingdom, WR5 1DD Contact: Jasper Trevelyan, MB ChB Northern General Hospital Not yet recruiting Sheffield, Yorkshire, United Kingdom, S5 7AU Contact: Robert Storey, BM, DM, FRCP, FESC 收起 << |
NCT01768481 | Obesity Dysli... 展开 >>pidemia 收起 << | Phase 3 | Completed | - | Canada, Quebec ... 展开 >> Hôpital Maisonneuve-Rosemont Montréal, Quebec, Canada, H1T 2M4 收起 << |
NCT00241488 | Hypercholesterolemia | Phase 3 | Completed | - | China ... 展开 >> Beijing, China Ching Qing, China Guang Zhou, China Harbin, China Ji Nan, China Nanjing, China Shanghai, China Shenyang, China Wu Han, China Hong Kong New Territories, Hong Kong Korea, Republic of Busan, Korea, Republic of Cheonan-si, Korea, Republic of Daegu, Korea, Republic of Ilsan, Korea, Republic of Incheon-Si, Korea, Republic of Kwangju, Korea, Republic of Pusan, Korea, Republic of Pyungchon Kyonggi, Korea, Republic of Seoul, Korea, Republic of Suwon, Korea, Republic of Wonju, Korea, Republic of Malaysia Kuching, Sarawak, Malaysia Bandar Sunway, Selangor, Malaysia Shah Alam, Selangor, Malaysia Kuala Lumpur, Malaysia Penang, Malaysia Petaling Jaya, Malaysia Seberang Perai Utara, Malaysia Taiwan Chunghua City, Taiwan Kaohsiung, Taiwan Taichung City, Taiwan Taipei, Taiwan Tao-Yuan, Taiwan Thailand Bangkok, Thailand 收起 << |
NCT03414840 | - | Recruiting | October 31, 2020 | Korea, Republic of ... 展开 >> Severance Cardiovascular Hospital, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 120-752 Contact: Hyuk-Jae Chang, MD, PhD 收起 << | |
NCT02681653 | Septic Shock | Not Applicable | Completed | - | India ... 展开 >> Department of Immunology, SGPGIMS Lucknow, UP, India, 226014 Department of Critical Care Medicine Lucknow, Uttar Pradesh, India, 226014 收起 << |
NCT02286544 | Myocardial Infarction ... 展开 >> Inflammation Acute Coronary Syndrome (ACS) Reperfusion Injury 收起 << | Phase 1 | Completed | - | Sweden ... 展开 >> Linköping University Hospital Linköping, Sweden, 58191 收起 << |
NCT00166530 | Atherosclerosis | Phase 4 | Completed | - | - |
NCT01213498 | Nephropathy C... 展开 >>ardiovascular Diseases 收起 << | Phase 2 | Completed | - | Denmark ... 展开 >> Medicinsk Forskning, Regionshospitalet Holstebro Holstebro, Denmark, 7500 收起 << |
NCT03346187 | Dyslipidemias | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Dong-A University Hospital Busan, Seo-gu, Korea, Republic of, 602-812 收起 << |
NCT01646307 | Focus of Study | Phase 4 | Unknown | June 2013 | China ... 展开 >> Beijing Anzhen Hospital Recruiting Beijing, China, 100029 Sub-Investigator: Ying-Xin Zhao, MD Principal Investigator: Yu-Jie Zhou, MD, PhD 收起 << |
NCT02392416 | - | Completed | - | Greece ... 展开 >> Gennimatas General State Hospital Athens, Attica, Greece 2nd Cardiology Department, University of Athens, Attikon Hospital, Haidari, Athens, Greece, 12462 收起 << | |
NCT02685462 | Healthy | Phase 1 | Completed | - | United States, Florida ... 展开 >> Miami, Florida, United States 收起 << |
NCT02614352 | Healthy Male Subjects | Phase 1 | Unknown | - | - |
NCT00004564 | Hypercholesterolemia ... 展开 >> Thrombosis 收起 << | Not Applicable | Unknown | - | United States, Michigan ... 展开 >> 1G323 University Hospital, Box 0048 1500 E Medical Center Drive Recruiting Ann Arbor, Michigan, United States, 48109 收起 << |
NCT01050348 | Acute Myocardial Infarction | Phase 4 | Completed | - | United States, Pennsylvania ... 展开 >> Allegheny General Hospital Pittsburgh, Pennsylvania, United States, 15212 The Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224 收起 << |
NCT03073863 | Cardiovascular Diseases | Phase 4 | Completed | - | - |
NCT02160743 | Food Effect Study of CJ-30056 ... 展开 >>20mg/500mg 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Inje University Busan Paik Hospital Busan, Korea, Republic of, 614-735 收起 << |
NCT01569100 | - | Completed | - | - | |
NCT00745836 | Hypercholesterolemia | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Gil Medical Center Incheon, Korea, Republic of, 405760 收起 << |
NCT00296400 | Hyperlipidemia | Phase 2 | Completed | - | - |
NCT01936103 | Acute Anterior Myocardial Infa... 展开 >>rction 收起 << | Phase 4 | Unknown | July 2014 | China, Liaoning ... 展开 >> Shenyang Northen Hospital Recruiting Shenyang, Liaoning, China, 110016 Contact: Wang Geng, Dr 13309886393 收起 << |
NCT00296400 | - | Completed | - | - | |
NCT00120887 | Systemic Lupus Erythematosus | Phase 4 | Completed | - | United States, Maryland ... 展开 >> Johns Hopkins Lupus Center 1830 E Monument Street, Ste 7500 Baltimore, Maryland, United States, 21205 收起 << |
NCT01372839 | Myocardial Infarction ... 展开 >> Unstable Angina 收起 << | Phase 4 | Unknown | - | China, Shaanxi ... 展开 >> Xijing Hospital Recruiting Xi'an, Shaanxi, China, 710032 Contact: Ling Tao, M.D Ph.D +86-15002955798 lingtao2006@gmail.com Principal Investigator: Ling Tao, M.D Ph.D 收起 << |
NCT02254824 | Hypertension | Phase 4 | Unknown | October 2016 | China, Beijing ... 展开 >> Fuwai Hospital Recruiting Beijing, Beijing, China, 100037 Contact: Naqiang Lv, Doctor 0086-10-13466500331 lvnaqiang@gmail.com Principal Investigator: Aimin Dang, Doctor 收起 << |
NCT00609063 | Hydroxymethylglutaryl-CoA Redu... 展开 >>ctase Inhibitors Muscular Diseases 收起 << | Not Applicable | Completed | - | United States, Connecticut ... 展开 >> Hartford Hospital Hartford, Connecticut, United States, 06102 University of Connecticut Storrs, Connecticut, United States, 06269 United States, Massachusetts University of Massachusetts Amherst, Massachusetts, United States, 01003 收起 << |
NCT00772564 | Myocardial Infarction | Phase 4 | Completed | - | Israel ... 展开 >> Rambam Health Care Campus Haifa, Israel, 31096 收起 << |
NCT01293097 | Non-ST Segment Elevation Myoca... 展开 >>rdial Infarction Unstable Angina Pectoris Stable Angina Pectoris 收起 << | Phase 4 | Completed | - | China ... 展开 >> Division of Cardiology, Peking University First Hospital Beijing, China, 10034 收起 << |
NCT01154036 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT01154036 | - | Completed | - | - | |
NCT02662569 | Diabetes, Hyperlipidemia, Mixe... 展开 >>d Dyslipidemia 收起 << | Phase 3 | Completed | - | - |
NCT00115830 | Atherosclerosis | Phase 3 | Completed | - | United States, Massachusetts ... 展开 >> Brigham and Womens Hospital Boston, Massachusetts, United States, 02115 收起 << |
NCT00463827 | Asthma COPD ... 展开 >> Smoking 收起 << | Phase 2 | Completed | - | United Kingdom ... 展开 >> Gartnavel General Hospital Glasgow, United Kingdom, G12 0YN 收起 << |
NCT00770679 | Diabetes | Not Applicable | Terminated(Delayed recruitment... 展开 >>, funding exhausted) 收起 << | - | United States, Maryland ... 展开 >> Harry SIlber, MD Baltimore, Maryland, United States, 21224 收起 << |
NCT00770679 | - | Terminated(Delayed recruitment... 展开 >>, funding exhausted) 收起 << | - | - | |
NCT02776956 | Atrial Fibrillation | Not Applicable | Unknown | May 2018 | China, Hebei ... 展开 >> The Second Hospital of Hebei Medical University Recruiting Shijiazhuang, Hebei, China, 050000 Contact: Xieruiqin 15803212537 13230178060@163.com 收起 << |
NCT00233480 | Heart Failure, Congestive | Phase 4 | Completed | - | United States, California ... 展开 >> Ahmanson-UCLA Cardiomyopathy Center Los Angeles, California, United States, 90095 收起 << |
NCT02668016 | Adverse Effects ... 展开 >> Cardiovascular Diseases Hyperlipidemias 收起 << | Phase 4 | Unknown | November 2018 | United Kingdom ... 展开 >> Imperial College London Recruiting London, Greater London, United Kingdom, W12 0HS Contact: Frances A Wood, Bsc RGN Mphil 0207 594 9647 ext 9647 f.wood@imperial.ac.uk Contact: David Thompson 0207 594 9647 ext 9647 david.thompson@imperial.ac.uk 收起 << |
NCT00816244 | Breast Cancer ... 展开 >> Postmenopausal 收起 << | Phase 2 | Completed | - | Sweden ... 展开 >> University Hospital, Department of Oncology Lund, Sweden, 221 85 收起 << |
NCT01236365 | - | Completed | - | - | |
NCT03018444 | Diabetes Mellitus, Type 2 ... 展开 >> Hydroxymethylglutaryl-CoA Reductase Inhibitors 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> University Hospital, Gentofte, Copenhagen Hellerup, Region Hovedstaden, Denmark, 2900 收起 << |
NCT00164086 | Myeloma | Phase 1 | Unknown | - | Australia, Victoria ... 展开 >> Alfred Hospital Not yet recruiting Melbourne, Victoria, Australia, 3181 Contact: Jennifer Martin, MBChB, FRACP 0405 341 676 jennifer.martin@med.monash.edu.au 收起 << |
NCT02496962 | Sleep Deprivation | Not Applicable | Unknown | - | China, Beijing ... 展开 >> PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Yang Shi, M.D. +8610-66876231 ggyyong@sina.com Principal Investigator: Yu Tang Wang, M.D. 收起 << |
NCT00494663 | Type 2 Diabetes | Phase 2 | Terminated(Program Terminated) | December 2008 | - |
NCT01759836 | Prostatic Neoplasms | Phase 2 | Unknown | October 2015 | Korea, Republic of ... 展开 >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Choung-Soo Kim, MD 82-2-3010-3734 cskim@amc.seoul.kr Contact: In Gab Jeong, MD 82-2-3010-5892 igjeong@amc.seoul.kr Principal Investigator: Choung-soo Kim, MD 收起 << |
NCT00530946 | Hypertension ... 展开 >>Hypercholesterolemia 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> Pfizer Investigational Site Fukuoka-shi, Fukuoka-ken, Japan Pfizer Investigational Site Kitakyushu-shi, Fukuoka-ken, Japan Pfizer Investigational Site Kurume-shi, Fukuoka-ken, Japan Pfizer Investigational Site Maebaru-shi, Fukuoka-ken, Japan Pfizer Investigational Site Annaka, Gunma, Japan Pfizer Investigational Site Sapporo-shi, Hokkaido, Japan Pfizer Investigational Site Teine, Hokkaido, Japan Pfizer Investigational Site Yokohama-shi, Kanagawa-ken, Japan Pfizer Investigational Site Yamashita-cho, Naka-ku, Kanagawa-ken, Japan Pfizer Investigational Site Kita-ku, Osaka-fu, Japan Pfizer Investigational Site Koshigaya-shi, Saitama-ken, Japan Pfizer Investigational Site Chofu, Tokyo, Japan Pfizer Investigational Site Kiyose, Tokyo, Japan Pfizer Investigational Site Setagaya-ku, Tokyo, Japan Pfizer Investigational Site Shinagawa-Ku, Tokyo, Japan Pfizer Investigational Site Shinagawa, Tokyo, Japan Pfizer Investigational Site Osaka, Japan 收起 << |
NCT02957162 | Acute Coronary Syndrome | Phase 4 | Recruiting | September 2018 | United Kingdom ... 展开 >> University Hospitals of North Midlands NHS Trust Recruiting Stoke-on-Trent, Staffordshire, United Kingdom, ST4 6QG Contact: Darren Clement, PhD 01782 675379 darren.clement@uhnm.nhs.uk Principal Investigator: Robert Butler 收起 << |
NCT01697735 | Dyslipidemias | Phase 4 | Terminated(Because of lack of ... 展开 >>participants and funds) 收起 << | - | China, Zhejiang ... 展开 >> Second Hospital of Wenzhou Medical College Wenzhou, Zhejiang, China, 325000 收起 << |
NCT03464682 | Primary Hypercholesterolemia | Phase 3 | Active, not recruiting | May 28, 2019 | - |
NCT00267267 | Hyperlipidemia ... 展开 >> Dyslipidemia 收起 << | Phase 3 | Terminated | - | - |
NCT00452842 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | United States, Florida ... 展开 >> Pfizer Investigational Site Clearwater, Florida, United States, 33756 收起 << | |
NCT01236365 | Diabetes Mellitus, Insulin-Dep... 展开 >>endent Hypercholesterolemia 收起 << | Phase 3 | Completed | - | United States, Delaware ... 展开 >> Alfred I duPont Hospital Wilmington, Delaware, United States United States, Florida Nemours Children's Clinic Jacksonville, Florida, United States, 32207 Nemours Children's Clinic Orlando, Florida, United States Nemours Children's Clinic Pensacola, Florida, United States, 32504 United States, Pennsylvania Nemours Children's Clinic-Jefferson Philadelphia, Pennsylvania, United States, 19107 收起 << |
NCT01987310 | Non Alcoholic Fatty Liver Dise... 展开 >>ase 收起 << | Not Applicable | Withdrawn(the study was stoppe... 展开 >>d because of lack of interest) 收起 << | - | Israel ... 展开 >> Sheba Medical Center Ramat Gan, Israel, 5265601 收起 << |
NCT02219191 | Rheumatoid Arthritis | Not Applicable | Active, not recruiting | December 2018 | China, Sichuan ... 展开 >> 270 Rongdu street, Jin-niu district,Rheumatology Center of Integrated Medicine, General Hospital of Chengdu Military Area Command PLA, Chengdu city, Sichuan, China, 610083 收起 << |
NCT00530946 | - | Completed | - | - | |
NCT00126048 | Asthma | Phase 2 Phase 3 | Completed | - | United Kingdom ... 展开 >> Asthma Clinical Research Centre, Level 6, Gartnavel General Hospital Glasgow, United Kingdom, G12 0YN 收起 << |
NCT01105975 | - | Completed | - | - | |
NCT00092690 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT01334671 | ST-elevation Myocardial Infarc... 展开 >>tion (STEMI) 收起 << | Phase 3 | Unknown | March 2013 | China ... 展开 >> General Hospital of Chinese People's Armed Police Forces Recruiting BeiJing, China, 100039 Contact: HuiIiang Liu, Doctor 86-10-57976531 lhl518@vip.sina.com Contact: Yong Yang, Doctor 86-10-57976533 672862837@qq.com;yangyongfmmu@yahoo.com.cn Principal Investigator: HuiLiang Liu, Doctor Principal Investigator: Yong Yang, Doctors Principal Investigator: Wenwen Yuan, Master 收起 << |
NCT03122639 | Obstructive Sleep Apnea of Adu... 展开 >>lt 收起 << | Early Phase 1 | Recruiting | August 30, 2021 | United States, New York ... 展开 >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Sanja Jelic, MD 212-543-8875 sj366@cumc.columbia.edu 收起 << |
NCT03308578 | Sleep Apnea, Obstructive | Phase 1 Phase 2 | Enrolling by invitation | July 2023 | United States, Minnesota ... 展开 >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 收起 << |
NCT00622089 | Type 2 Diabetes | Phase 2 Phase 3 | Terminated(Program terminated) | December 2008 | - |
NCT01541943 | Essential Hypertension ... 展开 >> Hyperlipidemia 收起 << | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Korea University Guro Hospital Seoul, Korea, Republic of 收起 << |
NCT00267280 | Hyperlipidemia ... 展开 >> Dyslipidemia Hypercholesterolemia 收起 << | Phase 3 | Terminated | - | - |
NCT01633359 | Coronary Artery Disease | Phase 4 | Unknown | May 2013 | China, Beijing ... 展开 >> Beijing Anzhen Hospital Not yet recruiting Beijing, Beijing, China, 100029 Contact: Ji Huang, MD 86-10-64456535 salyherry@163.com Principal Investigator: Ji Huang, MD 收起 << |
NCT02706860 | Coronary Artery Bypass Graftin... 展开 >>g 收起 << | Phase 4 | Completed | - | - |
NCT02633956 | - | Completed | - | - | |
NCT00736463 | HDL Cholesterol | Phase 4 | Unknown | - | United States, Oregon ... 展开 >> OHSU Hospital Recruiting Portland, Oregon, United States, 97239 Principal Investigator: Craig D Williams, PharmD 收起 << |
NCT00267254 | Hyperlipidemia ... 展开 >> Dyslipidemia Hypercholesterolemia 收起 << | Phase 3 | Completed | - | - |
NCT00587379 | Endothelial Dysfunction | Not Applicable | Withdrawn(Study closed per the... 展开 >> request of PI due to lack of participant accrual) 收起 << | May 2008 | - |
NCT02633956 | Nonalcoholic Steatohepatitis | Phase 2 | Completed | - | United States, Arizona ... 展开 >> St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States, 85013 United States, California Scripps Clinic La Jolla, California, United States, 92037 Inland Empire Liver Foundation Rialto, California, United States, 92377 United States, Florida Nature Coast Clinical Research Inverness, Florida, United States, 34452 University of Miamai, Schiff Center for Liver Diseases Miami, Florida, United States, 33136 South Florida Center of Gastroenterology Wellington, Florida, United States, 33414 Florida Medical Clinic, P.A. Zephyrhills, Florida, United States, 33542 United States, Hawaii The Queen's Medical Center - Liver Center Honolulu, Hawaii, United States, 96813 United States, Maryland Mercy Medical Center, Institute for Digestive Health & Liver Disease Baltimore, Maryland, United States, 21202 United States, Missouri Kansas City Research Institute Kansas City, Missouri, United States, 64131 St. Louis University Saint Louis, Missouri, United States, 63104 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Cumberland Research Associates, LLC Fayetteville, North Carolina, United States, 28304 United States, Ohio Consultants for Clinical Research Cincinnati, Ohio, United States, 45249 United States, Pennsylvania Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 United States, Rhode Island University Gastroenterology Liver Center Providence, Rhode Island, United States, 02905 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Tennessee ClinSearch Chattanooga, Tennessee, United States, 37421 United States, Texas Texas Clinical Research Institute, LLC Arlington, Texas, United States, 76012 Liver Associates of Texas, P.A. Houston, Texas, United States, 77030 American Research Corporation at the Texas Liver Institute San Antonio, Texas, United States, 78215 United States, Virginia McGuire DVAMC Richmond, Virginia, United States, 23249 收起 << |
NCT01239849 | Diabetes Mellitus, Hypercholes... 展开 >>sterolemia 收起 << | Phase 4 | Unknown | February 2011 | Korea, Republic of ... 展开 >> Sung Rae Kim Recruiting Bucheon, Kyeongki, Korea, Republic of, 420-717 Contact: SUNG RAE KIM, A. Professor +82-32-340-2025 kimsungrae@catholic.ac.kr Principal Investigator: JAE HYUNG CHO, Professor Principal Investigator: KI HO SONG, Professor Principal Investigator: SEUNG JUN OH, Professor Principal Investigator: HYE SOON KIM, Professor Principal Investigator: KYUNG MOOK CHOI, Professor Principal Investigator: IN JOO KIM, Professor Principal Investigator: SOO KYOUNG KIM, Professor Principal Investigator: SUNG HEE CHOI, Professor Principal Investigator: JONG WHA KIM, Professor Principal Investigator: CHAN HEE JUNG, Professor Principal Investigator: MIN KYOUNG MOON, Professor Principal Investigator: HYE JIN KIM, Professor Principal Investigator: YOUNG IL KIM, Professor Principal Investigator: KANG SEO PARK, Professor Principal Investigator: DONG JOON KIM, Professor Principal Investigator: SANG YOUNG KIM, Professor Principal Investigator: CHANG BUM LEE, Professor 收起 << |
NCT02056340 | Influenza | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> The Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 收起 << |
NCT01223586 | - | Completed | - | Japan ... 展开 >> Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine Ube, Yamaguchi, Japan, 755-8505 Division of Cardiology, Kyoto University Hospital Kyoto, Japan, 606-8507 收起 << | |
NCT00741078 | Hypertension | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Gil Medical Center Incheon, Korea, Republic of, 405-760 收起 << |
NCT02651753 | Dyslipidemia | Phase 1 | Completed | - | - |
NCT00491751 | Peripheral Arterial Disease | Phase 1 | Terminated(Insufficient enroll... 展开 >>ment) 收起 << | - | United States, Massachusetts ... 展开 >> Boston Medical Center Boston, Massachusetts, United States, 02118 收起 << |
NCT01859455 | Hypercholesterolemia ... 展开 >> LDL Cholesterol 收起 << | Phase 1 | Completed | - | United States, Florida ... 展开 >> Novartis Investigative Site Fort Myers, Florida, United States, 33901-8144 Novartis Investigative Site Miramar, Florida, United States, 33025 收起 << |
NCT02940366 | Metabolic Syndrome | Phase 4 | Recruiting | November 30, 2019 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Hyung-Kwan Kim, MD 82-2-2072-0243 cardiman73@gmail.com Principal Investigator: Hyung-Kwan Kim, MD 收起 << |
NCT00610870 | Angioplasty, Transluminal, Per... 展开 >>cutaneous Coronary 收起 << | Not Applicable | Completed | - | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 收起 << |
NCT00491751 | - | Terminated(Insufficient enroll... 展开 >>ment) 收起 << | - | - | |
NCT00651378 | Hypercholesterolemia ... 展开 >> Atherosclerosis Coronary Artery Disease 收起 << | Phase 4 | Terminated(Slow enrollment [HI... 展开 >>GH SCREEN FAILURE RATE]) 收起 << | - | - |
NCT01105975 | Dyslipidemia | Phase 2 | Completed | - | - |
NCT00343655 | Cardiovascular Diseases | Phase 3 | Terminated(The study was termi... 展开 >>nated on June 22, 2007 for inability to enroll patients within an appropriate timeframe. There were no efficacy/safety concerns.) 收起 << | - | United States, Massachusetts ... 展开 >> Pfizer Investigational Site Boston, Massachusetts, United States, 02114 收起 << |
NCT00723320 | Atherosclerosis | Not Applicable | Unknown | December 2010 | China, Beijing ... 展开 >> Peking University First Hospital Recruiting Beijing, Beijing, China, 100034 Contact lijianping@medmail.com.cn 收起 << |
NCT00960323 | - | Completed | - | - | |
NCT01228227 | Assess the Periprocedural Myoc... 展开 >>ardial Necrosis 收起 << | Phase 3 | Completed | - | Italy ... 展开 >> Policlinico Umberto I Roma, Italy 收起 << |
NCT00960323 | Healthy | Phase 1 | Completed | - | United States, North Dakota ... 展开 >> PRACS Institute, Ltd. - Cetero Research Fargo, North Dakota, United States, 58104 收起 << |
NCT00754507 | Hypercholesterolemia | Phase 4 | Completed | - | United States, California ... 展开 >> Los Angeles, California, United States United States, Colorado Castle Rock, Colorado, United States United States, Florida Jacksonville, Florida, United States Pembroke Pines, Florida, United States St. Petersburg, Florida, United States United States, Indiana Indianapolis, Indiana, United States United States, New York Rochester, New York, United States United States, Ohio Cincinnati, Ohio, United States Cleveland, Ohio, United States United States, Tennessee Bartlett, Tennessee, United States United States, Virginia Norfolk, Virginia, United States Richmond, Virginia, United States United States, Washington Seattle, Washington, United States 收起 << |
NCT00902967 | Abdominal Surgery | Phase 3 | Unknown | February 2010 | India ... 展开 >> Department of Pharmacology, Sassoon General Hospitals Not yet recruiting Pune, Maharastra, India, 411001 Contact: Bharati Daswani, M.D, PhD 919421965337 daswani_bharti@rediffmail.com Contact: Aaditya S Udupa, M.B.B.S 919823333793 draaditya.udupa@gmail.com Principal Investigator: Aaditya S Udupa, M.B.B.S 收起 << |
NCT01285544 | Dyslipidemia ... 展开 >>Cardiovascular Disease Hypercholesterolemia 收起 << | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of 收起 << |
NCT00174330 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 4 | Completed | - | China, Beijing ... 展开 >> Pfizer Investigational Site Beijing, Beijing, China, 100044 China, Guangdong Pfizer Investigational Site Guangzhou, Guangdong, China, 510080 Pfizer Investigational Site Guangzhou, Guangdong, China, 510100 Pfizer Investigational Site Guangzhou, Guangdong, China, 510515 China, Jiangsu Pfizer Investigational Site Nanjing, Jiangsu, China, 210029 China, Liaoning Pfizer Investigational Site Shen Yang, Liaoning, China, 110016 China, Shanghai Pfizer Investigational Site Shanghai, Shanghai, China, 200032 China, Zhejiang Pfizer Investigational Site Hangzhou, Zhejiang, China, 310016 China Pfizer Investigational Site Beijing, China, 100029 Pfizer Investigational Site Beijing, China, 100083 Pfizer Investigational Site Beijing, China Pfizer Investigational Site Shanghai, China, 200003 Pfizer Investigational Site Shanghai, China, 200025 Pfizer Investigational Site Shanghai, China, 200233 Pfizer Investigational Site Tianjin, China, 300211 收起 << |
NCT00174304 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 4 | Completed | - | - |
NCT01922687 | Arterial and Arteriolar Disord... 展开 >>ers 收起 << | Phase 4 | Unknown | December 2014 | China, Shanghai ... 展开 >> Shanghai Institute of Hypertension Recruiting Shanghai, Shanghai, China, 200025 Contact: Pingjin Gao 64370045 ext 610903 gaopingjin@yahoo.com.cn Principal Investigator: Pingjin Gao 收起 << |
NCT00199745 | Muscular Diseases | Phase 4 | Completed | - | Norway ... 展开 >> Lipidklinikken, Rikshospitalet-Radiumhospitalet HF Oslo, Norway, 0027 收起 << |
NCT01988571 | Breast Cancer | Phase 2 | Active, not recruiting | June 2020 | United States, North Carolina ... 展开 >> Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States, 27157 United States, Wisconsin University of Wisconsin Carbon Cancer Center Madison, Wisconsin, United States, 53792 收起 << |
NCT00367458 | HIV | Phase 2 | Completed | - | United States, California ... 展开 >> Naval Medical Center, San Diego San Diego, California, United States, 92134-5000 United States, Maryland National Naval Medical Center Bethesda, Maryland, United States, 20889 National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00412113 | Dyslipidemia ... 展开 >>Hypertension 收起 << | Phase 4 | Completed | - | - |
NCT00814255 | Focal Segmental Glomeruloscler... 展开 >>osis 收起 << | Phase 2 | Completed | - | United States, Florida ... 展开 >> University of Miami Miami, Florida, United States, 33136 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Kansas University of Kansas Kansas City, Kansas, United States, 66160 United States, Massachusetts Boston Children's Hospital Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55901 United States, Missouri Children's Mercy Hospital Kansas City, Missouri, United States, 64108 Cardinal Glennon Children's Medical Center Saint Louis, Missouri, United States, 63104 United States, New York Steven and Alexandra Cohen Children's Medical Center of New York New Hyde Park, New York, United States, 11040 NYU Langone Medical Center New York, New York, United States, 10016 Columbia University Medical Center New York, New York, United States, 10032 United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States, 28207 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Ohio State University Columbus, Ohio, United States, 43205 United States, Oregon Doernbecher Children's Hospital Portland, Oregon, United States, 97239 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Texas Tech University El Paso, Texas, United States, 79905 Canada, Alberta University of Alberta Edmonton, Alberta, Canada, T6G 2R7 收起 << |
NCT01375075 | Dyslipidemias | Phase 2 | Completed | - | Japan ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 660-0814 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 231-0023 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyoto, Japan, 615-8125 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 560-0005 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 111-0052 收起 << |
NCT00437892 | Venous Thromboembolism ... 展开 >> Hypercholesterolemia 收起 << | Phase 2 | Terminated(Competitive trials ... 展开 >>and slow recruitment rate) 收起 << | - | Italy ... 展开 >> University of Bologna Bologna, Italy Ospedale di Piacenza Piacenza, Italy University Of Insubria Varese, Italy, 21100 收起 << |
NCT02984982 | Hypercholesterolemia ... 展开 >> Acute Coronary Syndrome 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> Investigational Site Number 392026 Bunkyoku-ku, Japan Investigational Site Number 392022 Chiyoda-ku, Japan Investigational Site Number 392032 Fujisawa-shi, Japan Investigational Site Number 392004 Fukui-shi, Japan Investigational Site Number 392007 Fukuoka-shi, Japan Investigational Site Number 392048 Fukuoka-shi, Japan Investigational Site Number 392008 Gifu-shi, Japan Investigational Site Number 392039 Hiroshima-shi, Japan Investigational Site Number 392028 Isehara-shi, Japan Investigational Site Number 392036 Itabashi-ku, Japan Investigational Site Number 392037 Itabashi-ku, Japan Investigational Site Number 392024 Izumisano-shi, Japan Investigational Site Number 392013 Izunokuni-shi, Japan Investigational Site Number 392020 Kawaguchi-shi, Japan Investigational Site Number 392041 Kisarazu-shi, Japan Investigational Site Number 392009 Kitakyushu-shi, Japan Investigational Site Number 392034 Kitakyushu-shi, Japan Investigational Site Number 392044 Kochi-shi, Japan Investigational Site Number 392002 Kumamoto-shi, Japan Investigational Site Number 392011 Kumamoto-shi, Japan Investigational Site Number 392003 Kurashiki-shi, Japan Investigational Site Number 392018 Matsuyama-shi, Japan Investigational Site Number 392021 Morioka-shi, Japan Investigational Site Number 392017 Nagakute-shi, Aichi, Japan Investigational Site Number 392047 Nagaoka-shi, Japan Investigational Site Number 392038 Nagoya-shi, Japan Investigational Site Number 392042 Nagoya-shi, Japan Investigational Site Number 392033 Okayama-shi, Japan Investigational Site Number 392006 Osaka-shi, Japan Investigational Site Number 392010 Osaka-shi, Japan Investigational Site Number 392045 Osaka-shi, Japan Investigational Site Number 392046 Osaka-shi, Japan Investigational Site Number 392015 Sagamihara-shi, Japan Investigational Site Number 392019 Sakai-shi, Japan Investigational Site Number 392035 Sapporo-shi, Japan Investigational Site Number 392001 Tenri-shi, Japan Investigational Site Number 392016 Toyoake-shi, Japan Investigational Site Number 392025 Tsukuba-shi, Japan Investigational Site Number 392040 Tsukuba-shi, Japan Investigational Site Number 392005 Wakayama-shi, Japan Investigational Site Number 392027 Yokohama-shi, Japan Investigational Site Number 392043 Yokohama-shi, Japan 收起 << |
NCT00412113 | - | Completed | - | - | |
NCT00814255 | - | Completed | - | - | |
NCT01245608 | Cardiovascular Diseases | Phase 3 | Active, not recruiting | September 2018 | Iran, Islamic Republic of ... 展开 >> Golestan Cohort Center Gonbad, Golestan, Iran, Islamic Republic of 收起 << |
NCT01375075 | - | Completed | - | - | |
NCT00603590 | Cardiovascular Disease ... 展开 >> Hypertension Hyperlipidemia Heart Disease 收起 << | Phase 2 | Completed | - | Iran, Islamic Republic of ... 展开 >> Kalaleh Heart Study Center Kalaleh, Golestan, Iran, Islamic Republic of 收起 << |
NCT03228238 | Variant Angina | Phase 4 | Recruiting | February 28, 2021 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Hyo-Soo Kim, M.D., PhD 82-2-2072-2226 hyosoo@snu.ac.kr 收起 << |
NCT01342211 | - | Completed | - | - | |
NCT01342211 | Hypercholesterolemia ... 展开 >> Dyslipidemia 收起 << | Phase 2 | Completed | - | - |
NCT00944827 | Hypercholesterolemia | Phase 2 | Completed | - | Greece ... 展开 >> General Hospital of Trikala Trikala, Thessaly, Greece, 42100 收起 << |
NCT00603590 | - | Completed | - | - | |
NCT02314208 | Spastic Paraplegia, Hereditary | Phase 2 | Completed | - | France ... 展开 >> Pitié-Salpêtrière Hospital Paris, France 收起 << |
NCT00715273 | Coronary Artery Disease ... 展开 >> Carotid Artery Diseases Atherosclerosis 收起 << | Phase 4 | Active, not recruiting | February 2019 | United States, California ... 展开 >> University of Southern California Los Angeles, California, United States, 90089 United States, Idaho St. Luke's Idaho Cardiology Boise, Idaho, United States, 83712 United States, Washington University of Washington Coronary Atherosclerosis Research Lab Seattle, Washington, United States, 98104 Yakima Heart Center Yakima, Washington, United States, 98902 收起 << |
NCT00497016 | Hypertension | Not Applicable | Completed | - | Netherlands ... 展开 >> Radboud University Medical Center Nijmegen NIjmegen, Netherlands, 6500 HB 收起 << |
NCT02740699 | Cardiovascular Disease | Phase 4 | Recruiting | December 15, 2020 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov 收起 << |
NCT02596126 | Myocardial Infarction ... 展开 >> Cardiovascular Disease 收起 << | Phase 3 | Recruiting | January 2020 | - |
NCT00767130 | - | Unknown | December 2009 | United States, California ... 展开 >> University of California-San Francisco Recruiting San Francisco, California, United States, 94110 Contact: Alan H.B. Wu, PhD (415) 206-3540 wualan@labmed2.ucsf.edu Principal Investigator: Alan H.B. Wu, PhD United States, Connecticut Hartford Hospital Recruiting Hartford, Connecticut, United States, 06102 Contact: Richard L. Seip, PhD 860-545-5005 rseip@harthosp.org Principal Investigator: Paul D. Thompson, M.D. United States, New York Rogosin Institute, New York Presbyterian Hospital Recruiting New York, New York, United States, 10021 Contact: Chioma Okoro 212-702-9600 ext 105 cokoro@mail.rockefeller.edu Contact: Bruce Gordon, M.D. Principal Investigator: Bruce Gordon, M.D. 收起 << | |
NCT02081638 | HIV Infection | Phase 2 | Recruiting | March 2, 2020 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov United States, Minnesota Hennipen County Medical Center Recruiting Minneapolis, Minnesota, United States 收起 << |
NCT03753555 | Stroke, Ischemic ... 展开 >> Atherosclerosis, Cerebral 收起 << | Phase 4 | Not yet recruiting | November 30, 2021 | - |
NCT03590496 | Hypercholesterolemia | Phase 2 | Recruiting | November 30, 2020 | Germany ... 展开 >> St. Josef-hospital Ruhr-Univesity Bochum Recruiting Bochum, Nordrhein-Westfalen, Germany, 44791 Contact: Christos Krogias, PD MD +492345092411 christos.krogias@ruhr-uni-bochum.de Principal Investigator: Christos Krogias, PD Dr. med. Charité Universitätsmedizin Berlin Recruiting Berlin, Germany, 12203 Contact: Arash Haghikia, PD MD (0)30450513797 ext +49 arash.haghikia@charite.de Contact: Paul Schumann (0)30450513807 ext +49 paul.schumann@charite.de Principal Investigator: Arash Haghikia, PD MD Sub-Investigator: Friederike Zimmermann, MD 收起 << |
NCT02135029 | Hyperlipidemia | Phase 3 | Completed | - | - |
NCT02278471 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 2 | Completed | - | United States, Alabama ... 展开 >> Franklin Primary Health Center Mobile, Alabama, United States, 36603 收起 << |
NCT00664846 | Stroke | Not Applicable | Completed | - | - |
NCT02586155 | Diabetes Mellitus, Type 2 ... 展开 >> Coronary Artery Disease Cardiovascular Diseases 收起 << | Phase 3 | Recruiting | October 2018 | Israel ... 展开 >> Lady Davis Carmel Medical Center Recruiting Haifa, Israel, 34362 Contact: Basil Lewis, MD 收起 << |
NCT00327691 | Cardiovascular Disease ... 展开 >> Cerebrovascular Accident Coronary Heart Disease 收起 << | Phase 4 | Completed | - | - |
NCT00300430 | Dyslipidemia ... 展开 >>Coronary Heart Disease Mixed Dyslipidemia 收起 << | Phase 3 | Completed | - | United States, Illinois ... 展开 >> Global Medical Information North Chicago, Illinois, United States, 60064 收起 << |
NCT00300430 | - | Completed | - | - | |
NCT01984424 | - | Completed | - | - | |
NCT00494247 | Acute Coronary Syndromes ... 展开 >> Coronary Heart Disease 收起 << | Phase 4 | Completed | - | Poland ... 展开 >> Silesian School of Medicine, 3rd Division of Cardiology Katowice, Poland, 40-635 American Heart of Poland Ustron, Poland 收起 << |
NCT02380625 | Ebola Virus Disease | Phase 1 Phase 2 | Unknown | March 2016 | - |
NCT02641899 | Healthy | Phase 1 | Completed | - | United States, Kansas ... 展开 >> Quintiles Overland Park, Kansas, United States, 66211 收起 << |
NCT01984424 | Hyperlipidemia | Phase 3 | Completed | - | - |
NCT03255044 | Heart Failure | Phase 4 | Recruiting | May 2019 | Egypt ... 展开 >> Ain Shams University Hospital Cardiology Rehab Unit Recruiting Cairo, Egypt Contact: Hazem Khorshid, PhD +201227442219 hazemkhorshid@yahoo.com Principal Investigator: Nouran Omar, MSc 收起 << |
NCT02374047 | Hypercholesterolemia | Phase 1 | Completed | - | United States, Wisconsin ... 展开 >> Spaulding Clinical Research West Bend, Wisconsin, United States, 53095 收起 << |
NCT02156492 | Healthy Volunteers | Phase 1 | Completed | - | China ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100034 收起 << |
NCT02503865 | - | Completed | - | - | |
NCT03275376 | Overall Survival ... 展开 >> Tumor Responses 收起 << | Phase 2 | Recruiting | December 21, 2023 | Taiwan ... 展开 >> Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 40705 Contact: Teng-Yu Lee, PhD 4-23592525 ext 3301 tylee@vghtc.gov.tw 收起 << |
NCT02156492 | - | Completed | - | - | |
NCT02135029 | - | Completed | - | - | |
NCT00433823 | Coronary Heart Disease ... 展开 >> Diabetes Mellitus Non-Coronary Atherosclerotic Disease Hypercholesterolemia 收起 << | Phase 4 | Unknown | - | Turkey ... 展开 >> Bolu Izzet Baysal School of Medicine Recruiting Bolu, Turkey, 14280 Contact: Mustafa Kanat, MD +905385448782 mustafa.kanat@gmail.com 收起 << |
NCT03459560 | Cardiovascular Diseases | Phase 3 | Active, not recruiting | August 1, 2021 | Iran, Islamic Republic of ... 展开 >> Pars Cohort Center Shiraz, Fars, Iran, Islamic Republic of 收起 << |
NCT00793754 | Diabetes Mellitus | Phase 4 | Completed | - | Argentina ... 展开 >> Centro de Educación Médica e Investigaciones Clínicas (CEMIC) Buenos Aires, Argentina 收起 << |
NCT02503865 | Metabolic Syndrome | Phase 1 Phase 2 | Completed | - | Kazakhstan ... 展开 >> Republican Scientific Center for Emergency Medicine Astana, Kazakhstan, 010000 收起 << |
NCT00243672 | Atherosclerosis | Phase 4 | Withdrawn(The study chair chan... 展开 >>ged his employment, the realization of the study was not possible) 收起 << | - | - |
NCT00458055 | Coronary Arteriosclerosis ... 展开 >> Hypoalphalipoproteinemias Genetic Diseases, Inborn 收起 << | Not Applicable | Completed | - | Canada, Quebec ... 展开 >> MUHC-Royal Victoria Hospital Montreal, Quebec, Canada, H3A 1A1 收起 << |
NCT03541109 | Ischemic Heart Disease ... 展开 >> Acute Coronary Syndrome Revascularization 收起 << | Phase 3 | Not yet recruiting | August 2023 | Iran, Islamic Republic of ... 展开 >> Cardiovascular Research Institute Not yet recruiting Isfahan, Iran, Islamic Republic of Contact: Safoora yazdekhasti 00983136115208 sfa.yazdekhasti@gmail.com Sub-Investigator: Nizal Sarrafzadegan, Professor Sub-Investigator: Shervin Gh Hoseini, MD, PhD Sub-Investigator: Hamidreza Roohafza, MD Sub-Investigator: Marjan Mansourian, PhD Sub-Investigator: Jamshid Najafian, MD Sub-Investigator: Alireza Nateghi Nateghi, PhD 收起 << |
NCT00407537 | Hypertension ... 展开 >>Hypercholesterolemia 收起 << | Phase 4 | Completed | - | - |
NCT00407537 | - | Completed | - | - | |
NCT01953328 | Hyperlipidemia or Mixed Dyslip... 展开 >>idemia at High Risk for Cardiovascular Events 收起 << | Phase 3 | Completed | - | - |
NCT03431909 | Acute Ischemic Stroke | Phase 4 | Completed | - | - |
NCT00965185 | Cardiovascular Disease ... 展开 >> HIV Atherosclerosis Inflammation Statins, HMG-CoA HIV Infections 收起 << | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 << |
NCT03195153 | Diabetes Mellitus Type 2 Plate... 展开 >>lets Reactivity Statin 收起 << | Phase 4 | Recruiting | July 15, 2017 | Italy ... 展开 >> Policlinico Umberto I Recruiting Rome, Roma, Italy, 00155 Contact: MARINA MD POLACCO 3333347960 POLAMARI@LIBERO.IT 收起 << |
NCT01953328 | - | Completed | - | - | |
NCT00110435 | Type 2 Diabetes Mellitus ... 展开 >> Hypercholesterolemia 收起 << | Phase 3 | Completed | - | - |
NCT00211939 | Calcinosis Ar... 展开 >>teriosclerosis Hyperparathyroidism, Secondary 收起 << | Phase 4 | Completed | - | United States, Texas ... 展开 >> University of Texas Health Sciences Center San Antonio, Texas, United States, 78229-3900 收起 << |
NCT01043380 | Hypercholesterolemia ... 展开 >> Coronary Artery Disease 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> Kumamoto University Kumamoto, Japan, 8608556 收起 << |
NCT00965185 | - | Completed | - | - | |
NCT00150722 | Atherosclerosis | Phase 3 | Completed | - | Canada, Alberta ... 展开 >> Foothills Medical Centre Calgary, Alberta, Canada, T2N 2T9 收起 << |
NCT02790528 | Angina Pectoris, Variant ... 展开 >> Statins, HMG-CoA 收起 << | Phase 4 | Withdrawn(Funding issue) | December 2023 | Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Songpa-gu, Korea, Republic of, 138-736 收起 << |
NCT02550288 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00805311 | Carotid Artery Stenosis ... 展开 >> Atherosclerosis Stroke 收起 << | Phase 4 | Terminated(Due to the clear ad... 展开 >>vantage of carotid endarterectomy) 收起 << | - | Russian Federation ... 展开 >> Russian Cardiology Research and Production Center Moscow, Russian Federation, 121552 Russian Cardiology Research and Production Center Moscow, Russian Federation 收起 << |
NCT02550288 | - | Completed | - | - | |
NCT00804843 | - | Completed | - | - | |
NCT00818103 | Multiple Sclerosis | Not Applicable | Unknown | January 2016 | China, Guangdong ... 展开 >> Department of Neurology, The Third Affilated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510630 Contact: Qiang Xue Hu, PhD +862085252336 huxueqiangzssy@yahoo.com.cn 收起 << |
NCT00522158 | Type 2 Diabetes Mellitus ... 展开 >> Cardiovascular Disease LDL Cholesterol Cognition 收起 << | Phase 4 | Completed | - | - |
NCT03176498 | Cerebral Infarction | Phase 1 Phase 2 | Not yet recruiting | August 2018 | China, Inner Mongolia ... 展开 >> Inner Mongolia International Mongolian Hospital Not yet recruiting Hohhot, Inner Mongolia, China, 010065 Contact: Wulantuya 864715182155 收起 << |
NCT00804843 | Carotid Atherosclerosis | Phase 2 | Completed | - | - |
NCT02850081 | Carotid Artery Stenosis ... 展开 >> Strokes 收起 << | Phase 3 | Recruiting | April 2022 | United States, New Jersey ... 展开 >> Valley Hospital Not yet recruiting Ridgewood, New Jersey, United States, 07450 Contact: Avery Freed 201-389-0194 afreed@valleyhealth.com Contact: Kathleen Sayles KSAYLES@valleyhealth.com Principal Investigator: Dorothea Altschul, MD United States, New York Albany Medical College/The Vascular Group at Albany Not yet recruiting Albany, New York, United States, 12208-3479 Contact: Ryan Kaim KaimR@mail.amc.edu Contact: Angela Sheehan SheehaA@mail.amc.edu Principal Investigator: Courtney Warner, MD Sub-Investigator: Ralph C Darling, MD State University of New York at Buffalo Not yet recruiting Buffalo, New York, United States, 14260-7016 Contact: Jennifer Gay 716-440-4231 jgay@ubns.com Contact: Reagan O'Toole rotoole@ubns.com Principal Investigator: Adnan Siddiqui, MD New York University School of Medicine Not yet recruiting New York, New York, United States, 10016-6402 Contact: Jacqueline Bott 212-263-2268 jacqueline.bott@nyumc.org Principal Investigator: Thomas Maldonado, MD Icahn School of Medicine at Mount Sinai Not yet recruiting New York, New York, United States, 10029 Contact: Rebecca Apruzzese 212-241-8349 rebecca.apruzzese@mountsinai.org Contact: Milerva Santos milerva.santos@mountsinai.org Principal Investigator: J Mocco, MD Sub-Investigator: Emilia Bagiella, MD Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Rebeca Aragon Garcia, BS 212-305-4679 ra2356@cumc.columbia.edu Contact: Josephine U Pucci, BA 21123054679 jup2102@cumc.columbia.edu Principal Investigator: Edward S Connolly, MD Sub-Investigator: Elise A Caccappolo Van Vliet, PhD Sub-Investigator: Yaakov Stern, MD Sub-Investigator: Richard Buchsbaum Sub-Investigator: Eric J Heyer, MD Sub-Investigator: Erin L Heinzen-Cox, PhD Cornell University Medical College (Weill) Not yet recruiting New York, New York, United States, 10065-4805 Contact: Ruchita Mehta rum2006@med.cornell.edu Principal Investigator: Peter Connolly, MD 收起 << |
NCT01394848 | Stable Angina | Phase 4 | Terminated(Previous other stud... 展开 >>y including EPC capture stent raised the issue of safety (significant high incidence of instent restenosis)) 收起 << | - | Korea, Republic of ... 展开 >> Yonsei university Wonju College of Medicine Wonju, Gangwon-do, Korea, Republic of, 220-701 收起 << |
NCT00579254 | - | Terminated(See the termination... 展开 >> reason in detailed description.) 收起 << | - | - | |
NCT00977288 | Dyslipidemia | Phase 2 | Completed | - | - |
NCT00579254 | - | Terminated(See the termination... 展开 >> reason in detailed description.) 收起 << | - | - | |
NCT02347098 | Acute Coronary Artery Syndrome | Phase 3 | Completed | - | United States, Colorado ... 展开 >> VA Eastern Colorado Health Care System, Denver, CO Denver, Colorado, United States, 80220 United States, Oklahoma Oklahoma City VA Medical Center, Oklahoma City, OK Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Tennessee Valley Healthcare System Nashville Campus, Nashville, TN Nashville, Tennessee, United States, 37212-2637 United States, Texas VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX Dallas, Texas, United States, 75216 收起 << |
NCT00479388 | Primary Hypercholesterolemia ... 展开 >> Mixed Dyslipidemia 收起 << | Phase 3 | Completed | - | - |
NCT03635749 | Acute Stroke ... 展开 >>Transient Ischemic Attack 收起 << | Phase 3 | Not yet recruiting | December 30, 2023 | - |
NCT01567826 | Coronary Artery Disease | Phase 4 | Completed | - | United States, New York ... 展开 >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 收起 << |
NCT03418974 | Dyslipidemias | Phase 4 | Active, not recruiting | December 31, 2021 | China, Beijing ... 展开 >> Heart Center of Peking University People's Hospital Beijing, Beijing, China, 100044 China, Shanghai School of Public Health, Fudan University Shanghai, Shanghai, China, 200032 收起 << |
NCT01567826 | - | Completed | - | - | |
NCT00728013 | Acute Coronary Syndrome | Not Applicable | Unknown | December 2010 | China, Hu Nan ... 展开 >> The Second Xiangya Hospital of Central South University Recruiting ChangSha, Hu Nan, China, 410011 Contact: Shuiping Zhao, MD,PHD 86-731-5295806 zhaosp@medmail.com.cn Contact: Daoquan Peng, MD,PHD 86-139-748-22567 pengdq@hotmail.com Principal Investigator: Shuiping Zhao, MD 收起 << |
NCT01674686 | Variant Angina | Phase 4 | Recruiting | December 31, 2018 | Korea, Republic of ... 展开 >> Hyoen-Cheol Gwon, MD,PhD Recruiting Seoul, Korea, Republic of, 135-710 Contact: Hyoen-Cheol Gwon, MD,PhD 82-2-3410-3418 hcgwon@skku.edu 收起 << |
NCT01130246 | Acute Coronary Syndrome | Phase 3 | Terminated(Lack of efficacy) | - | - |
NCT00092716 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00479388 | - | Completed | - | - | |
NCT02549846 | Ischemic Stroke | Phase 4 | Completed | - | Japan ... 展开 >> Hyogo collage of Medicine Nishinomiya, Hyogo, Japan, 665-8501 收起 << |
NCT00491530 | Mixed Dyslipidemia | Phase 3 | Completed | - | United States, Illinois ... 展开 >> Medical Information Specialist Abbott Park, Illinois, United States, 60064 收起 << |
NCT00491530 | - | Completed | - | - | |
NCT00150384 | Hypertension ... 展开 >>Dyslipidemia 收起 << | Phase 4 | Completed | - | - |
NCT02977065 | Dyslipidemias | Phase 2 | Completed | - | Australia ... 展开 >> Not provided Adelaide, Australia 收起 << |
NCT02084069 | Heart Valve Diseases | Phase 3 | Completed | - | Iran, Islamic Republic of ... 展开 >> Seyyed-al-Shohada Heart Center Urmia, West-Azerbaijan, Iran, Islamic Republic of 收起 << |
NCT00133380 | Hypercholesterolemia | Phase 2 | Completed | - | - |
NCT02460159 | Hypercholesterolemia ... 展开 >> Heterozygous Familial Hypercholesterolemia 收起 << | Phase 3 | Completed | - | - |
NCT02460159 | - | Completed | - | - | |
NCT01078285 | - | Completed | - | United States, Illinois ... 展开 >> Prairie Heart Institute Springfield, Illinois, United States, 62701 Memorial Medical Center Springfield, Illinois, United States, 62702 Prairie Diagnostic Center Springfield, Illinois, United States, 62702 收起 << | |
NCT01332747 | Hyperlipidemia | Phase 2 | Completed | - | India ... 展开 >> Majeedia Hospital New Delhi, Delhi, India, 110062 收起 << |
NCT00664859 | Dyslipidemia | Phase 2 Phase 3 | Completed | - | United States, Illinois ... 展开 >> Radiant Research, 515 N State St, Suite 2700 Chicago, Illinois, United States, 60610 收起 << |
NCT00652327 | Hypercholesterolemia | Phase 4 | Completed | - | - |
NCT01730040 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00652327 | - | Completed | - | - | |
NCT01730040 | - | Completed | - | - | |
NCT03024684 | HepatoCellular Carcinoma | Phase 4 | Recruiting | January 2022 | Taiwan ... 展开 >> E-DA Hospital Recruiting Kaohsiung, Taiwan Chi Mei Medical Hospital Not yet recruiting Tainan, Taiwan National Cheng-Kung University Hospital Not yet recruiting Tainan, Taiwan Tainan Municipal Hospital Not yet recruiting Tainan, Taiwan Mackay Memorial Hospital Not yet recruiting Taipei, Taiwan National Taiwan University Hospital Yun-Lin Branch Not yet recruiting Yunlin, Taiwan 收起 << |
NCT03186404 | Cancer Heart ... 展开 >>Failure Cardiotoxicity 收起 << | Phase 2 | Recruiting | March 2020 | Canada, Ontario ... 展开 >> Toronto General Hospital Recruiting Toronto, Ontario, Canada, M5G 2N2 Contact: Paaladinesh Thavendiranathan 416-340-5326 收起 << |
NCT01062802 | Abdominal Aortic Aneurysm | Phase 4 | Completed | - | United Kingdom ... 展开 >> Hull & east Yorkshire Hospitals NHS Trust Hull, United Kingdom, HU3 2JZ 收起 << |
NCT02084069 | - | Completed | - | - | |
NCT03360916 | Cardiovascular Diseases | Phase 4 | Not yet recruiting | July 1, 2022 | United States, Kansas ... 展开 >> University of Kansas Medical Center Not yet recruiting Kansas City, Kansas, United States, 66160 收起 << |
NCT02863185 | Chronic Kidney Disease | Phase 4 | Recruiting | December 2019 | Korea, Republic of ... 展开 >> Won Suk An Recruiting Busan, Korea, Republic of, 602-715 Contact: Won Suk An, M.D., Ph.D. +82-51-240-2811 anws@dau.ac.kr Dong-A University Not yet recruiting Busan, Korea, Republic of, 602715 Contact: Su Mi Lee, MD +822405549 promise131@hanmail.net 收起 << |
NCT01071993 | Nephropathy | Not Applicable | Terminated(Sponsor can not sup... 展开 >>ply drugs anymore.) 收起 << | - | United States, Oklahoma ... 展开 >> Oklahoma University Health Science Center Oklahoma City, Oklahoma, United States, 73104 Veterans Affairs Medical Center Oklahoma City, Oklahoma, United States, 73104 收起 << |
NCT01071993 | - | Terminated(Sponsor can not sup... 展开 >>ply drugs anymore.) 收起 << | - | - | |
NCT01099176 | Hyperlipidemia ... 展开 >> Impaired Fasting Glycemia 收起 << | Not Applicable | Completed | - | Poland ... 展开 >> Department of Pharmacology Katowice, Śląskie, Poland, 40-762 收起 << |
NCT03596684 | Atorvastatin | Not Applicable | Not yet recruiting | May 1, 2020 | France ... 展开 >> Endocrinology and diabetology service, Louis Pradel Hospital Not yet recruiting Bron, France, 69500 Contact: Sybil CHARRIERE, MD 4 27 85 66 66 ext +33 sybil.charriere@chu-lyon.fr Sub-Investigator: Philippe MOULIN, MD Principal Investigator: Sybil CHARRIERE, MD Sub-Investigator: Laure Groisne, MD 收起 << |
NCT00153166 | Arterial Occlusive Disease ... 展开 >> Intermittent Claudication Insulin Resistance 收起 << | Phase 2 Phase 3 | Completed | - | United States, Massachusetts ... 展开 >> Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 收起 << |
NCT00259662 | Gynecologic Oncological Pelvic... 展开 >>/Abdominal Surgery 收起 << | Not Applicable | Completed | - | United States, Connecticut ... 展开 >> Yale-New Haven Hospital New Haven, Connecticut, United States, 06510 收起 << |
NCT00666029 | - | Completed | - | - | |
NCT00990808 | Dyslipidemia | Phase 1 | Completed | - | - |
NCT00153166 | - | Completed | - | - | |
NCT01557075 | Drug-eluting Stent (DES) | Phase 4 | Unknown | August 2015 | Korea, Republic of ... 展开 >> Hong Myeong-Ki Recruiting Seoul, Korea, Republic of Contact: Myeong-Ki Hong, MD.PhD +82 2 2228 8458 mkhong61@yuhs.ac Contact: Byeong-Keuk Kim, MD.PhD +82 2 2228 8465 kimbk@yuhs.ac Principal Investigator: Myeong-Ki Hong, MD.PhD 收起 << |
NCT00462748 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT01518166 | Diabetes Heal... 展开 >>thy 收起 << | Phase 1 | Completed | - | Sweden ... 展开 >> Novo Nordisk Investigational Site Uppsala, Sweden, 75323 收起 << |
NCT00987974 | Ischemia Reperfusion Injury ... 展开 >> Endothelial Dysfunction 收起 << | Phase 4 | Completed | - | Netherlands ... 展开 >> RUNMC Nijmegen, Netherlands, 6500HB 收起 << |
NCT00666029 | Metabolic Syndrome | Phase 2 | Completed | - | - |
NCT00701883 | Hyperlipidemia | Phase 2 | Completed | - | - |
NCT00452608 | Sepsis | Phase 2 | Unknown | December 2009 | Brazil ... 展开 >> HCPA - Clinical Hospital fo Porto Alegre Recruiting Porto Alegre, Rio Grande do Sul, Brazil, 90035-903 Sub-Investigator: Karen F Prado 收起 << |
NCT03358017 | Triple Negative Breast Cancer | Phase 2 | Recruiting | July 25, 2020 | Italy ... 展开 >> Azienda Socio Sanitaria Territoriale ASST Lariana - Presidio Ospedaliero Ospedale S. Anna Not yet recruiting San Fermo della Battaglia, Como, Italy, 22020 Contact: Monica Giordano, MD + 39 031 5859372 monica.giordano@asst-lariana.it Principal Investigator: Monica Giordano, MD Azienda Socio Sanitaria Territoriale - ASST Papa Giovanni XXIII Recruiting Bergamo, Italy, 24127 Contact: Alberto Zambelli, MD + 39 035 2673694 alberto.zambelli@asst-pg23.it Principal Investigator: Alberto Zambelli, MD Azienda Ospedaliero Universitaria di Bologna Policlinico S.Orsola - Malpighi Not yet recruiting Bologna, Italy, 40138 Contact: Claudio Zamagni, MD + 39 051 2144548 zamagniclaudio.sper@aosp.bo.it Principal Investigator: Claudio Zamagni, MD Azienda Socio Sanitaria Territoriale - ASST di Cremona Not yet recruiting Cremona, Italy, 26100 Contact: Manuela Milani, MD 0372 408026 manuela.milani@googlemail.com Principal Investigator: Manuela Milani, MD Azienda Socio Sanitaria Territoriale - ASST di Lodi Not yet recruiting Lodi, Italy, 26900 Contact: Paola Sagrada, MD +39 0371 372229 paola.sagrada@asst-lodi.it Principal Investigator: Paola Sagrada, MD Azienda Socio Sanitaria Territoriale Fatebenefratelli Sacco Sede Ospedale Fatebenefratelli Not yet recruiting Milano, Italy, 20121 Contact: Nicla La Verde, MD + 39 02 63632167 nicla.laverde@asst-fbf-sacco.it Principal Investigator: Nicla La Verde, MD Azienda Socio Sanitaria Territoriale ASST Monza - Ospedale S. Gerardo Recruiting Monza, Italy, 20900 Contact: Marina Cazzaniga, MD + 39 039 2339037 marina.cazzaniga@asst-monza.it Principal Investigator: Marina Cazzaniga, MD Azienda Ospedaliera Universitaria Federico II Not yet recruiting Napoli, Italy, 80131 Contact: Grazia Arpino, MD + 39 081 676799 grazia.arpino@unina.it Principal Investigator: Grazia Arpino, MD Istituti Clinici Scientifici Maugeri Not yet recruiting Pavia, Italy, 27100 Contact: Antonio Bernardo, MD + 39 0382 592657 antonio.bernardo@icsmaugeri.it Principal Investigator: Antonio Bernardo, MD IFO - Istituto Nazionale dei Tumori Regina Elena Recruiting Roma, Italy, 00144 Contact: Alessandra Fabi, MD +39 06 52665144 alessandra.fabi@ifo.gov.it Principal Investigator: Alessandra Fabi, MD 收起 << |
NCT03769870 | Diabete Mellitus | Phase 1 | Not yet recruiting | July 2019 | - |
NCT00462748 | - | Completed | - | - | |
NCT02791958 | Hypertension | Phase 2 | Active, not recruiting | October 2017 | - |
NCT00157924 | Hypercholesterolemia | Phase 4 | Completed | - | - |
NCT01081548 | Hypercholesterolemia | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Severance Hospital Seoul, Korea, Republic of 收起 << |
NCT03228017 | Cardiovascular Diseases ... 展开 >> Myocardial Infarction Atherosclerotic Cardiovascular Disease Thrombotic Vascular Disease 收起 << | Phase 4 | Recruiting | December 1, 2019 | United States, New York ... 展开 >> New York University School of Medicine Recruiting New York, New York, United States, 10016 Contact: Michael Garshick 212-263-4004 Michael.Garshick@nyumc.org Principal Investigator: Jeffrey Berger, MD 收起 << |
NCT00579098 | Atrial Fibrillation ... 展开 >> Arrhythmia Inflammation Endothelial Dysfunction 收起 << | Phase 4 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT00579098 | - | Completed | - | - | |
NCT00678184 | Healthy Subjects | Phase 4 | Completed | - | Denmark ... 展开 >> Department of Medical Research, Holstebro Hospital Holstebro, Denmark, 7500 Medical Research Holstebro, Denmark, 7500 收起 << |
NCT01370590 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00344370 | Type II Diabetes Mellitus ... 展开 >> Dyslipidemia 收起 << | Phase 3 | Completed | - | Denmark ... 展开 >> CCBR Aalborg Aalborg, Denmark CCBR A/S Vejle, Denmark CCBR Vejle Vejle, Denmark Germany Gemeinschaftspraxis am Bahnhof Berlin-Spandau, Germany Pharmakologisches Studienzentum Chemnitz Chemnitz, Germany Internistische Diabetische Schwerpunktpraxis Dr. Frankfurt Am Main, Germany Internistische Gemeinschaftspraxis Mainz, Germany Gemeinschaftspraxis Dr. Senftleber, Dr. Kohler Messkirch, Germany India Bhagwan Mahaveer Jain Heart Centre Bangalore, India Sri Ramachandra Medical College Hospital Chennai, India Apollo Hospitals Hyderabaad, India CARE Group of Hospitals Hyderabaad, India PD Hinduja Hospital Mumbai, India Netherlands Andromed Breda Breda, Netherlands Andromed Eindhoven Eindhoven, Netherlands Andromed Noord Groningen, Netherlands Andromed Leiden Leiden, Netherlands Andromed Nijmegen Nijmegen, Netherlands Andromed Rotterdam Rotterdam, Netherlands Andromed Oost Velp, Netherlands Andromed Zoetermeer Zoetermeer, Netherlands Poland Podlaski Osrodek Kardiologii Bialystok, Poland NZOZ GCP Dobra Praktyka Lekaska Gruziadz, Poland NZOZ Terapia Optima Katowice, Poland NZOZ Esculap, Przychodnia Lekary Rodzinnych Losice, Poland NZOZ Centrum, Poradnia Kardiologiczna Siedlce, Poland Spec. Gab. Lek. Internistyczno-Kardiologicznly Tarnow, Poland Woj.Szp.Spec.Nr 1 im. Prof. J. Gasinskiego Tychy, Poland Instytut Zywnosci i Zywienia Warszawa, Poland Lecznica PROSEN SMO Warszawa, Poland Szpital Wolski,im. Dr A. Gostynskiej Warszawa, Poland United Kingdom Synexus Reading Clinical Research Centre Berkshire, United Kingdom Synexus Lancashire Clinical Research Centre Lancashire, United Kingdom Synexus Merseyside Clinical Research Centre Liverpool, United Kingdom Synexus Manchester Clinical Research Centre Manchester, United Kingdom 收起 << |
NCT01370590 | - | Completed | - | - | |
NCT01370603 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00344370 | - | Completed | - | - | |
NCT01370603 | - | Completed | - | - | |
NCT02035215 | Hyperlipidemia, Familial Combi... 展开 >>ned 收起 << | Phase 3 | Unknown | December 2014 | Korea, Republic of ... 展开 >> Hallym University Sacred Heart Hospital Active, not recruiting Anyang, Gyeonggi, Korea, Republic of, 431-070 Gachon University Gil Hospital Not yet recruiting Incheon, Korea, Republic of, 405-760 Korea University Guro Hospital Recruiting Seoul, Korea, Republic of, 152-703 Uijongbu St. Mary`s Hospital Active, not recruiting Uijongbu, Gyeonggi, Korea, Republic of, 480-717 收起 << |
NCT01218204 | Dyslipidaemias | Phase 2 | Completed | - | - |
NCT00529542 | Polycystic Ovary Syndrome | Phase 2 | Completed | - | United States, Pennsylvania ... 展开 >> Penn State Milton S Hershey Medical Center, College of Medicine Hershey, Pennsylvania, United States, 17033 收起 << |
NCT01518231 | Stroke | Phase 1 | Unknown | December 2013 | China, Zhejiang ... 展开 >> Yaguo Li Recruiting Hangzhou, Zhejiang, China, 310013 Contact: Yumiao Zhou, master 0086-0571-87987373 ext 5094 zlf859@yahoo.com.cn 收起 << |
NCT03096288 | Atherosclerotic Cardiovascular... 展开 >> Disease 收起 << | Phase 4 | Recruiting | September 2019 | United States, Florida ... 展开 >> University of Florida Recruiting Jacksonville, Florida, United States, 32209 Contact: Dominick J Angiolillo, MD, PhD dominick.angiolillo@jax.ufl.edu Principal Investigator: Dominick J Angiolillo, MD, PhD 收起 << |
NCT02938468 | Chronic Subdural Hematoma | Phase 2 Phase 3 | Unknown | September 2018 | Canada, Alberta ... 展开 >> University of Calgary Recruiting Calgary, Alberta, Canada, T2N1N4 Contact: Clare Gallagher, MD.,PhD 4039448447 galclare@gmail.com Contact: Michael Opoku-Darko, MD.,MSc. mopokuda@ucalgary.ca Principal Investigator: Clare Gallagher, MD.,PhD. Sub-Investigator: Steve Casha, MD.,PhD. Sub-Investigator: Michael Opoku-Darko, MD.,MSc. 收起 << |
NCT03287609 | Acute Coronary Syndrome | Phase 3 | Recruiting | June 30, 2019 | Switzerland ... 展开 >> Basel University Hospital Recruiting Basel, BS, Switzerland, 4031 Contact: Christoph Kaiser, Prof., MD +41 61 556 58 16 christoph.kaiser@usb.ch HFR Kantonsspital Recruiting Fribourg, FR, Switzerland, 1708 Contact: Stephane Cook, Prof., MD +41 26 426 81 40 stephane.cook@unifr.ch Hopitaux Universitaires Geneve Recruiting Geneva, GE, Switzerland, 1211 Contact: Francois Mach, Prof., MD +41 22 372 71 92 Francois.Mach@hcuge.ch Cardiocentro Ticino Recruiting Lugano, TI, Switzerland, 6900 Contact: Tiziano Moccetti, Prof., MD +41918053111 SRC@cardiocentro.org Centre Hospitalier Universitaire Vaudois Not yet recruiting Lausanne, VD, Switzerland Contact: Olivier Muller, MD +41 79 556 54 96 olivier.muller@chuv.ch University Hospital Not yet recruiting Zurich, ZH, Switzerland Contact: Christian Matter, Prof., MD +41 44 635 64 67 christian.matter@uzh.ch 收起 << |
NCT01014260 | Cardiovascular Disease | Phase 4 | Withdrawn(We could not get fun... 展开 >>ding for study.) 收起 << | March 2011 | United States, Maryland ... 展开 >> Johns Hopkins University SOM. 1830 East Monument St, Ste 7500 Baltimore, Maryland, United States, 21205 收起 << |
NCT00349895 | Coronary Artery Disease ... 展开 >> Coronary Artery Stenosis 收起 << | Phase 4 | Completed | - | Austria ... 展开 >> Medizinische Universitätsklinik Graz, Austria, 8036 Belgium OLV Ziekenhuis Aalst Aalst, Belgium, 9300 AZ Middelheim Antwerp, Belgium, 2020 University Hospital Antwerp Edegem, Belgium, 2650 Virga Jesse Ziekenhuis Hasselt, Belgium, 3500 France Hôpital Henri Mondor Creteil, France, 94010 Germany Herzzentrum Bad Krozingen Bad Krozingen, Germany, 79189 Herz- und Diabeteszentrum Nordrhein-Westfalen Bad Oeynhausen, Germany, 32545 Internistische Klinik Dr. Müller Munich, Germany, 81379 Netherlands Academisch Medisch Centrum Amsterdam, Netherlands, 1105 AZ Amphia Ziekenhuis Breda, Netherlands, 4818 CK Sint Antonius Ziekenhuis Nieuwegein, Netherlands, 3435 CM Erasmus Medisch Centrum Rotterdam, Netherlands, 3015 GD United Kingdom Kings College Hospital London, United Kingdom, SE5 9RS John Radcliflfe Hospital Oxford, United Kingdom, OX3 9DU 收起 << |
NCT00360217 | Hypertriglyceridemia (TG>200<5... 展开 >>00) Hyperlipidemia Coronary Artery Disease Coronary Risk Equivalent Diabetes 收起 << | Not Applicable | Completed | - | United States, Maine ... 展开 >> Maine Center for Lipids and Cardiovascular Health Scarborough, Maine, United States, 04074 收起 << |
NCT00269048 | Atherosclerosis | Phase 2 | Completed | - | - |
NCT01972178 | Dyslipidemia | Phase 2 | Terminated | - | - |
NCT01837823 | Obstructive Coronary Artery Di... 展开 >>sease Coronary Artery Disease 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 收起 << |
NCT03204058 | Chronic Periodontitis | Phase 2 Phase 3 | Completed | - | - |
NCT03121521 | Hepatopathy | Phase 4 | Completed | - | - |
NCT00400439 | Coronary Heart Disease | Phase 2 | Completed | - | United States, Indiana ... 展开 >> Indianapolis, Indiana, United States, 46260 United States, Iowa Iowa City, Iowa, United States, 52242 United States, Kentucky Louisville, Kentucky, United States, 40213 United States, Maryland Bethesda, Maryland, United States, 20817 United States, Minnesota Minneapolis, Minnesota, United States, 55455 United States, North Carolina Statesville, North Carolina, United States, 28677 United States, Ohio Cincinnati, Ohio, United States, 45212 Cincinnati, Ohio, United States, 45219 United States, Utah Salt Lake City, Utah, United States, 84132 收起 << |
NCT01063426 | Thrombosis Pr... 展开 >>evention Surgery 收起 << | Phase 4 | Unknown | March 2012 | Korea, Republic of ... 展开 >> Hallym University Sacred Heart Hospital, Department of Cardiology and Orthopedic Surgery Recruiting Anyang-si, Gyeonggi-do, Korea, Republic of, 431-070 Contact: Sang-Ho Jo, MD 82-31-380-3722 sophi5@medimail.co.kr 收起 << |
NCT00353522 | Coronary Heart Disease | Phase 2 | Completed | - | United States, Illinois ... 展开 >> Chicago, Illinois, United States, 60610 United States, Indiana Indianapolis, Indiana, United States, 46260 United States, Iowa Iowa City, Iowa, United States, 52242 United States, Kentucky Louisville, Kentucky, United States, 40213 United States, Maryland Bethesda, Maryland, United States, 20817 United States, Minnesota Minneapolis, Minnesota, United States, 55455 United States, North Carolina Statesville, North Carolina, United States, 28677 United States, Ohio Cincinnati, Ohio, United States, 45212 Cincinnati, Ohio, United States, 45219 United States, Utah Salt Lake City, Utah, United States, 84132 Germany Berlin, Germany, 10707 Bochum, Germany, 06097 Dortmund, Germany, 44137 Erlangen, Germany, 91054 Freiburg, Germany, 79106 Hamburg, Germany, 20249 München, Germany, 80336 收起 << |
NCT01274559 | Primary Hypercholesterolemia ... 展开 >> Mixed Dyslipidemia 收起 << | Phase 3 | Terminated(In HPS2-THRIVE, MK-... 展开 >>0524A did not meet the primary efficacy objective and there was a significant increase in incidence of some types of non-fatal SAEs) 收起 << | - | - |
NCT01274559 | - | Terminated(In HPS2-THRIVE, MK-... 展开 >>0524A did not meet the primary efficacy objective and there was a significant increase in incidence of some types of non-fatal SAEs) 收起 << | - | - | |
NCT01257971 | - | Completed | - | Croatia ... 展开 >> Research Site Biograd na moru, Croatia Research Site Bjelovar, Croatia Research Site Cakovec, Croatia Research Site Crikvenica, Croatia Research Site Dubrovnik, Croatia Research Site Gospic, Croatia Research Site Karlovac, Croatia Research Site Koprivnica, Croatia Research Site Krapina, Croatia Research Site Krapinske toplice, Croatia Research Site Opatija, Croatia Research Site Osijek, Croatia Research Site Porec, Croatia Research Site Pula, Croatia Research Site Rijeka, Croatia Research Site Sisak, Croatia Research Site Slavonski brod, Croatia Research Site Split, Croatia Research Site Stubicke toplice, Croatia Research Site Umag, Croatia Research Site Vinkovci, Croatia Research Site Virovitica- Slatina, Croatia Research Site Virovitica, Croatia Research Site Vukovar, Croatia Research Site Zadar, Croatia Research Site Zageb, Croatia Research Site Zagreb, Croatia 收起 << | |
NCT01008345 | Coronary Artery Disease ... 展开 >> Diabetes 收起 << | Phase 4 | Completed | - | Lebanon ... 展开 >> Hotel Dieu de France Hospital Achrafieh, Beirut, Lebanon, 0000 收起 << |
NCT03017950 | Hypertension ... 展开 >>Hyperlipidemias 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Inha University Hospital Incheon, Korea, Republic of 收起 << |
NCT00396110 | - | Completed | - | - | |
NCT00726362 | - | Completed | - | Taiwan ... 展开 >> Research Site Changhua, Taiwan Research Site Hualien, Taiwan Research Site Kaohsiung, Taiwan Research Site Pingtung, Taiwan Research Site Taichung, Taiwan Research Site Tainan, Taiwan Research Site Taipei, Taiwan Research Site Yun-Lin, Taiwan 收起 << | |
NCT01218204 | - | Completed | - | - | |
NCT00127218 | Atherosclerosis ... 展开 >> Cardiovascular Disease 收起 << | Phase 3 | Completed | - | United States, Maryland ... 展开 >> Johns Hopkins Unversity School of Medicine Baltimore, Maryland, United States, 21218 收起 << |
NCT01837823 | - | Completed | - | - | |
NCT01483950 | - | Completed | - | Bosnia and Herzegovina ... 展开 >> Research Site Banja Luka, Bosnia and Herzegovina Research Site Bijeljina, Bosnia and Herzegovina Research Site Doboj, Bosnia and Herzegovina Reserach Site Gradiška, Bosnia and Herzegovina Research Site Kakanj, Bosnia and Herzegovina Research Site Maglaj, Bosnia and Herzegovina Research Site Prijedor, Bosnia and Herzegovina Research Site Sarajevo, Bosnia and Herzegovina Research Site Tešanj, Bosnia and Herzegovina Research Site Trebinje, Bosnia and Herzegovina Research Site Visoko, Bosnia and Herzegovina Research Site Zavidovići, Bosnia and Herzegovina Research Site Zenica, Bosnia and Herzegovina Research Site Zvornik, Bosnia and Herzegovina 收起 << | |
NCT00465322 | - | Completed | - | Switzerland ... 展开 >> Cardiology University Hospital Bern, Switzerland, 3010 收起 << | |
NCT00636766 | Carotid Atherosclerosis ... 展开 >> Stroke Type 2 Diabetes Metabolic Syndrome 收起 << | Not Applicable | Completed | - | Greece ... 展开 >> General Hospital of Thessaloniki "Hippokratio" Thessaloniki, Greece 收起 << |
NCT01007279 | Periprocedural Myocardial Necr... 展开 >>osis 收起 << | Phase 3 | Completed | - | Italy ... 展开 >> Policlinico Umberto I Rome, Italy, 00166 收起 << |
NCT00127218 | - | Completed | - | - | |
NCT00349661 | Coronary Heart Disease | Phase 3 | Completed | - | France ... 展开 >> Department of Cardiology Brest, France, 29200 收起 << |
NCT00303277 | Alzheimer's Disease ... 展开 >> Aging 收起 << | Phase 4 | Completed | - | United States, Washington ... 展开 >> VA Puget Sound Health Care System Seattle, Washington, United States, 98108 收起 << |
NCT00145574 | Hypercholesterolemia | Phase 4 | Completed | - | - |
NCT00145574 | - | Completed | - | - | |
NCT01970215 | Dyslipidemia | Phase 2 | Completed | - | Denmark ... 展开 >> H:S Amager Hospital Copenhagen, Denmark Sydvestjysk Sygehus Esbjerg, Denmark Herlev University Hospital Herlev, Denmark Hvidovre Hospital Hvidovre, Denmark Regionshopitalet - Silkeborg Silkeborg, Denmark Netherlands EB FlevoResearch B.V Almere, Netherlands Academic Medical Centre Amsterdam-Zuidoost, Netherlands Andromed Amsterdam Amsterdam, Netherlands Andromed Leiden Amsterdam, Netherlands Andromed Breda B.V Breda, Netherlands Andromed Eindhoven Eindhoven, Netherlands Andromed Noord B.V Groningen, Netherlands Andromed Zoetermeer Leiderdorp, Netherlands Andromed Rotterdam BV Rotterdam, Netherlands Albert Schweitzer Ziekenhuis Sliedrecht, Netherlands Andromed Oost Velp, Netherlands Praktijk Zwijndrecht Zwijndrecht, Netherlands 收起 << |
NCT01502943 | Coronary Heart Disease ... 展开 >> Stable Angina Pectoris 收起 << | Phase 4 | Completed | - | China, Jilin ... 展开 >> Affiliated hospital of Changchun university of TCM Changchun, Jilin, China, 110000 Jilin integrative Chinese and western medicine hospital Changchun, Jilin, China, 110000 China, Liaoning Dalian integrative of Chinese and Western medicine hospital Dalian, Liaoning, China, 110000 Dandong TCM hospital Dandong, Liaoning, China, 110000 Fuxin TCM hospital Fuxin, Liaoning, China, 110000 Affiliated hospital of Liaoning university of TCM 2 Shenyang, Liaoning, China, 110000 Affiliated hospital of Liaoning university of TCM Shenyang, Liaoning, China, 110000 Shengjing Hospital of China Medical University Shenyang, Liaoning, China, 110000 Yingkou TCM hospital Yingkou, Liaoning, China, 110000 China, Tianjin Affiliated hospital of Tianjin university of TCM Tianjin, Tianjin, China, 110000 收起 << |
NCT03417388 | Coronary Artery Disease | Phase 4 | Recruiting | December 30, 2022 | United States, California ... 展开 >> Cedars-Sinai Heart Institute Recruiting Los Angeles, California, United States, 90048 Contact: Sophie Yoo, MS 310-423-3300 jihye.yoo@cshs.org Principal Investigator: Chrisandra Shufelt, MD LA BioMedical Recruiting Torrance, California, United States, 90502 Principal Investigator: Matthew Budoff, MD United States, Florida Family Medicine at Eastside Community Practice Recruiting Gainesville, Florida, United States, 32206 Family Medicine at Hampton Oaks Medical Plaza (Adults and Peds) Recruiting Gainesville, Florida, United States, 32607 Internal Medicine at Tower Hill Recruiting Gainesville, Florida, United States, 32607 Family Medicine at Haile Plantation (Adults & Peds) Recruiting Gainesville, Florida, United States, 32608 Cardiovascular Clinic at UF Health UF Recruiting Gainesville, Florida, United States, 32610 Internal Medicine at UF Health Medical Plaza Recruiting Gainesville, Florida, United States, 32610 UF Health at the University of Florida Recruiting Gainesville, Florida, United States, 32610 Cardiology West at Doctors Park Recruiting Gainesville, Florida, United States, 32611 Family Medicine at 4th Ave Recruiting Gainesville, Florida, United States, 32611 Family Medicine at Old Town (Adults and Peds) Recruiting Gainesville, Florida, United States, 32680 Baptist Health Recruiting Jacksonville, Florida, United States, 32207 Principal Investigator: Ruple Galani, MD Naval Hospital Jacksonville Recruiting Jacksonville, Florida, United States, 32214 UF Primary Care at Lake City SW Recruiting Lake City, Florida, United States, 32024 UF Primary Care at Lake City West Recruiting Lake City, Florida, United States, 32024 Novel Clinical Research Recruiting Miami, Florida, United States, 33186 Contact: Heber L Varela, MD 786-773-2737 Daytona Heart Group Recruiting Multiple Locations, Florida, United States, 32114 Contact: Glenn Rayos, MD 386-258-8722 Ocala Research Institute Inc. Recruiting Ocala, Florida, United States, 34480 Contact: Rakesh Prashad, MD 352-412-5989 Orlando Health Recruiting Orlando, Florida, United States, 32806 Principal Investigator: Arnold Einhorn, MD Naval Hospital Pensacola Recruiting Pensacola, Florida, United States, 32512 Principal Investigator: Carrie Gray, MD Florida Hospital Tampa - Pepin Heart Institute Recruiting Tampa, Florida, United States, 33613 Contact: Charles R Lambert, MD 813-615-7527 Interventional Cardiac Consultants Recruiting Tampa, Florida, United States, 33613 Contact: Carlos J Bayron, MD 727-842-9526 United States, Kentucky University of Kentucky Recruiting Lexington, Kentucky, United States, 40506 Principal Investigator: Gretchen Wells, MD 收起 << |
NCT00125125 | Dyslipidemia | Phase 4 | Completed | - | United States, New Jersey ... 展开 >> Novartis East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany 收起 << |
NCT01246778 | - | Completed | - | Netherlands ... 展开 >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500HB 收起 << | |
NCT02931188 | - | Completed | - | United Kingdom ... 展开 >> Clinical Investigation Ward, Addenbrooke's Hospital Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ 收起 << | |
NCT01700075 | Myocardial Infarction ... 展开 >> Coronary Artery Diseases Diabetes Mellitus, Type 2 Atherosclerosis of Femoral Artery 收起 << | Phase 4 | Completed | - | Kazakhstan ... 展开 >> Scientific Research Institute of Cardiology and Internal Diseases Almaty, Kazakhstan, 050000 收起 << |
NCT01516879 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT01516879 | - | Completed | - | - | |
NCT01499511 | - | Unknown | March 2014 | United Kingdom ... 展开 >> International Centre for Circulatory Health Not yet recruiting London, United Kingdom, W2 1LA Contact: Judith A Mackay, MBBS PhD MRCP +442075941395 judith.mackay@imperial.nhs.uk Contact: Peter S Sever, MBCHB PhD FRCP +442075941099 p.sever@imperial.ac.uk Principal Investigator: Judith A Mackay, MBBS PhD MRCP 收起 << | |
NCT01709500 | Heterozygous Familial Hypercho... 展开 >>lesterolemia 收起 << | Phase 3 | Completed | - | Czech Republic ... 展开 >> Hradec Kralove, Czech Republic Praha 2, Czech Republic Praha 5, Czech Republic Praha 8, Czech Republic Trutnov, Czech Republic Vyskov, Czech Republic Netherlands Alkmaar, Netherlands Amsterdam, Netherlands Apeldoorn, Netherlands Enschede, Netherlands Goes, Netherlands Groningen, Netherlands Hoogeveen, Netherlands Hoorn, Netherlands Rotterdam, Netherlands Sittard- Geleen, Netherlands Utrecht (2 locations), Netherlands Venlo, Netherlands Waalwijk, Netherlands Norway Oslo, Norway United Kingdom Cardiff, United Kingdom London, United Kingdom Manchester, United Kingdom Middlesex, United Kingdom Newcastle upon Tyne, United Kingdom West Bromwich, United Kingdom 收起 << |
NCT00359281 | Healthy | Phase 2 | Completed | - | United States, Pennsylvania ... 展开 >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT00664469 | Hypercholesterolemia | Phase 3 | Terminated(Poor enrollment) | - | Canada, Quebec ... 展开 >> Merck Frosst Canada Ltd. Kirkland, Quebec, Canada, H9H 3L1 收起 << |
NCT01763866 | - | Completed | - | - | |
NCT01709500 | - | Completed | - | - | |
NCT01763866 | Hyperlipidemia | Phase 3 | Completed | - | - |
NCT02715726 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT02029118 | Stable Angina Pectoris | Early Phase 1 | Unknown | August 2015 | China, Sichuan ... 展开 >> Affiliated hospital of Chengdu University of TCM Recruiting Chengdu, Sichuan, China, 610072 Contact: Dehua Li 18980079361 1259362295@qq.com 收起 << |
NCT00249899 | Hypercholesterolemia | Phase 3 | Terminated(Overall profile of ... 展开 >>the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents) 收起 << | - | - |
NCT00359281 | - | Completed | - | - | |
NCT01665235 | Blood Pressure Variability ... 展开 >> Intracranial Artery Stenosis 收起 << | Not Applicable | Unknown | August 2014 | China, Shanghai ... 展开 >> RenJi Hospital Recruiting Shanghai, Shanghai, China, 200127 Principal Investigator: Guowen Shi, MD 收起 << |
NCT02205775 | Stable Coronary Artery Disease... 展开 >> Undergoing PCI 收起 << | Phase 3 | Terminated(difficult recruitme... 展开 >>nt) 收起 << | - | Italy ... 展开 >> SS. Annunziata Hospital Chieti, CH, Italy, 66100 Fondazione IRCCS Policlinico S. Matteo Pavia, PV, Italy, 27100 A.O. S. Anna e S. Sebastiano - II Università di Napoli Caserta, Italy, 81100 Azienda ASL 6 - P. Ospedaliero Livorno Livorno, Italy, 57100 Ospedale Civile G. Fornaroli Magenta, Italy, 20013 Azienda Ospedaliera - Ospedale San Paolo Milano, Italy, 20142 收起 << |
NCT00000941 | HIV Infections | Phase 1 | Completed | - | United States, California ... 展开 >> Univ of Southern California / LA County USC Med Ctr Los Angeles, California, United States, 900331079 San Francisco Gen Hosp San Francisco, California, United States, 941102859 Stanford Univ Med Ctr Stanford, California, United States, 943055107 United States, Colorado Univ of Colorado Health Sciences Ctr Denver, Colorado, United States, 80262 United States, Florida Univ of Miami School of Medicine Miami, Florida, United States, 331361013 United States, Hawaii Univ of Hawaii Honolulu, Hawaii, United States, 96816 United States, Indiana Indiana Univ Hosp Indianapolis, Indiana, United States, 462025250 United States, Louisiana Tulane Univ School of Medicine New Orleans, Louisiana, United States, 70112 United States, Maryland Johns Hopkins Hosp Baltimore, Maryland, United States, 21287 United States, Minnesota Univ of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Bellevue Hosp / New York Univ Med Ctr New York, New York, United States, 10016 United States, South Carolina Julio Arroyo West Columbia, South Carolina, United States, 29169 United States, Washington Univ of Washington Seattle, Washington, United States, 98104 收起 << |
NCT03709355 | HIV-1-infection | Phase 1 | Not yet recruiting | February 2019 | - |
NCT00090168 | Hypercholesterolemia ... 展开 >> Atherosclerotic Disease Coronary Disease 收起 << | Phase 3 | Completed | - | - |
NCT02942602 | Hyperlipidemia | Not Applicable | Completed | - | Korea, Republic of ... 展开 >> Division of Cardiology, Department of Internal Medicine, Seoul, Korea, Republic of, 03722 收起 << |
NCT01715714 | Coronary Artery Disease | Phase 4 | Recruiting | December 2019 | Germany ... 展开 >> Heart Center Freiburg-Bad Krozingen Active, not recruiting Freiburg, Baden-Württemberg, Germany, 79106 Heart Center Bad Neustadt Recruiting Bad Neustadt An Der Saale, Bayern, Germany, 97616 Contact: Arno Diegeler, Prof., MD Contact: Wilko Reents, MD University of Aachen Recruiting Aachen, NRW, Germany, 52074 Contact: Rüdiger Autschbach, MD, Prof. Sub-Investigator: Andreas Goetzenich, MD Principal Investigator: Rüdiger Autschbach, MD, Prof. Heart Center Bad Oeynhausen Recruiting Bad Oeynhausen, NRW, Germany, 32545 Contact: Jan Gummmert, MD, Prof. Principal Investigator: Jochen Börgermann, MD, PhD Principal Investigator: Jan Gummert, MD, Prof. University of Bochum Recruiting Bochum, NRW, Germany Contact: Justus Strauch, MD, Prof. Principal Investigator: Mügge, MD, Prof. Sub-Investigator: Peter Haldenwang, MD University of Bonn Active, not recruiting Bonn, NRW, Germany, 53127 University of Cologne Recruiting Cologne, NRW, Germany, 50924 Contact: Oliver J Liakopoulos, MD, PhD +49 221 478 ext 32450 oliver.liakopoulos@uk-koeln.de Principal Investigator: Oliver J Liakopoulos, MD, PhD Principal Investigator: Thorsten Wahlers, MD, Prof. University of Essen Recruiting Essen, NRW, Germany, 45122 Contact: Matthias Thielmann, MD, PhD Principal Investigator: Matthias Thielmann, MD, PhD Principal Investigator: Heinz Jakob, MD, Prof. Sub-Investigator: Daniel Wendt, MD University of Muenster Active, not recruiting Muenster, NRW, Germany, 48149 Helios Heart Center Wuppertal Active, not recruiting Wuppertal, NRW, Germany, 42117 收起 << |
NCT02518503 | - | Completed | - | - | |
NCT01581476 | Type 1 Diabetes | Phase 3 | Completed | - | Australia ... 展开 >> University of Western Australia Perth, Australia Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada 收起 << |
NCT02913664 | Cognitively Normal Older Adult... 展开 >>s Hypertension Subjective Cognitive Decline Family History of Alzheimer's Disease 收起 << | Phase 2 Phase 3 | Recruiting | September 2022 | United States, Kansas ... 展开 >> University of Kansas Medical Center Research Institute Recruiting Kansas City, Kansas, United States, 66160 Contact: Angela VanSciver 913-945-5029 avansciver@kumc.edu Principal Investigator: Jeffrey Burns, MD United States, Louisiana Pennington Biomedical Research Center Recruiting Baton Rouge, Louisiana, United States, 70808 Contact: Sara Goff 225-763-0910 sara.goff@pbrc.edu Principal Investigator: Jeffrey Keller, PhD United States, Missouri Washington University in St. Louis Recruiting Saint Louis, Missouri, United States, 63110 Contact: Monica Sewell 314-286-2716 sewellm@wustl.edu Principal Investigator: Ellen Binder, MD United States, Texas UT Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact: Lauren Braunfeld, BS 214-345-7134 LaurenBraunfeld@texashealth.org Contact: Ann Jacob, BSN 214-345-4665 AnnJacob@TexasHealth.org Principal Investigator: Rong Zhang, PhD 收起 << |
NCT02518516 | - | Completed | - | Canada, British Columbia ... 展开 >> Dept. of Anesthesiology, Pharmacology & Therapeutics (APT), University of British Columbia Vancouver, British Columbia, Canada, V6T 1Z3 收起 << | |
NCT00718796 | Cardiovascular Disease | Phase 3 | Completed | - | Canada, Ontario ... 展开 >> Canadian College of Naturopathic Medicine Toronto, Ontario, Canada, M2K 1E2 收起 << |
NCT03072082 | Coronary Artery Disease(CAD) | Phase 4 | Not yet recruiting | February 2019 | - |
NCT03072121 | Coronary Artery Disease(CAD) | Phase 4 | Not yet recruiting | February 2019 | - |
NCT02305355 | Diabetes Mellitus, Type 2 ... 展开 >> Hypertriglycemia 收起 << | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Bucheon St. Mary's Hospital Bucheon, Korea, Republic of 收起 << |
NCT03507374 | Stroke Intrac... 展开 >>ranial Atherosclerosis Intraplaque Hemorrhage 收起 << | Early Phase 1 | Not yet recruiting | September 28, 2021 | - |
NCT00952770 | Coronary Artery Disease | Phase 4 | Unknown | - | Korea, Republic of ... 展开 >> Chungnam National University Hospital Recruiting Daejeon, Korea, Republic of Contact: Jae-Hyeong Park, MD, PhD 82-42-280-7167 jaehpark@cnuh.co.kr 收起 << |
NCT02201381 | Cancer Overal... 展开 >>l Survival 收起 << | Phase 3 | Recruiting | October 22, 2023 | United Kingdom ... 展开 >> Care Oncology Clinic Recruiting London, United Kingdom, W1G 9PP Contact: Gregory Stoloff +44 207 580 3266 info@careoncologyclinic.com Contact: Robin Bannister, PhD +44 207 153 6577 robin.bannister@seekacure.com 收起 << |
NCT03355027 | Atherosclerosis ... 展开 >> Cardiovascular Diseases 收起 << | Not Applicable | Recruiting | May 8, 2019 | United Kingdom ... 展开 >> Addenbrooke's Hospital Recruiting Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Contact: Paul Cacciottolo 01223256653 pjc99@medschl.cam.ac.uk Principal Investigator: Joseph Cheriyan, MBChB, MA, FRCP 收起 << |
NCT00930670 | Coronary Artery Disease | Phase 4 | Completed | - | Canada, Quebec ... 展开 >> Institut Universitaire de Cardiologie et de Pneumologie de Quebec Quebec City, Quebec, Canada, G1V4G5 收起 << |
NCT03273972 | Atherosclerosis ... 展开 >> Cardiovascular Diseases 收起 << | Not Applicable | Recruiting | April 2019 | United Kingdom ... 展开 >> Addenbrooke's Hospital Recruiting Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Contact: J Hurlock 01223256621 james.hurlock@addenbrookes.nhs.uk Principal Investigator: Joseph Cheriyan, MBChB, MA, FRCP 收起 << |
NCT01190007 | - | Completed | - | - | |
NCT00092625 | Hypercholesterolemia ... 展开 >> Coronary Disease 收起 << | Phase 3 | Completed | - | - |
NCT00092638 | Hypercholesterolemia ... 展开 >> Coronary Disease 收起 << | Phase 3 | Completed | - | - |
NCT00734123 | Atherosclerosis ... 展开 >> Cardiovascular Diseases 收起 << | Phase 4 | Unknown | May 2013 | Spain ... 展开 >> Hospital Arnau de Vilanova Recruiting Lleida, Catalunya, Spain, 25260 Contact: Blai Coll, MD,PhD +34 619633249 bcoll@arnau.scs.es Sub-Investigator: Blai Coll, MD,PhD Sub-Investigator: Merce Borras, MD,PhD 收起 << |
NCT01190007 | Hypertension ... 展开 >>Hypercholesterolemia Angina Pectoris 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> Healthcare Corporation MEDOC Medical Dock&Clinic Nagoya, Aichi, Japan Beppu Medical Clinic Dazaifu, Fukuoka, Japan Morizono medical clinic Kitakyushu, Fukuoka, Japan Gakkentoshi Clinic Nishi-ku, Fukuoka, Japan Department of internal gastro-intestinal medicine Ohshima clinic Sapporo, Hokkaido, Japan Oofuji Clinic Amagasaki, Hyogo, Japan Mizutani Clinic Kobe, Hyogo, Japan Nada Clinic Kobe, Hyogo, Japan Idaimae-naika Clinic Kawasaki, Kanagawa, Japan Sakakibara Clinic, Wakaumekai Medical Corporation Yokohama, Kanagawa, Japan Masunaga Clinic Fujimi, Saitama, Japan Sugiura Clinic Kawaguchi, Saitama, Japan Masuda Clinic Adachi-ku, Tokyo, Japan Wakasugi Family Clinic Arakawa-ku, Tokyo, Japan Medical Care Law Person Corporation Kenseikai, Kobayashi Internal Medicine Clinic Koto-ku, Tokyo, Japan Banno Clinic Ohta-ku, Tokyo, Japan Hatano Medical Clinic Setagaya-ku, Tokyo, Japan Suzuki Circulatory Medical Clinic Setagaya-ku, Tokyo, Japan Yano Cardiovascular Clinic Fukuoka, Japan Nakaoka Clinic Osaka, Japan 收起 << |
NCT01127945 | Acute Heart Failure | Not Applicable | Completed | - | Korea, Republic of ... 展开 >> Severance Cardiovascular hospital, Yonsei University College of Medicine Seoul, Korea, Republic of 收起 << |
NCT00730132 | - | Completed | - | - | |
NCT00730132 | - | Completed | - | - | |
NCT01673178 | - | Completed | - | - | |
NCT01350141 | Hypercholesterolemia ... 展开 >> Dyslipidemia 收起 << | Phase 2 | Completed | - | - |
NCT03660293 | Diabetes Mellitus, Type 1 | Not Applicable | Recruiting | April 2019 | Egypt ... 展开 >> Faculty of Medicine- Tanta University Recruiting Tanta, Gharbia, Egypt, 0000 Contact: Rasha M Gamal, MD +201227405988 rashagamal1978@gmail.com Principal Investigator: Osama A El Razaky, MD Principal Investigator: Adel A Erfan, MD Principal Investigator: Amal A Elbendary, MD Principal Investigator: Doaa M El Amrousy, MD Principal Investigator: Alshimaa M Badr Eldeen, MsC 收起 << |
NCT01673178 | Diabetes Melliuts, Type 2 | Phase 1 | Completed | - | United States, California ... 展开 >> Anaheim Clinical Trials, LLC Anaheim, California, United States, 92801 Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 Diablo Clinical Research, Inc. Walnut Creek, California, United States, 94598 United States, Florida Avail Clinical Research, LLC DeLand, Florida, United States, 32720 Elite Research Institute Miami, Florida, United States, 33169 Miami Research Associates, Inc. South Miami, Florida, United States, 33143 MRA Clinical Research, LLC South Miami, Florida, United States, 33143 United States, Kentucky Central Kentucky Research Associates, Inc. Lexington, Kentucky, United States, 40509 L-MARC Research Center Louisville, Kentucky, United States, 40213 United States, Minnesota Prism Research Saint Paul, Minnesota, United States, 55114 United States, North Carolina High Point Clinical Trials Center, LLC High Point, North Carolina, United States, 27265 Carolina Phase 1 Research Raleigh, North Carolina, United States, 27612 Wake Internal Medicine Consultants Raleigh, North Carolina, United States, 27612 United States, Ohio Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States, 45227 Community Research Cincinnati, Ohio, United States, 45255 Mercy Hospital Pharmacy Cincinnati, Ohio, United States, 45255 United States, Texas Covance Clinical Research Unit Dallas, Texas, United States, 75247 收起 << |
NCT01004406 | Acute Coronary Syndrome | Phase 3 | Completed | - | United States, Illinois ... 展开 >> Edward Hines, Jr. VA Hospital Hines, Illinois, United States, 60141-5000 United States, Oklahoma Oklahoma City VA Medical Center, Oklahoma City, OK Oklahoma City, Oklahoma, United States, 73104 United States, Texas VA North Texas Health Care System, Dallas Dallas, Texas, United States, 75216 收起 << |
NCT01271985 | Cardiovascular Diseases | Phase 3 | Unknown | April 2018 | Iran, Islamic Republic of ... 展开 >> Golestan Cohort Study Center Gonbad, Golestan, Iran, Islamic Republic of 收起 << |
NCT03659149 | Hypertension ... 展开 >>Dyslipidemias 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Seoul Saint Mary's Hospital Seoul, Korea, Republic of 收起 << |
NCT01837069 | Osteoarthritis ... 展开 >> Cardiovascular Disease 收起 << | Phase 4 | Suspended(Low recruitment / DS... 展开 >>MB approval to halt recruitment) 收起 << | December 2018 | United States, New York ... 展开 >> NYU Hospital for Joint Diseases New York, New York, United States, 10003 收起 << |
NCT02584504 | Hypercholesterolemia | Phase 3 | Completed | - | Japan ... 展开 >> Investigational Site Number 392028 Ageo-Shi, Japan Investigational Site Number 392007 Chuo-Ku, Japan Investigational Site Number 392029 Chuo-Ku, Japan Investigational Site Number 392014 Fukui-Shi, Japan Investigational Site Number 392023 Hachioji-Shi, Japan Investigational Site Number 392013 Itoshima-Shi, Japan Investigational Site Number 392010 Kanazawa-Shi, Japan Investigational Site Number 392024 Kasuga-Shi, Japan Investigational Site Number 392004 Kawanishi-Shi, Japan Investigational Site Number 392015 Kitakyushu-Shi, Japan Investigational Site Number 392005 Komatsu-Shi, Japan Investigational Site Number 392032 Matsudo-Shi, Japan Investigational Site Number 392017 Matsumoto-Shi, Japan Investigational Site Number 392003 Mito-Shi, Japan Investigational Site Number 392018 Morioka-Shi, Japan Investigational Site Number 392009 Moriya-Shi, Japan Investigational Site Number 392006 Nagoya-Shi, Japan Investigational Site Number 392011 Nagoya-Shi, Japan Investigational Site Number 392019 Nagoya-Shi, Japan Investigational Site Number 392025 Nagoya-Shi, Japan Investigational Site Number 392027 Osaka-Shi, Japan Investigational Site Number 392030 Sakura-Shi, Japan Investigational Site Number 392016 Shinagawa-Ku, Japan Investigational Site Number 392001 Shinjuku-Ku, Japan Investigational Site Number 392008 Shinjuku-Ku, Japan Investigational Site Number 392012 Shizuoka-Shi, Japan Investigational Site Number 392002 Suita-Shi, Japan Investigational Site Number 392031 Suita-Shi, Japan Investigational Site Number 392020 Toyonaka-Shi, Japan Investigational Site Number 392022 Yao-Shi, Japan 收起 << |
NCT02501200 | Healthy | Phase 1 | Completed | - | - |
NCT01350141 | - | Completed | - | - | |
NCT02584504 | - | Completed | - | - | |
NCT02461004 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> The Korea University Anam Hospital Seoul, Korea, Republic of 收起 << |
NCT00760786 | Acute Coronary Syndrome | Not Applicable | Unknown | - | Korea, Republic of ... 展开 >> Cardiac and Vascular Center; Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Hyeon-Cheol Gwon, Professor 82234103419 hc.gwon@samsung.com 收起 << |
NCT01569867 | - | Recruiting | March 2022 | United States, Ohio ... 展开 >> The Ohio State University Medical Center Recruiting Columbus, Ohio, United States, 43210 Principal Investigator: Joseph P Kitzmiller, MD PhD Sub-Investigator: Wolfgang Sadee, Dr rer nat Sub-Investigator: Mitch Phelps, PhD Sub-Investigator: Rebecca Jackson, MD 收起 << | |
NCT01569854 | - | Withdrawn(Insufficient recruit... 展开 >>ment) 收起 << | March 2022 | United States, Ohio ... 展开 >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 收起 << | |
NCT02938949 | Myocardial Infarction ... 展开 >> Hypercholesterolemia 收起 << | Phase 4 | Active, not recruiting | December 2018 | United States, Virginia ... 展开 >> Virginia Commonwealth University Richmond, Virginia, United States, 23298 收起 << |
NCT00201552 | Paroxysmal Atrial Fibrillation | Not Applicable | Unknown | - | Taiwan ... 展开 >> National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Chia-Ti Tsai Principal Investigator: Chia-Ti Tsai, MD 收起 << |
NCT00559962 | Hyperlipidemia | Phase 2 | Completed | - | United States, California ... 展开 >> Scripps Clinic San Diego, California, United States, 92128 Radiant Research Santa Rosa, California, United States, 95405 United States, District of Columbia MedStar Research Institute Washington, District of Columbia, United States, 20003 United States, Illinois Radiant Research Chicago, Illinois, United States, 60610 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Kentucky LMARC Louisville, Kentucky, United States, 40213 United States, Maine Maine Research Associates Auburn, Maine, United States, 04210 United States, Maryland Health Trends Research Baltimore, Maryland, United States, 21209 Johns Hopkins Baltimore, Maryland, United States, 21287 United States, Missouri Washington Univ. School of Medicine Saint Louis, Missouri, United States, 63110 United States, Ohio Sterling Research Group Cincinnati, Ohio, United States, 45219 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Clinical Trial Network Houston, Texas, United States, 77074 dgd Research San Antonio, Texas, United States, 78229 收起 << |
NCT02001883 | Coronary Artery Disease | Phase 4 | Unknown | December 2015 | Italy ... 展开 >> University Sapienza Recruiting Rome, Please Select, Italy, 00161 Contact: FRANCESCO PELLICCIA f.pelliccia@mclink.it 收起 << |
NCT01856374 | Multi-vessel Diseases, Angina | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Severance Hospital Seoul, Korea, Republic of, 120-752 收起 << |
NCT00973271 | Hypertriglyceridemia | Phase 3 | Withdrawn(Did not continue wit... 展开 >>h development of DCCR in Very High Triglycerides) 收起 << | - | - |
NCT02714569 | Dyslipidemias | Phase 1 | Completed | - | United States, Florida ... 展开 >> Clinical Pharmacology of Miami, Inc. Miami, Florida, United States, 33014 United States, Kansas PRA Health Sciences Lenexa, Kansas, United States, 06219 United States, New Jersey PRA Health Sciences Marlton, New Jersey, United States, 08053 United States, Utah PRA Health Sciences Salt Lake City, Utah, United States, 84106 收起 << |
NCT00017758 | HIV Infections ... 展开 >> HIV Seronegativity Lipodystrophy 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> Stanford Univ Med Ctr Stanford, California, United States, 943055107 United States, Colorado Univ of Colorado Health Sciences Ctr Denver, Colorado, United States, 80262 United States, Maryland Johns Hopkins Hosp Baltimore, Maryland, United States, 21287 United States, Minnesota Univ of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington Univ / St Louis Connect Care Saint Louis, Missouri, United States, 63108 Washington Univ School of Medicine St Louis, Missouri, United States, 63108 United States, New York Univ of Rochester Medical Center Rochester, New York, United States, 14642 United States, Ohio Univ of Cincinnati Cincinnati, Ohio, United States, 452670405 United States, Pennsylvania Univ of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Washington Univ of Washington Seattle, Washington, United States, 98104 收起 << |
NCT03372785 | Chronic Total Occlusion of Cor... 展开 >>onary Artery Percutaneous Coronary Intervention Coronary Artery Disease Viable Myocardium 收起 << | Phase 4 | Enrolling by invitation | December 2020 | China ... 展开 >> Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University Beijing, China 收起 << |
NCT02133807 | Atherosclerosis ... 展开 >> Coronary Disease Carotid Artery Diseases 收起 << | Phase 3 | Completed | - | Russian Federation ... 展开 >> Russian Cardiology Research and Production Center Moscow, Russian Federation, 121552 收起 << |
NCT00850460 | Statin Adverse Reaction | Phase 4 | Terminated(Investigator left i... 展开 >>nstitution and no PI has been found to continue the study) 收起 << | - | United States, New York ... 展开 >> Rockefeller University New York, New York, United States, 10065 收起 << |
NCT00850460 | - | Terminated(Investigator left i... 展开 >>nstitution and no PI has been found to continue the study) 收起 << | - | - | |
NCT00449410 | Atrial Fibrillation ... 展开 >> Neuropsychology Magnetic Resonance Imaging Inflammation Hemostasis 收起 << | Phase 4 | Completed | - | Netherlands ... 展开 >> Gheorghe AM Pop Nijmegen, Netherlands, 6500 HB 收起 << |
NCT01634906 | Hyperlipidemia ... 展开 >> Atherosclerosis 收起 << | Not Applicable | Completed | - | Netherlands ... 展开 >> Sint Franciscus Gasthuis Rotterdam, Zuid Holland, Netherlands, 3004 BA 收起 << |
NCT00651560 | Hyperlipidemia | Phase 3 | Completed | - | - |
NCT03289429 | Arrhythmias | Phase 4 | Recruiting | February 2018 | Egypt ... 展开 >> Assiut University Recruiting Assiut, Egypt, 71515 Contact: Fatma N. Mohamed, M.Sc. +201003633992 fatmanabil2012@gmail.com Contact: Esam Eldin M. Abdallah, M.D. esamel_deen@yahoo.com Principal Investigator: Fatma N. Mohamed, M.Sc. Principal Investigator: Esam Eldin M. Abdallah, M.D. Principal Investigator: Abdelrady S. Ibrahim, M.D. Principal Investigator: Ahmed El-Minshawy, M.D. 收起 << |
NCT00529542 | - | Completed | - | - | |
NCT00355251 | HIV Infections | Phase 4 | Terminated(On the basis of pub... 展开 >>lished results of SMART study, it has been observed that the results are worse in patients who have interrupted their treatments.) 收起 << | - | Spain ... 展开 >> Germans Trias i Pujol Hospital Badalona, Barcelona, Spain, 08916 收起 << |
NCT00653744 | Hypercholesterolemia ... 展开 >> Dyslipidaemia 收起 << | Phase 3 | Completed | - | - |
NCT01617772 | Non-alcoholic Steatohepatitis | Phase 2 | Recruiting | December 2019 | Iran, Islamic Republic of ... 展开 >> Pars Cohort Center Active, not recruiting Shiraz, Fars, Iran, Islamic Republic of Masoud Clinic Recruiting Tehran, Iran, Islamic Republic of, 14117 Contact: Shahin Merat +989171173966 shahin.merat@gmail.com 收起 << |
NCT02114346 | Contrast-Induced Nephropathy | Phase 2 Phase 3 | Completed | - | Iran, Islamic Republic of ... 展开 >> Alzahra Hospital Isfahan, Iran, Islamic Republic of 收起 << |
NCT00490698 | Kidney Cancer ... 展开 >> Renal Cell Carcinoma 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00559962 | - | Completed | - | - | |
NCT01126684 | Hypertension ... 展开 >>Hypercholesterolemia 收起 << | Not Applicable | Completed | - | Greece ... 展开 >> AHEPA University Hospital of Thessaloniki Thessaloniki, Greece, 54636 收起 << |
NCT00490698 | - | Completed | - | - | |
NCT02579499 | Coronary Artery Diseasse | Phase 4 | Recruiting | March 2022 | Korea, Republic of ... 展开 >> Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 120-752 Contact: MYEONG-KI HONG, MD, Ph.D 82-2-2228-8460 MKHONG61@yuhs.ac 收起 << |
NCT00299884 | - | Completed | - | Canada, Ontario ... 展开 >> Vascular Disease Prevention and Research Centre, Hotel Dieu Hospital Kingston, Ontario, Canada, K7L 5G2 收起 << | |
NCT01648829 | Coronary Artery Disease | Phase 4 | Unknown | December 2017 | Italy ... 展开 >> Sapienza University Not yet recruiting Rome, Italy, 00166 Contact: Francesco Pelliccia, MD +39064997 ext 123 f.pelliccia@mclink.it Principal Investigator: Francesco Pelliccia, MD 收起 << |
NCT01974544 | Type 2 Diabetes | Not Applicable | Unknown | December 2016 | Chile ... 展开 >> Pontificia Universidad Católica de Chile Recruiting Santiago, Región Metropolitana, Chile, 8330033 Contact: Castillo Alejandra, Nurse 56223543527 macastia@uc.cl Contact: Vega Andrea, Nurse 56223543879 abvega@uc.cl Principal Investigator: Boza Camilo, MD surgeon Sub-Investigator: Valderas Juan Patricio, MD Sub-Investigator: Arrese Marco, MD Internist Sub-Investigator: Muñoz Rodrigo, MD 收起 << |
NCT02767401 | Hibernation, Myocardial ... 展开 >> Complete Occlusion of Coronary Artery 收起 << | Phase 4 | Unknown | December 2018 | - |
NCT01644188 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00113477 | Statin Therapy | Phase 4 | Completed | - | Norway ... 展开 >> Lipidklinikken, Rikshospitalet Oslo, Norway, 0027 收起 << |
NCT01644188 | - | Completed | - | - | |
NCT01563731 | Stroke Transi... 展开 >>ent Ischemic Attack Hypertension 收起 << | Phase 4 | Recruiting | November 2018 | Russian Federation ... 展开 >> Almazov Federal Heart, Blood and Endocrinology Centre Recruiting Saint-Petersburg, Russian Federation, 197341 收起 << |
NCT00081731 | Atherosclerosis ... 展开 >> Cardiovascular Diseases Hypertension, Renovascular Renal Artery Obstruction 收起 << | Phase 3 | Completed | - | United States, Ohio ... 展开 >> University of Toledo Toledo, Ohio, United States, 43614 收起 << |
NCT00081731 | - | Completed | - | - | |
NCT00150943 | Renal Artery Obstruction ... 展开 >> Kidney Failure 收起 << | Phase 3 | Completed | - | Netherlands ... 展开 >> UMC Utrecht Utrecht, Netherlands, 3584 CX 收起 << |
NCT01455935 | Stroke | Phase 2 | Unknown | February 2014 | United States, New York ... 展开 >> Millard Fillmore Gates Circle Hospital Recruiting Buffalo, New York, United States, 14209 Contact: Annemarie Crumlish 716-887-5548 acrumlish@thejni.org Principal Investigator: Tareq Kass-Hout, MD Principal Investigator: Elad Levy, MD Sub-Investigator: Adnan H Siddiqui, MD,PhD Sub-Investigator: Kenneth V Snyder, MD, PhD Sub-Investigator: L N Hopkins, MD Sub-Investigator: Robert N Sawyer, MD Sub-Investigator: Marilou Ching, MD Sub-Investigator: David Janicke, MD 收起 << |
NCT00256750 | - | Completed | - | - | |
NCT01047501 | Hypertriglyceridemia | Phase 3 | Completed | - | - |
NCT00256750 | Kidney Transplantation ... 展开 >> Chronic Kidney Failure 收起 << | Phase 3 | Completed | - | - |
NCT01890967 | Hypercholesterolemia | Phase 2 | Completed | - | - |
NCT01890967 | - | Completed | - | - | |
NCT03610217 | Scleroderma, Systemic ... 展开 >> Sclerosis, Systemic 收起 << | Not Applicable | Not yet recruiting | October 2021 | Canada, Ontario ... 展开 >> Saint Joseph's Health Care London Not yet recruiting London, Ontario, Canada, n6a 4v2 Contact: Janet E Pope, MD, MPH, FRCPSC 15196466332 Janet.Pope@sjhc.london.on.ca Contact: Andreu Fernandez-Codina 151964661023 doccodina@gmail.com 收起 << |
NCT01318564 | - | Completed | - | United States, Texas ... 展开 >> Kelsey Seybold Clinics Houston, Texas, United States, 77025 University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << | |
NCT01492361 | Cardiovascular Diseases | Phase 3 | Completed | - | - |
NCT00532311 | Hypercholesterolemia | Phase 3 | Terminated(Overall profile of ... 展开 >>the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents) 收起 << | - | - |
NCT02207634 | Dyslipidemia | Phase 3 | Completed | - | - |
NCT03133260 | - | Recruiting | December 31, 2019 | Spain ... 展开 >> Hospital Del Mar Recruiting Barcelona, Spain, 08003 Contact: Sandra Beltran, MD 0034932483350 94451@parcdesalutmar.cat 收起 << | |
NCT01047683 | Hypertriglyceridemia | Phase 3 | Completed | - | - |
NCT02207634 | - | Completed | - | - | |
NCT02072161 | Hypercholesterolemia | Phase 2 | Completed | - | - |
NCT03510715 | Hypercholesterolemia | Phase 3 | Recruiting | June 2020 | United States, California ... 展开 >> Investigational Site Number 8400004 Recruiting Los Angeles, California, United States, 90027 Austria Investigational Site Number 0400001 Recruiting Wien, Austria, 1090 Brazil Investigational Site Number 0760001 Recruiting Sao Paulo, Brazil, 05403-000 Canada Investigational Site Number 1240002 Recruiting Montreal, Canada, H3T 1C5 Investigational Site Number 1240001 Recruiting Quebec, Canada, G1V 4W2 Denmark Investigational Site Number 2080001 Recruiting Viborg, Denmark, 8800 France Investigational Site Number 2500001 Recruiting Bron Cedex, France, 69677 Italy Investigational Site Number 3800001 Recruiting Palermo, Italy, 90127 Mexico Investigational Site Number 4840006 Recruiting Oaxaca, Mexico, 68000 Netherlands Investigational Site Number 5280001 Recruiting Amsterdam, Netherlands, 1105 AZ Norway Investigational Site Number 5780001 Recruiting Oslo, Norway, 0373 Russian Federation Investigational Site Number 6430002 Recruiting Kemerovo, Russian Federation, 650002 Slovenia Investigational Site Number 7050001 Recruiting Ljubljana, Slovenia, 1000 Spain Investigational Site Number 7240001 Recruiting A Coruna, Spain, 15001 Taiwan Investigational Site Number 1580001 Recruiting Taipei, Taiwan, 112 Turkey Investigational Site Number 7920002 Recruiting Ankara, Turkey, 06500 Investigational Site Number 7920001 Recruiting Izmir, Turkey, 35040 收起 << |
NCT03510884 | Hypercholesterolaemia | Phase 3 | Recruiting | March 2022 | - |
NCT02107898 | Hypercholesterolemia | Phase 3 | Completed | - | Japan ... 展开 >> Investigational Site Number 392016 Adachi-Ku, Japan Investigational Site Number 392029 Adachi-Ku, Japan Investigational Site Number 392024 Aki-Gun, Japan Investigational Site Number 392012 Chuo-Ku, Japan Investigational Site Number 392013 Chuo-Ku, Japan Investigational Site Number 392032 Fukui-Shi, Japan Investigational Site Number 392004 Hakusan-Shi, Japan Investigational Site Number 392028 Kaga-Shi, Japan Investigational Site Number 392002 Kanazawa-Shi, Japan Investigational Site Number 392005 Kanazawa-Shi, Japan Investigational Site Number 392023 Kawanishi-Shi, Japan Investigational Site Number 392009 Kisarazu-Shi, Japan Investigational Site Number 392026 Kitakyushu-Shi, Japan Investigational Site Number 392003 Komatsu-Shi, Japan Investigational Site Number 392011 Kuki-Shi, Japan Investigational Site Number 392017 Matsumoto-Shi, Japan Investigational Site Number 392007 Mito-Shi, Japan Investigational Site Number 392006 Moriya-Shi, Japan Investigational Site Number 392018 Nagoya-Shi, Japan Investigational Site Number 392014 Oota-Ku, Japan Investigational Site Number 392019 Osaka-Shi, Japan Investigational Site Number 392020 Osaka-Shi, Japan Investigational Site Number 392022 Osaka-Shi, Japan Investigational Site Number 392030 Osaka-Shi, Japan Investigational Site Number 392027 Oyabe-Shi, Japan Investigational Site Number 392010 Saitama-Shi, Japan Investigational Site Number 392015 Shinjuku-Ku, Japan Investigational Site Number 392031 Shizuoka-Shi, Japan Investigational Site Number 392021 Suita-Shi, Japan Investigational Site Number 392025 Takamatsu-Shi, Japan Investigational Site Number 392008 Tsuchiura-Shi, Japan Investigational Site Number 392001 Yamagata-Shi, Japan 收起 << |
NCT02107898 | - | Completed | - | - | |
NCT01507831 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT01617655 | Hypercholesterolaemia | Phase 3 | Completed | - | - |
NCT00132717 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT01617655 | - | Completed | - | - | |
NCT01644175 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT01623115 | - | Completed | - | - | |
NCT02289963 | Hypercholesterolemia | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Investigational Site Number 410009 Anyang-Si, Korea, Republic of, 431-070 Investigational Site Number 410001 Anyang, Korea, Republic of, 431-070 Investigational Site Number 410017 Busan, Korea, Republic of, 602-715 Investigational Site Number 410007 Busan, Korea, Republic of, 614-735 Investigational Site Number 410002 Daegu, Korea, Republic of, 700-712 Investigational Site Number 410011 Goyang-Si, Korea, Republic of, 410-773 Investigational Site Number 410003 Gwangju, Korea, Republic of, 501-757 Investigational Site Number 410012 Incheon, Korea, Republic of, 405-760 Investigational Site Number 410018 Jeonju-Si, Korea, Republic of, 561-712 Investigational Site Number 410006 Seoul, Korea, Republic of, 06591 Investigational Site Number 410004 Seoul, Korea, Republic of, 07061 Investigational Site Number 410015 Seoul, Korea, Republic of, 08308 Investigational Site Number 410008 Seoul, Korea, Republic of, 110-746 Investigational Site Number 410005 Seoul, Korea, Republic of, 134-727 Investigational Site Number 410010 Seoul, Korea, Republic of, 152-703 Investigational Site Number 410013 Ulsan, Korea, Republic of Taiwan Investigational Site Number 158007 Changhua, Taiwan, 500 Investigational Site Number 158005 Hsinchu, Taiwan, 30071 Investigational Site Number 158011 Kaohsiung, Taiwan, 807 Investigational Site Number 158010 Kaohsiung, Taiwan, 833 Investigational Site Number 158006 Taichung, Taiwan Investigational Site Number 158009 Tainan Hsien, Taiwan, 710 Investigational Site Number 158008 Tainan, Taiwan, 704 Investigational Site Number 158001 Taipei, Taiwan, 100 Investigational Site Number 158003 Taipei, Taiwan, 104 Investigational Site Number 158002 Taipei, Taiwan, 112 Investigational Site Number 158004 Taoyuan Hsien, Taiwan 收起 << |
NCT02289963 | - | Completed | - | - | |
NCT01507831 | - | Completed | - | - | |
NCT00687076 | Peripheral Arterial Disease | Phase 4 | Completed | - | United States, Texas ... 展开 >> Baylor College of Medicine Houston, Texas, United States, 77030 收起 << |
NCT02819869 | Hepatocellular Carcinoma | Phase 2 | Terminated(insufficient for th... 展开 >>e fund) 收起 << | - | Taiwan ... 展开 >> Taipei Medical University - WanFang Hospital Taipei, Taiwan 收起 << |
NCT00687076 | - | Completed | - | - | |
NCT01623115 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT03207698 | Furcation Defects | Phase 2 Phase 3 | Completed | - | India ... 展开 >> Government Dental College and Research Institute Bangalore, Karnataka, India, 560002 收起 << |
NCT01926782 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT02363725 | Acute Myocardial Infarction | Phase 2 | Completed | - | France ... 展开 >> University Hospital Arnaud de Villeneuve Montpellier, France, 34295 收起 << |
NCT01686230 | Angina, Stable | Not Applicable | Unknown | July 2017 | China, Sichuan ... 展开 >> Chengdu University of Traditional Chinese Medicine Recruiting Chengdu, Sichuan, China, 610075 Contact: hui zhen, doctor 0086-13518137928 30103752@qq.com Contact: de-hua h li, doctor 0086-18980079361 si_ff@163.com 收起 << |
NCT03061487 | - | Recruiting | April 27, 2018 | Italy ... 展开 >> University Magna Graecia of Catanzaro Recruiting Catanzaro, Italy, 88100 Contact: Raffaele Serra, M.D., Ph.D. +3909613647380 rserra@unicz.it Sub-Investigator: Stefano de Franciscis, M.D. Sub-Investigator: Luca Gallelli, M.D.; Ph.D 收起 << | |
NCT01644175 | - | Completed | - | - | |
NCT02323425 | Stroke | Not Applicable | Recruiting | March 2018 | China, Shaanxi ... 展开 >> The First Affiliated Hospital of Xi'an Jiaotong University Recruiting Xi'an, Shaanxi, China, 710061 Contact: Meng Wei, graduate +8613572516964 67183723@qq.com Contact: GuoGang Luo, M.D/Ph.D +8618991232449 lguogang@163.com Principal Investigator: GuoGang Luo, M.D/Ph.D Principal Investigator: XunMing Ji, M.D/Ph.D 收起 << |
NCT03411291 | - | Completed | - | United States, California ... 展开 >> Cedars-Sinai Medical Center, S. Mark Taper Foundation Imaging Center Los Angeles, California, United States, 90048 收起 << | |
NCT02539810 | Hypertension ... 展开 >>Hypertension Resistant to Conventional Therapy Angiographically Proven Grade III Unilateral or Bilateral Atherosclerotic Renal Artery Stenosis (ARAS) Greater Than or Equal to 60 Percent 收起 << | Phase 4 | Terminated | - | France ... 展开 >> Hopital Pasteur Nice, Alpes-Maritimes, France, 06002 Hopital Saint Andre - CHU Bordeaux Bordeaux, Gironde, France, 33075 Hopital Rangueil - CHU Toulouse Toulouse, Haute-Garonne, France, 31059 Hopital Lapeyronie - CHU Montpellier Montpellier, Herault, France, 34295 Hopital Arthur Gardiner Dinard, Ille-et-Vilaine, France, 35800 Hopital Pontchaillou - CHU Rennes Rennes, Ille-et-Vilaine, France, 35033 Groupe Hospitalier Mutualiste Grenoble, Isere, France, 38028 Hopital Michallon - CHU Grenoble La Tronche, Isere, France, 38700 Institut Lorrain du Cœur et des Vaisseaux Louis Mathieu Vandoeuvre les Nancy, Meurthe-et-Moselle, France, 54500 Hopital de Brabois Vandoeuvre les Nancy, Meurthe-et-Moselle, France, 54511 Hopital Cardiologique - CHRU Lille Lille, Nord, France, 59037 CHU Clermont-Ferrand Clermont-Ferrand, Puy-de-Dome, France, 63000 Hopital de la Croix-Rousse - CHU Lyon Lyon, Rhone, France, 69004 Hopital de la Pitie Salpetriere Paris, France, 75013 Hopital Europeen Georges Pompidou (HEGP) Paris, France, 75015 收起 << |
NCT00639080 | - | Completed | - | Canada, British Columbia ... 展开 >> Endocrine Research Society Vancouver, British Columbia, Canada, V6E 1M7 收起 << | |
NCT00332761 | Hypertension ... 展开 >>Dyslipidemia 收起 << | Phase 4 | Completed | - | - |
NCT02357212 | Acute Coronary Syndrome | Not Applicable | Completed | - | - |
NCT03218293 | Acute Ischemic Stroke, Cerebra... 展开 >>l Embolism and Thrombosis 收起 << | Not Applicable | Recruiting | June 30, 2020 | China ... 展开 >> The First Affiliated Hospital of Xi'an Jiaotong University Recruiting Xi'an, China, 710061 Contact: Guogang Luo, Ph.D. 86-13991974085 收起 << |
NCT01926782 | - | Completed | - | - | |
NCT01259791 | Statin Myopathy | Not Applicable | Completed | - | Canada, Ontario ... 展开 >> St. Joseph's Health Care London, Ontario, Canada, N6A 4V2 收起 << |
NCT03127631 | Prostate Cancer ... 展开 >> Cardiovascular Disease 收起 << | Not Applicable | Recruiting | September 2020 | Canada, British Columbia ... 展开 >> Vancouver General Hospital Active, not recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Canada, Ontario William Osler Health System Recruiting Brampton, Ontario, Canada, L6R 3J7 Contact: Achal Sharma achal.sharma@williamoslerhs.ca Principal Investigator: Dr. Tamara Wallington, MD,FRCPC St. Joseph's Healthcare Recruiting Hamilton, Ontario, Canada, L8N4A6 Contact: Aishwarya Sudakaran sudakaran@hhsc.ca Principal Investigator: Dr. Bobby Shayegan, MD,FRCSC Juravinski Cancer Centre Recruiting Hamilton, Ontario, Canada, L8V1C3 Contact: Amanda Thiessen thiessena@hhsc.ca Principal Investigator: Dr. Jehonathan Pinthus, MD,FRCS(C),PhD Queen's University Recruiting Kingston, Ontario, Canada, K7L 3J7 Contact: Wendy Anstey, RN wendy.anstey@krcc.on.ca Principal Investigator: Dr. Robert Siemens, MD,FRCSC Grand River Hospital, Grand River Regional Cancer Centre Recruiting Kitchener, Ontario, Canada, N2G 1G3 Contact: Elyse Wellhauser Elyse.Wellhauser@grhosp.on.ca Principal Investigator: Darin Gopaul, MD London Health Sciences Centre Recruiting London, Ontario, Canada, N6A 5W9 Contact: Mounirah May mounirah.may@lhsc.ca Principal Investigator: Dr. Patrick Luke, MD,FRCSC London Health Sciences, Victoria Hospital Recruiting London, Ontario, Canada, N6A 5W9 Contact: Amanda Anderson Amanda.Anderson@lhsc.on.ca Principal Investigator: Joseph Chin, MD, FRCSC Niagara Health, St. Catharines Site Active, not recruiting Niagara, Ontario, Canada, L2S 0A9 Ottawa Hospital Research Institute Recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: Christopher Knee, ND, MSc cknee@ohri.ca Principal Investigator: Dr. Luke Lavallee, MDCM,MSc,FRCSC Sunnybrook Health Sciences Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Marlene Kebabdjian marlene.kebabdjian@sunnybrook.ca Principal Investigator: Dr. Laurence Klotz, MD,FRCS(C) University Health Network, Princess Margaret Cancer Centre Active, not recruiting Toronto, Ontario, Canada, M5G 2C1 Canada, Quebec University Hospital of Montreal Recruiting Montreal, Quebec, Canada, H2X 0A9 Contact: Roberta Carling roberta-daila.carling.chum@ssss.gouv.qc.ca Principal Investigator: Dr. Emmanuelle Duceppe, MD,FRCPC Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T 1E2 Contact: Amandine Laffitte amandine.laffitte.ccomtl@ssss.gouv.qc.ca Principal Investigator: Dr. Tamim Niazi, MDCM McGill University Active, not recruiting Montréal, Quebec, Canada, H3A 0G4 Laval University Recruiting Quebec City, Quebec, Canada, G1V 0A6 Contact: Denise St-Onge denise.st-onge@crchudequebec.ulaval.ca Principal Investigator: Dr. Vincent Fradet, MD,PhD,FRCSC 收起 << |
NCT00457405 | Ischemia-Reperfusion Injury ... 展开 >> Atherosclerosis 收起 << | Phase 4 | Completed | - | Netherlands ... 展开 >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500HB 收起 << |
NCT02800174 | Carotid Artery Stenosis | Not Applicable | Completed | - | - |
NCT01588795 | Diabetic Nephropathy ... 展开 >> Persistent Proteinuria With Type II Diabetes 收起 << | Phase 4 | Completed | - | France ... 展开 >> CIC Hopital europeen george pompidou Paris, France, 75015 收起 << |
NCT01954394 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00079638 | Dyslipidemia ... 展开 >>Coronary Heart Disease Atherosclerosis Stroke Diabetes 收起 << | Phase 4 | Completed | - | - |
NCT01954394 | - | Completed | - | - | |
NCT00379418 | - | Completed | - | United States, Georgia ... 展开 >> Atlanta VA Medical Center Atlanta, Georgia, United States, 30033 Emory University Hospital Atlanta, Georgia, United States, 30322 收起 << | |
NCT03318484 | Peripheral Arterial Disease ... 展开 >> Atherosclerosis Cardiovascular Diseases 收起 << | Phase 1 Phase 2 | Not yet recruiting | November 2019 | - |
NCT00868127 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT01925079 | Acute Coronary Syndrome | Not Applicable | Unknown | June 2015 | China, Fujian ... 展开 >> Fujian Medical University Union Hospital Not yet recruiting Fuzhou, Fujian, China Principal Investigator: Ziliang Chen, Professor China, Heilongjiang The 2nd affiliated hospital of harbin medical university Not yet recruiting Harbin, Heilongjiang, China, 150001 Principal Investigator: Bo Yu, Professor China, Shanxi Xi'an Jiaotong University College of Medicine Not yet recruiting Xi'an, Shanxi, China, 710061 Principal Investigator: Zhuyi Yuan, Professor China The Luhe Teaching Hospital of the Capital Medical University Not yet recruiting Beijing, China Principal Investigator: Jincheng Guo, Professor Shanghai Zhongshan Hospital Not yet recruiting Shanghai, China, 200032 Principal Investigator: Junbo Ge, Professor 收起 << |
NCT03370705 | Peripheral Arterial Obstructiv... 展开 >>e Disease 收起 << | Phase 3 | Not yet recruiting | March 30, 2019 | Tunisia ... 展开 >> InvSite Poseidon0031 Not yet recruiting Sfax, Tunisia, 3000 Contact: Nizar Elleuche, MD nelleuche@yahoo.com Sub-Investigator: Nizar Elleuche, MD Principal Investigator: Imed Frikha, MD InvSite Poseidon 0022 Not yet recruiting Sousse, Tunisia, 4000 Contact: Sofiene Jerbi, MD jerbisofiane@yahoo.fr Principal Investigator: Sofiene Jerbi, MD InvSite Poseidon0011 Not yet recruiting Tunis, Tunisia, 1006 Contact: Melek Ben Mrad, MD benmradmelek@yahoo.fr Principal Investigator: Raouf Denguir, MD Sub-Investigator: Melek Ben Mrad, MD 收起 << |
NCT00251680 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT03504735 | Metabolic Syndrome | Phase 4 | Completed | - | - |
NCT00673660 | - | Completed | - | Turkey ... 展开 >> Pfizer Investigational Site Mecidiyekoy, Istanbul, Turkey, 34394 Pfizer Investigational Site Bolu, Turkey Pfizer Investigational Site Haseki/Istanbul, Turkey, 34390 Pfizer Investigational Site Istanbul, Turkey, 34098 Pfizer Investigational Site Istanbul, Turkey 收起 << | |
NCT01558245 | Cerebrovascular Disease | Phase 2 | Unknown | December 2013 | China, Jiangsu ... 展开 >> Department of Neurology, Jinling Hospital, Nanjing University School of Medicine Recruiting Nanjing, Jiangsu, China Contact: Renliang Zhang, MD + 86-25-8480386 zhangrenliang@gmail.com 收起 << |
NCT03703635 | Intracranial Artery Stenosis | Phase 3 | Not yet recruiting | December 2023 | China, Beijing ... 展开 >> Beijing Tian Tan Hospital, Capital Medical University Not yet recruiting Beijing, Beijing, China, 100070 Contact: Zhongrong Miao, MD Principal Investigator: Zhongrong Miao, MD 收起 << |
NCT00673660 | - | Completed | - | - | |
NCT00691314 | Stroke Transi... 展开 >>ent Ischemic Attack Atherosclerosis Stenosis Stents 收起 << | Not Applicable | Completed | - | China, Beijing ... 展开 >> Beijing Tiantan Hospital Beijing, Beijing, China, 100050 Xuanwu Hospital Capital Medical University Beijing, Beijing, China, 100053 Peking Union Medical College Hospital Beijing, Beijing, China, 100730 China, Chongqing Southwest Hospital Chongqing, Chongqing, China, 400038 Daping Hospital Chongqing, Chongqing, China, 400042 China, Jiangsu Nanjing General Hospital of Nanjing Military Command Nanjing, Jiangsu, China, 210002 China, Jilin Jilin University Changchun, Jilin, China, 130021 China, Shanghai Huashan Hospital Fudan University Shanghai, Shanghai, China, 200040 China, Sichuan West China Center of Medical Sciences Chengdu, Sichuan, China, 610041 China, Tianjin The General Hospital Under Tianjin Medical Sciences University Tianjin, Tianjin, China, 300052 收起 << |
NCT01702987 | - | Completed | - | - | |
NCT00986583 | Pain | Not Applicable | Completed | - | United States, Ohio ... 展开 >> Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 收起 << |
NCT00986583 | - | Completed | - | - | |
NCT03770702 | Rheumatoid Arthritis | Phase 3 | Recruiting | December 1, 2026 | Egypt ... 展开 >> Sherief Abd-Elsalam Recruiting Tanta, Egypt, 35111 Contact: Ahmed El-Abd, Msc 收起 << |
NCT00023231 | End-Stage Renal Disease | Not Applicable | Completed | - | United States, Maryland ... 展开 >> Lauren Schenker Rockville, Maryland, United States, 20850 收起 << |
NCT00396721 | Glomerulonephritis, IGA ... 展开 >> Nephropathy, IGA IGA Nephropathy 收起 << | Phase 2 | Completed | - | Spain ... 展开 >> Nephrology Department. Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain, 08907 收起 << |
NCT01748279 | COPD | Phase 4 | Completed | - | Poland ... 展开 >> Department of Lung Diseases and Tuberculosis, Medical University of Bialystok Bialystok, Poland, 15-540 收起 << |
NCT00640744 | Atherosclerosis | Phase 4 | Unknown | February 2010 | United States, Texas ... 展开 >> Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Joel D Morrisett, PhD 713-798-4164 morriset@bcm.tmc.edu Contact: Addison Taylor, MD/PhD 713-798-4721 ataylor@bcm.tmc.edu Principal Investigator: Joel D Morrisett, PhD 收起 << |
NCT02243098 | Diabetes Heal... 展开 >>thy 收起 << | Phase 1 | Completed | - | Germany ... 展开 >> Novo Nordisk Investigational Site Berlin, Germany, 14050 收起 << |
NCT00665834 | Dyslipidemia ... 展开 >>Acute Coronary Syndromes 收起 << | Phase 4 | Completed | - | Canada, Ontario ... 展开 >> Kingston General Hospital Kingston, Ontario, Canada, K7L 2V7 Vascular Disease Prevention and Research Centre, Hotel Dieu Hospital Kingston, Ontario, Canada, K7L 5G2 收起 << |
NCT00080587 | - | Completed | - | United States, Maryland ... 展开 >> National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States, 20892 收起 << | |
NCT01185236 | Type 2 Diabetes Mellitus Witho... 展开 >>ut Insulin Treatment 收起 << | Phase 4 | Unknown | August 2011 | Korea, Republic of ... 展开 >> Seoul national university hospital Not yet recruiting Seoul, Korea, Republic of, 110744 Principal Investigator: Hyun-Jae Kang 收起 << |
NCT00143676 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT02587416 | Hypercholesteremia | Phase 1 | Completed | - | - |
NCT00487994 | Dyslipidemia | Phase 3 | Completed | - | - |
NCT00143741 | End-Stage Kidney Disease | Phase 1 | Completed | - | United States, Illinois ... 展开 >> The University of Chicago Chicago, Illinois, United States, 60637 收起 << |
NCT02069821 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Chungnam national university hospital Daejeon, Jung-gu, Korea, Republic of, 301-721 收起 << |
NCT01780740 | Disorder; Heart, Functional, P... 展开 >>ostoperative, Cardiac Surgery Cardiac Insufficiency Following Cardiac Surgery Atrial Fibrillation Ischaemia-reperfusion Injury 收起 << | Phase 4 | Completed | - | United Kingdom ... 展开 >> Oxford University Hospitals NHS trust Oxford, Oxfordshire, United Kingdom, OX3 9DU 收起 << |
NCT02416427 | Breast Neoplasms | Phase 2 | Unknown | December 2016 | - |
NCT02842359 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Korea Seoul, Korea, Republic of 收起 << |
NCT00368589 | - | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 2GG 收起 << | |
NCT01222182 | - | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 收起 << | |
NCT02113540 | Contrast Induced Nephropathy | Phase 3 | Unknown | - | Iran, Islamic Republic of ... 展开 >> Recruiting Isfahan, Iran, Islamic Republic of Contact: payman bidram, resident, MD 0989131102802 pbidram2000@yahoo.com 收起 << |
NCT01073800 | Myocardial Infarction ... 展开 >> Stroke Renal Failure 收起 << | Phase 2 Phase 3 | Completed | - | Canada, Alberta ... 展开 >> University of Alberta Edmonton, Alberta, Canada, T6G 2B7 收起 << |
NCT02781064 | Cardiovascular Disease | Phase 4 | Recruiting | October 31, 2019 | - |
NCT01702987 | Myopathy HMG ... 展开 >>COA Reductase Inhibitor Adverse Reaction Hypercholesterolemia 收起 << | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 收起 << |
NCT00024531 | Alzheimer Disease | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Sun Health Research Institute Sun City, Arizona, United States, 85351 收起 << |
尊敬的 Ambeed 客户您好,
请您选择所在区域,我们将转接对应客服为您服务!